Performance Report 2013
Department of Pathophysiology &
Allergy Research
Center of Pathophysiology, Infectiology and Immunology
Medical University Vienna
Coordinated by:
Marion Sack
Content Page
Introduction 3
Organigram 6
Personnel 9
Impulsseminare 10
1. Detailed Reports of Divisions 11
1.1. Division for Comparative Immunology and Oncology 11
1.2. Division for Cellular and Molecular Pathophysiology 38
1.3. Division for Immunopathology 61
1.4. Division for Medical Biotechnology 84
1.5. Division for Allergy Research 103
Rooms 114
Social Events 115
3
Chance only favours the prepared mind.
Louis Pasteur __________________________________________________________________________
This report shall give a detailed overview on the scientific and academic achievements of the
Institute of Pathophysiology and Allergy Research (IPA). In view of the more and more
restricted funding and the reduction of personnel it is more and more difficult to keep our
output at the high level that has been reached in previous years. Still, the IPA has performed
very well in 2013! Again, the team of the IPA has accomplished excellent standards of
internationally-recognized scientific output and academic teaching. I wish to express my
sincere thanks to all who have contributed to the IPA´s remarkable scientific and teaching
achievements and to those who supported us through administrative, organizational and
financial matters as well as the cleaning staff and those taking care of the animal facility. Our
success is due to exemplary teamwork, laudable commitment and a high level of
identification of all IPA members with the major goals of the IPA and of the Medical
University of Vienna.
In the future we will probably face more strenuous times regarding financial support for
research and personnel. Still, I want to encourage everybody to continue your individual
efforts and our teamwork in all ranks! These commitments will well prepare our department
for the future!
Barbara Bohle
Head of the IPA
4
General overview
In 2013, 20 highly active research groups at the IPA have worked successfully on both basic
and translational aspects in cellular and molecular pathophysiology, immunopathology,
comparative immunology, oncology, medical biotechnology and allergology.
Numerous publications in peer-reviewed high-impact journals, research awards and many
contributions to prestigious scientific national and international meetings were accomplished.
A total sum of 228 impact factors was gained in 2013 which is an improvement compared to
the previous year. Figure 1 shows the total sum of the IPA´s impact factors since 2004. The
drop of the total sum of impact factors in 2012 compared to previous years is explained by
the change of counting the impact factors. The members of the IPA have decided to now
count the full impact factor if they are first, last or corresponding authors. If IPA members are
co-authors only 50% of the journal´s impact factor is counted.
Figure 1
0
100
200
300
400
500
600
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
tota
l s
um
of
imp
ac
t fa
cto
rs
//
Also in terms of recruiting third party funding and research grants, the members of the IPA
have been very successful in 2013. Several research projects funded by the Austrian
Science Fund (FWF) and other funding agencies, e.g. the Österreichische Nationalbank, the
medizinisch-wissenschaftlicher Fonds des Bürgermeisters der Stadt Wien as well as the
European Commission, are ongoing at the IPA. Congratulations to all project leaders! This
positive funding situation also reflects that the members of the IPA are highly active
researchers and well embedded in the international fields of their expertise. The IPA is proud
of several successful and long lasting collaborations with national and international research
partners.
New calculation of IF
5
A total sum of 229.17 semester hours for 2013 reflects the high commitment of the IPA’s
members to teaching. The total numbers of semester hours of the members of the IPA held
at the Medical University from 2004-2012 are illustrated in Figure 2.
Figure 2
0
50
100
150
200
250
300
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
su
m o
f s
em
es
ter
ho
urs
at
the
MU
V
Figure 3
0
10
20
30
40
50
60
70
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
tota
l n
um
be
r o
f s
tud
en
ts
In addition to giving lectures, an important task of all members of the IPA is to train young
scientists in the laboratories. In 2013, a total of 117 Austrian and international bachelor,
diploma and PhD students were educated at the IPA. Figure 3 shows that the total numbers
of diploma (white circles), PhD (black circles) and bachelor students (black triangles)
continuously increased at the IPA since 2004. The positive feed back of the trainees who
finished their education at our department shows that all instructors are highly dedicated to
excellent and personal supervision.
Besides the education of young scientists, the IPA was also active in training physicians for
specializations in pathophysiology and immunology. Regular “Impulse Seminars” were
organized by the IPA which can be regarded as advanced training for medical doctors and
students and combined basic research with clinical aspects. Furthermore, members of the
IPA are active in teaching and examining not only at the Medical University but at other
universities, including universities of applied sciences. Several IPA members also act as
reviewers of external diploma and PhD theses, Habilitations, scientific manuscripts and
research grants, and are active on editorial and advisory boards and on the boards of
national and international research societies.
In summary, we are looking back at a very successful year! Our outstanding reference
values were achieved by outstanding individual efforts, a strong team spirit and the great
commitment of all IPA members. Such a successful team forms a solid basis which is
important to combat possible challenges awaiting us in the future!
Performance Report 2013 Organigram
6
Organigram (December 2013) Head: Barbara Bohle, PhD, Professor for Cellular Allergology Deputy Head: Peter Pietschmann, MD, Assoc. Professor Department Secretary: Marion Sack Check point: Andreas Kunrath Student Secretary: Marion Krones
Division for Comparative Immunology and Oncology Head: Erika Jensen-Jarolim, MD, Professor for Pathophysiology, Professor for Comparative Medicine Secretary: Nora Diallo, substituted by Katharina Josipovic Erika Bajna, CTA, 50%
WG AllergoOncology: Head: Erika Jensen-Jarolim, MD, Professor Beatrix Pfanzagl, Ass. Professor Kumiko Oida, PhD-Student Franziska Roth-Walter, PhD Martina Muhr, Diploma Student Lukas Einhorn, PhD-Student Alexandra Schoos, Diploma Student Judit Fazekas, PhD-Student Anna Moskovskich, Diploma Student Caroline Stremnitzer, PhD-Student Gesa Bindke, Diploma Student Josef Singer, PhD-Student Miroslawa Matz, Tech. Ass
WG Tumor Pathology: Head: Enikö Kallay, PhD, Assoc. Professor Charlotte Gröschel, MD Abhishek Aggarwal, PhD-Student Julia Höbaus, PhD-Student Lukas Gober, Diploma Student Doris Hummel, PhD-Student Maximilian Wohlgennannt, Diploma Student Irfete Fetahu, PhD-Student Teresa Manhardt, CTA Samawansha Tennakoon, PhD-Student Maria Elena Manfredini, Project manager
WG Gastrointestinal Immunology: Head: Eva Untersmayr-Elsenhuber, MD, Priv.-Doz. Katharina Beitl, Diploma Student Anna Ondracek, Diploma Student Vera Elisabeth Assmann, Diploma Student Cornelia Schultz, BMA
WG Molecular System Biology and Pathophysiology Head: Diana Mechtcheriakova, PhD, Priv.-Doz. Martin Svoboda, PhD Susi Wöhrer, Diploma Student Anastasia Meshcheryakova, PhD-Student Elfi Scharf, Diploma Student
Division for Cellular and Molecular Pathophysiology Head: Peter Pietschmann, MD, Assoc. Professor Secretary: Birgit Schwarz Erika Bajna, CTA, 50%
WG Bone, Cartilage and conn. Tissue Research: Head: Peter Pietschmann, MD, Assoc. Professor Ursula Föger-Samwald, PhD-Student Alaghebandan Afarin, Diploma-Student Eduardo Maldonado-Gonzalez, PhD-Student Körbler Florian, Diploma-Student Gfrerer Lisa, PhD-Student Lamm Christiane, Diploma-Student Umar Zahra, Diploma-Student Katharina Wahl, CTA
Performance Report 2013 Organigram
7
WG Cell Biology: Head: Renate Fuchs, PhD, Assoc. Professor Leszek Gajdzik, Technician Ganjian Haleh, PhD-Student Julian Otto, Diploma Student Manuel Jalali, Diploma Student Spanberger Thomas, Diploma Student
WG Pathophysioloy of the Placenta: Head: Isabella Ellinger, PhD, Assoc, Professor Klameth Lukas, PhD-Student Kemper Jost, Diploma-Student Mytsko Yuliya, Diploma Student Reiter Martin, Diploma Student Pia Habringer, Diploma Student Voss Agnes, Diploma Student Marin Schaffhauser, Diploma Student Hana Uher, BMA
WG Cellular Pathology and Pharmacokinetics: Head: Theresia Thalhammer, PhD, Assoc. Professor Erdentetsetseg Rentsen, PhD-Student Aida Larijani, Diploma Student Radu Rogojanu, PhD-Student Durmaz Yasemin, Diploma-Student Riha Juliane, PhD-Student Eric Branislava, Diploma-Student Katic Ana, Diploma-Student Eskandari Hamidreza, Diploma-Student Mungenast Felicitas, Diploma-Student Simone Zotter, Diploma Student Ocko Katharina, Diploma Student Sheikh Maidah, Diploma Student Türkay Emel, Diploma Student Zhang Wenyi, Diploma Student
Division for Immunopathology Head: Rudolf Valenta, MD, Professor for Allergology Secretary: Doris Werjant Editorial Secretary: Sanna Lippert SFB-Secretary: Anna Guentcheva Milena Weber, CTA
WG Molecular Immunopathology: Head: Rudolf Valenta, MD, Professor Birgit Linhart, PhD Cabauattan Clarissa, PhD-Student Christian Lupinek, MD Narayanan Meena Balakumari, PhD-Student Raffaela Campana, PhD Cornelius Carolin, PhD-Student Katarzyna Niespodziana, PhD Dzoro Sheron, PhD-Student Curin Mirela, PhD, Wollmann Eva, PhD-Student Wei-Chen Kuan, PhD Srinivasan Bharani, PhD-Student Garmatiuk Tetiana, MD Borochova Kristina, Diploma Student Gallerano Daniela, PhD-Student Kiss Renata, CTA
WG Immunotechnology: Head: Susanne Vrtala, PhD, Assoc. Professor Irene Mittermann, PhD Srinita Banerjee, PhD-Student Alexandra Baar, PhD-Student Yvonne Resch, PhD-Student Sandra Pahr, PhD-Student Huey-Jy Huang, PhD-Student
WG Immunochemistry: Head: Margarete Focke-Tejkl, PhD, Univ.-Doz. Katharina Marth, MD Ochome Mary, PhD-Student
WG Antibody Research Head: Sabine Flicker, PhD, Priv.-Doz. Elisabeth Gadermaier, PhD Nazanin Najafi, PhD-Student Christoph Madritsch, PhD-Student
Performance Report 2013 Organigram
8
Division for Medical Biotechnology Head: Heimo Breiteneder, PhD, Professor for Medical Biotechnology Secretary: Julia Krüger Nina Lengger, BMA
WG Biotechnology & Biochemical Diagnostics: Head: Heimo Breiteneder, PhD, Professor Merima Bublin, PhD Daniele Pucciarelli, PhD-Student Christine Hafner, MD Palladino Chiara, PhD-Student Barbara Gepp, PhD-Student Daniele Ackerbauer, Diploma Student
WG Molecular Allergology: Head: Karin Hoffmann-Sommergruber, PhD, Assoc. Professor Kazem Ashjaei, PhD-Student Magdolna Vermes, ARat Dubiela Pawel, PhD-Student Gerlinde Hofstetter, BMA
WG Biochemistry and Bioinformatics: Head: Christian Radauer, PhD, Assoc. Professor Eva Gushl, PhD-Student
WG Molecular Research in Traditional Chinese Medicine: Head: Yan Ma, PhD, Assoc. Professor Administration TCM: Linda Lam He Shan, PhD-Student
Division for Experimental Allergology Head: Barbara Bohle, PhD, Professor for Cellular Allergology Secretary: Dorothea Angelides CD-Laboratory Secretary: Bana Haddad Birgit Nagl, BMA
WG Allergy Research: Head: Barbara Bohle, PhD Claudia Kitzmüller, PhD Dagmar Kollmann, PhD-Student Stephan Deifl, PhD-Student Dominika Polak, PhD-Student Nora Zulehner, PhD-Student Sandra Heizer, BMA Brinda Subbarayal, PhD-Student
WG Cellular Allergology: Head: Beatrice Jahn-Schmid, PhD, Priv.-Doz. Nazanin Samadi, PhD-Student
Facility Services and Animal Keeping:
Katharina Reinberger Brigitte Schwarz Andrea Vlasaty
Performance Report 2013 Personnel
9
a) Personnel of IPA (between January and December 2013)1
Personnel (p.) 01.01.2013 31.12.2013
MUW total female total female
Univ.Prof. (full professors) RV, EJJ, BB, HB 4.00 2.00 4.00 2.00
Ao.Univ.Prof (Assoc.Prof) IE, RF, PP, TT, CR 5.00 4.00 5.00 4.00
Univ./Priv.Doz. (Assoc.Prof) EUE,BJS, KHS,EK,SV,YM
6.00 6.00 6.00 6.00
Assistant professors BP, BL 2.00 2.00 2.00 2.00
Technical personnel NL,LG,TM,MM,MV,KW,BN,MW,
EB
9.00 8.00 NL,LG,TM,MM,MV,KW,BN,MW,
EB
9.00 8.00
Administrative personnel CB,MS,KJ,MK½,
JK½,AK, DW,DA,BS½
7.50 6.50 MS, AK, KJ, JK, DW, DA, BS½, MK½, BH½
7.50 6.50
Supportive personnel AV, KR, BS 3.00 3.00 3.00 3.00
36.50 31.50 36.50 31.50
Third party funded p.
Scientific personnel Univ.Doz.
(Assoc.Prof)
MFT, SF, DM, IPS,MB
5.00 5.00 5.00 5.00
PostDoc 19.00 17.00 18.00 15.00
Doctoral students2 33.00 27.00 40.00 32.00
Technical personnel BMA 4.00 4.00 3.00 3.00
CTA 3.00 3.00 2.00 2.00
Administrative personnel BH, SL, JK 3.00 3.00 BH, SL, AG 3.00 3.00
Project employees MEM, UFS , LL 1.25 1.25 MEM, UFS , LL
1.25 1.25
Diploma students (FB3) 9.00 7.00 7.00 7.00
72.25 62.25 74.25 63.25
Other scientific coworkers
Doctoral students 4.00 2.00 3.00 2.00
Diploma students 17.00 7.00 18.00 14.00
Student apprentices
2.00 1.00 3.00 1.00
23.00 10.00 24.00 17.00
MUW personnel total 131.75 103.75 134.75 111.75
At the end of 2013 27,09% of the entire personnel was MUV-paid personnel.
Of all IPA-employees 82.93% were female.
1 in full time equivalents “FTE” 40 h = 1 FTE 2 due to novel rules by FWF PhD students are employed 75 % FTE to be able to spend time for education 3 FB: Forschungsbeihilfe: defined financial support
Performance Report 2013 Impulsseminare
10
Continuous education of staff
Among the activities in the field of continuous education of the members of the
Department in 2013 eight “impulse seminars” were held. In these seminars, research
group leaders present and discuss recent results from their projects. The seminars
were very well attended and significantly promoted communication and active
discussion among the members of the IPA. The “impulse seminars” are recognized
as continuous medical education by the Austrian Chamber of Physicians. In 2013 the
following topics were covered:
11.01.2013 Renate Fuchs Virus entry pathways
01.03.2013 Karin Hoffmann-
Sommergruber
Authentication of Food Allergens
05.04.2013 Beatrice Jahn-Schmid Mugwort pollen allergy - a model to study allergen-specific T cells
03.05.2013 Erika Jensen-Jarolim Neues aus der Komparativen Medizin
07.06.2013 Sabine Flicker Allergen-specific antibodies- from basic findings to future applications
04.10.2013 Yan Ma Herbal interactions in the traditional Chinese medical formula Sini Tang- a novel concept of detoxification
15.11.2013
Diana Mechtcheriakova Activation-induced cytidine deaminase (AID): AIDing in B-cell immunity, chronic inflammation and cancer
13.12.2013 Peter Pietschmann Osteoporosis - an inflammatory disease?
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
11
1. Detailed Reports of Divisions
1.1. Division for Comparative Immunology and Oncology Head: Erika Jensen-Jarolim, MD, Professor
1. Publications4
IF Number Top/Std/Subst
Erika Jensen-Jarolim 22.524 7 5/2/0
Isabella Pali-Schöll 14.189 4 4/0/0
Eva Untersmayr-E. 6.061 2 2/0/0
Enikö Kallay 26.496 6 3/3/0
Diana Mechtcheriakova 6.394 (50%)= 3.197 4 1/3/0
Division Sum 62.558
Top point score 2 - among top 20 % of journal in field
Standard point score 1 - between 21-60 %, Substandard point score 0,2
2. Supervision of diploma and doctoral students
Bachelor st. Diploma st. Doctoral st.
Erika Jensen-Jarolim 1 7 6
Isabella Pali-Schöll - - -
Eva Untersmayr-E. - 3 -
Enikö Kallay - 2 7
Diana Mechtcheriakova 1 3 1
Sum 2 15 14
3. Teaching SS* WS* total W+S oral Exams
AG Erika Jensen-Jarolim 6.84 4.61 11.45 AG Isabella Pali-Schöll 0 0 0 AG Eva Untersmayr-E. 0 5.71 5.71 AG Enikö Kallay 1.91 8.24 10.15 AG Diana Mechtcheriakova 1.52 1.49 3.01
Sum 10.27 20.05 30.32
4For working groups IFs of all publications including joint publications with other working groups are presented. In contrast, the
given sum of the division represents the net value of IFs without overlaps due to joint publications.
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
12
1.1.1. Publications
a) Peer-reviewed original articles: n= 15
Nr. Article IF Class pro-rata IF
1. Almer G, Frascione D, Pali-Schöll I, Vonach C, Lukschal A, Stremnitzer C, Diesner SC, Jensen-Jarolim E, Prassl R, Mangge H. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.Mol Pharm. 2013 JanNov;85(3):656-64. doi: 10.1016/j.ejpb.2013.03.003.
4.570 Top 2.235
2. Pali-Schöll I, Szöllösi H, Starkl P, Scheicher B, Stremnitzer C, Hofmeister A, Roth-Walter F, Lukschal A, Diesner SC, Zimmer A, Jensen-Jarolim E. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice. Eur. J Pharm Biopharm. 2013 Nov;85 (3):656-64. doi: 10.1016/j.ejpb.2013.03.003. Epub 2013 Mar 21.
3.826 Top
3.826
3. Gradauer K, Dunnhaupt S, Vonach C, Szollosi H, Pali-Scholl I, Mangge H, Jensen-Jarolim E, Bernkop-Schnurch A, Prassl R. 2013. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties. Journal of controlled release: official journal of the Controlled Release Society 165: 207-215.
7.633 Top 3.818
4. Roth-Walter F, Starkl P, Zuberbier T, Hummel K, Nobauer K, Razzazi-Fazeli E, Brunner R, Pali-Scholl I, Kinkel J, Felix F, Jensen-Jarolim E*, Kinaciyan T. 2013. Glutathione exposes sequential IgE-epitopes in ovomucoid relevant in persistent egg allergy. Molecular nutrition & food research. Mar;57 (3):536-44.
4.310 Top
4.310
5. Gómez-Casado C, Roth-Walter F, Jensen-Jarolim E, Díaz-Perales A, Pacios LF. 2013. Modeling iron-catecholates binding to NGAL protein. J Mol. Graphics and Modelling, 45; 111 – 121.
2.325 Std
1.163
6. Pfanzagl B, Andergassen D, Edlmayr J, Niespodziana K, Valenta R, Blaas D.Entry of human rhinovirus 89 via ICAM-1 into HeLa epithelial cells is inhibited by actin skeleton disruption and by bafilomycin. Arch Virol. 2013 Aug 4.
2.030
Std 1.015
7. Höbaus J, Hummel DM, Thiem U, Fetahu IS, Aggarwal A, Müllauer L, Heller G, Egger G, Mesteri I, Baumgartner-Parzer S, Kallay E. Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer. Int J Cancer. 2013 Sep 15; 133(6):1380-8. doi: 10.1002/ijc.28143. Epub 2013 Apr 5.
6.198 Top 6.198
8. Brennan SC, Thiem U, Roth S, Aggarwal A, Fetahu I, Tennakoon S, Gomes AR, Brandi ML, Bruggeman F, Mentaverri R, Riccardi D, Kallay E. Calcium sensing
4.808 Top 4.808
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
13
receptor signalling in physiology and cancer. Biochim Biophys Acta. 2013 Jul; 1833(7):1732-44. Epub 2012 Dec 23.
9 Peterlik M, Kállay E, Cross HS. Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases. Nutrients. 2013 Jan 22;5(1):302-27.
2.072 Std 2.072
10. Hummel DM, Thiem U, Höbaus J, Mesteri I, Gober L, Stremnitzer C, Graça J, Obermayer-Pietsch B, Kallay E. Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis. J Steroid Biochem Mol Biol. 2013 Jul; 136:284-8. doi: 10.1016/j.jsbmb.2012.09.003. Epub 2012 Sep 11.
3.984 Std 3.984
11. Höbaus J, Fetahu IS, Khorchide M, Manhardt T, Kallay E. Epigenetic regulation of the 1,25-dihydroxyvitamin D(3) 24-hydroxylase (CYP24A1) in colon cancer cells. J Steroid Biochem Mol Biol. 2013 Jul; 136:296-9. Epub 2012 Aug 20.
3.984 Std 3.984
12. Kovarik JJ, Holzl MA, Hofer J, Waidhofer-Sollner P, Sobanov Y, Koeffel R, Saemann MD, Mechtcheriakova D, Zlabinger GJ (2013) Eicosanoid modulation by the short-chain fatty acid n-butyrate in human monocytes. Immunology . 10.1111/imm.12089 [doi].
3.700 Std 1.850
13. Pils D, Bachmayr-Heyda A, Auer K, Svoboda M, Auner V, Hager G, Obermayr E, Reiner A, Reinthaller A, Speiser P, Braicu I, Sehouli J, Lambrechts S, Vergote I, Mahner S, Berger A, Cacsire Castillo-Tong D, Zeillinger R. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - A study of the OVCAD consortium. Eur J Cancer. 2013 Oct 28. doi:pii: S0959-8049(13)00851-4. 10.1016/j.ejca.2013.09.011. PubMed PMID: 24176298.
5.060 Top 2.530
14. Secky L, Svoboda M, Klameth L, Bajna E, Hamilton G, Zeillinger R, Jäger W, Thalhammer T. The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors. J Drug Deliv. 2013; 2013:957605. doi: 10.1155/2013/957605. Epub 2013 Feb 13. PubMed PMID: 23476785; PubMed Central PMCID: PMC3586502.
2.015 Std 1.007
15. Buxhofer-Ausch V, Secky L, Wlcek K, Svoboda M, Kounnis V, Briasoulis E, Tzakos AG, Jaeger W, Thalhammer T. Tumor-specific expression of organicanion-transporting polypeptides: transporters as novel targets for cancertherapy. J Drug Deliv. 2013; 2013:863539. doi: 10.1155/2013/863539. Epub 2013 Feb 3. PubMed PMID: 23431456; PubMed Central PMCID: PMC3574750.
2.015 Std 1.007
sum
63.876 49.153
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
14
b) Invited Articles & Reviews with IF: n= 3 Nr. Article IF Class pro-rata IF 1. Höbaus J, Thiem U, Hummel DM, Kallay E. Role of
calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.Anticancer Agents Med Chem. 2013 Jan;13(1):20-35. PMID: 23094918
2.610 Std 2.610
2. Singer J,Jensen-Jarolim E. IgE-based Immunotherapy of Cancer: Challenges and chances. Allergy, 2013 Oct 14. doi: 10.1111/all.12276.
5.883 Top 5.883
3. Kállay E. "The role of the calcium sensing receptor (CaSR) in health and disease, implications for translational medicine" or the multifaceted CaSR: a Training Network for young scientists. Best Pract Res Clin Endocrinol Metab. 2013 Jun; 27(3):279-81. doi: 10.1016/j.beem.2013.05.004. Epub 2013 Jun 6.
4.912 Top 4.912
sum 13.405 13.405 c) Invited Articles & Reviews without IF: n = 2 1. Eva Untersmayr. Protect Your Digestion, the First Line of Defense Against Food
Allergies – Invited guest editorial at: http://www.asthmaallergieschildren.com, August 2013
2. Eva Untersmayr. Nahrungsmittel-Allergien - Fehler und Fallen bei pädiatrischen Patienten. Nutriton News 2013; 1:5-8
d) Book contributions: n =7 1. Jensen-Jarolim E (2014) Definition of Comparative Medicine: History and New
Identity. In: Jensen-Jarolim (Ed) Comparative Medicine - Anatomy and Physiology. Springer, p. 1-18. ISBN: 978-3-7091-1558-9 (Print) 978-3-7091-1559-6 (Online)
2. Panakova L and Szalai K (2014) Surface, Barrier, and Interface Zone: Comparative Aspects of the Skin. In: Jensen-Jarolim (Ed) Comparative Medicine. Springer p. 103-117.
3. Zeugswetter FK and Jensen-Jarolim E (2014) Body Messaging: The Endocrine Systems.In: Jensen-Jarolim (Ed)Comparative Medicine - Anatomy and Physiology. Springer p. 119-137.
4. Jensen-Jarolim, Schöpper H, Grabner S (2014) Volume and Clearance: Kidneys and Excretory Systems. In: Jensen-Jarolim (Ed) Comparative Medicine. Springer p. 161-177.
5. Schöpper H, Bartel C, Szalai K. Breathing: Comparative Aspects of the Respiratory System. In: Jensen-Jarolim (Ed) Comparative Medicine - Anatomy and Physiology. Springer p. 179-194.
6. Roth-Walter F, Riemer AB, Jensen-Jarolim E (2014) Common Concepts of Immune Defense: Innate Immunity, the oldest type of defense. In: Jensen-Jarolim (Ed) Comparative Medicine - Anatomy and Physiology. Springer p. 220-242.
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
15
7. Roth-Walter F, Jensen-Jarolim E, Stockinger H. (2014) Common Concepts of Immune Defense: Principles and Comparative Aspects of adaptive immunity. In: Jensen-Jarolim (Ed) Comparative Medicine - Anatomy and Physiology. Springer p. 243-266.
e) Abstracts, printed in periodicals: n = 15 1. Kinaciyan T, Roth-Walter F, Starkl P, Zuberbier T, Brunner R, Pali-Schöll I, Kinkel J,
Felix F, Jensen-Jarolim E. Sequential IgE-epitopes of ovomucoid exposed by glutathione are relevant in persistent egg allergy. Food Allergy and Anaphylaxis Meeting (FAAM 2013) Nice, France. 7-9 February 2013. Clinical and Translational Allergy. 07/2013; 3(3)
2. Roth-Walter F, Willensdorfer A, Stremnitzer C, Schultz C, Diesner S, Szalai K, Fazekas J, Birnleitner H, Jensen-Jarolim E. Acrolein suppress allergic sensitization and promotes tumor growth in BALB/c mice. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, 22-26 June 2013. Allergy 68, SI, Suppl. 97, 271, Sep 2013
3. Moskovskich A, Gomez-Casado C, Willensdorfer A, Singer J, Fuchs HC, Roth-Walter F, Jensen-Jarolim E. Modulatory impact of cinnamaldehyde on immune cells is partly due to induction of apoptosis. European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy , 68, SI, Suppl. 97, 658, Sep 2013
4. Smole, Ursula; Ackerbauer, Daniela; Lengger, Nina; Allergenicity of the major birch pollen allergen Bet v 1 might arise from molecular mimicry of homologous bacterial proteins; Conference: 100th Annual Meeting of the American-Association-of-Immunologists Location: Honolulu, HI Date: MAY 03-07, 2013 Sponsor(s): Amer Assoc Immunologists Source: JOURNAL OF IMMUNOLOGY Volume: 190 Meeting Abstract: 624 Published: MAY 1 2013
5. Oida K, Hadzijusufovic E, Panakova L, Roth-Walter F, Singer J, Fazekas J, Valent P, Szalai K, Tanaka A, Matsuda H, Jensen-Jarolim E. House dust mite allergens induce IgE-independent activation of canine mast cells NI-1. European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy, 68, SI, Suppl. 97, 113-114, Sep 2013
6. Fazekas J, Singer J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E. Passive anti-EGFR immunotherapy in canine cancer patients – a comparative medicine study. Allergy, 68: p.590. doi: 10.1111/all.12252
7. Fazekas, J.; Singer, J.; Wang, W.; Passive anti-EGFR immunotherapy in canine cancer patients; Conference: World Allergy and Asthma Congress of the European-Academy-of-Allergy-and-Clinical-Immunology and World-Allergy-Organization Location: Milan, ITALY Date: JUN 22-26, 2013 Sponsor(s): European Acad Allergy & Clin Immunol; World Allergy Org Source: ALLERGY Volume: 68 Special Issue: SI Supplement: 97 Pages: 590-590 Published: SEP 2013
8. Bindke G.M, Roth-Walter F, Singer J, Gomez-Casado C, Brunthaler R, Köhler K, Jäger K, Willensdorfer A, Jensen-Jarolim E. Properties, binding and stability of Aleuria Aurantia Lectin on mucosal sites in dogs (Canis familiaris). European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy, 68, SI, Suppl. 97, 117, Sep 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
16
9. Diesner SC, Schultz C, Wang XY, Assmann VE, Ratzinger G, Roth-Walter F, Starkl P, Eiwegger T, Szepfalusi Z, Pali-Scholl I, Jensen-Jarolim E, Gabor F, Untersmayr, E. Neuraminidase is a safe functionalization substance of allergen-loaded microparticles for oral immunotherapy of food allergy. European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy, 68, SI, Suppl. 97, 117, Sep 2013
10. Diesner SC, Schultz C, Ackaert C, Oostingh GJ, Roth-Walter F, Fazekas J, Stremnitzer C, Willensdorfer A, Schrom S, Assmann VE, Kreiner K, Eiwegger T, Szepfalusi Z, Jensen-Jarolim E, Duschl A, Untersmayr E. The influence of food protein nitration on the anaphylactic response in a murine food allergy model.European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy, 68, SI, Suppl. 97, 134, Sep 2013
11. Diesner SC, Schultz C, Pfitzner B, Assmann VE, Krishnamurthy D, Kreiner K, Weichselbaumer M, Starkl P, Eiwegger E, Szepfalusi Zs, Fehrenbach H, Jensen-Jarolim E, Hartmann A, Pali-Schöll I, Untersmayr E. Factors influencing anaphylactic responses in an oral OVA food allergy model under gastric acid suppression. European Academy of Allergy and Clinical Immunology & World Allergy Organization World Allergy & Asthma Congress 2013, 22 – 26 June, Milan, Italy. Allergy, 68, SI, Suppl. 97, 134, Sep 2013
12. Roth-Walter F, Willensdorfer A, Stremnitzer C, Schultz C, Diesner S, Szalai K, Fazekas J, Moskovskich A, Birnleiter H, Jensen-Jarolim E. Acrolein inhibits antibody formation and allergic sensitization, but promotes tumor growth. Annual meeting of the Austrian Society of Pneumology, 24-26 Oct, 2013. Wiener Klinische Wochenschrift, 125, 19-20: 657, Oct 2013
13. Roth-Walter F, Moskovskich A, Willensdorfer A, Gomez-Casado C, Glenk LM, Pollak-Monje Quiroga D, Jensen-Jarolim E. Mouse model of specific fragrance allergy: The haptenous state determines site-specific tolerance or allergy. 5th International Symposium of Molecular Allergy (ISMA), Vienna, December 5 – 7, 2013. Clinical and Translational Allergy, in press.
14. Satorina J, Szalai K, Lukschal A, Willensdorfer A, Mothes-Luksch N, Jensen-Jarolim E. Do hypoallergenic cats exist? – Determination of major cat allergen Fel d 1 production in normal and hypoallergenic cat breeds. 5th International Symposium of Molecular Allergy (ISMA), Vienna, December 5 – 7, 2013. Clinical and Translational Allergy, in press.
15. Roth-Walter F, Moskovskich A, Willensdorfer A, Gomez-Casado C, Pollak-Monje Quiroga D, Jensen-Jarolim E. Site specific protection against mucosal application of the contact allergen cinnamonaldehyde as hapten or conjugate. EAACI ISMA 2013 : 5th International Symposium on Molecular Allergology, 5 – 7 December 2013, Vienna, Austria. Clinical and Translational Allergy
f) Abstracts, in congress proceedings or abstract books: n = 68
1. Fetahu IS, Höbaus J, Kállay E. Relevance of in vitro epigenetic data in understanding regulation of the calcium sensing receptor expression in colorectal cancer. Challenges, Opportunities and Perspectives, Barcelona Conference on Epigenetics and Cancer. November 21-22, 2013
2. Tennakoon S, Hegedus L, Aggarwal A, Wohlgenannt M, Kallay E.; Signalling pathways regulated by the calcium sensing receptor in colon cancer cells; Autumn Scientific Meeting of the ÖGKM, November 16, 2013, Vienna
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
17
3. Gröschel C, Aggarwal A, Fetahu I, Höbaus J, Hummel D, Tennakoon S, Manhardt T, Marian B, Kallay E. Modulating the wnt-pathway in colorectal adenoma cells by 1,25-dihydroxyvitamin D3, Herbstagung ÖGKM, November 16, 2013, Vienna
4. Höbaus J, Tennakoon S, Gröschl C, Hummel D, Aggarwal A, Thiem U, Fetahu I, Manhardt T, Kallay E. Consequences of the Overexpression of the Vitamin D Degrading Enzyme CYP24A1 ÖGKM, November 16, 2013, Vienna
5. Jensen-Jarolim E, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Willmann M, Thalhammer JG, Singer J. Comparative oncology: Development of xenogenic vaccines and recombinant antibodies for dog cancer patients. ColdSpringHarbour (CSH) Asia conference on Tumor Immunology and Immunotherapy, Suzhou, China, October 28 - November 1, 2013.
6. Aggarwal A, Tennakoon S, Höbaus J, Wohlgenannt M, Boudot C, Mentaverri R, Baumgartner-Parzer S, Kallay E: Loss of the Calcium Sensing Receptor provides a growth advantage to colon cancer cells. International Conference on Stem Cell and Cancer (ICSCC), India October 19-22, 2013
7. Fetahu I S, Höbaus J, Aggarwal A, Hummel D, Tennakoon S, Mesteri I, Baumgartner-Parzer S, Kallay E: Epigenetic Regulation of the Calcium-Sensing Receptor in Colorectal Cancer. FEBS workshop, October 13-16, 2013, Capri, Italy.
8. Stremnitzer C, Szalai K, Singer J, Willensdorfer A, Starkl P, Pieper M, König P, Mildner M, Jensen-Jarolim. The cysteine protease papain triggers breakdown of tight junction proteins and induces a strong Th-2-biased immune response in the skin. 2nd meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia, Oct. 10-13, 2013
9. Lukschal A, Bublin M, Wallmann J, Neumann D, Stockner T, Breiteneder H, Pali-Scholl I, Jensen-Jarolim E. A peptide mimicking an important epitope cross-reactive between birch pollen and celery allergen Api g 5. 2nd meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia, Oct. 10-13, 2013
10. Szalai K, Satorina J, Lukschal A, Willensdorfer A, Mothes-Luksch N, Jensen-Jarolim. E. Why cat allergic patients react less toward some cats: Determination of Fel d 1 levels in normal and hypoallergenic cats
11. Fazekas J, Weichselbaumer M, Willmann M, Singer J, Pagitz M, Starkl P, Knittelfelder R, Thell K, Willensdorfer A, Thalhammer JG, Jensen-Jarolim E.. A xenogeneic CEA-vaccination study in canine mammary carcinoma patients. 2nd meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia, Oct. 10-13, 2013
12. Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E. Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients. 2nd meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia, Oct. 10-13, 2013
13. Roth-Walter F, Willensdorfer A, Stremnitzer C, Schultz C, Diesner S, Szalai K, Fazekas J, Birnleitner H, Jensen-Jarolim E. Novel insights into Acrolein mechanism: pro Tumor, anti-Allergy? 2nd meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia, Oct. 10-13, 2013
14. Fetahu S, Höbaus J, Aggarwal A, Hummel D, Tennakoon S, Mesteri I, Baumgartner-Parzer S, Kallay E: Role of DNA methylation and histone modifications on calcium-sensing receptor expression in colorectal cancer. Cell Symposia, October 6-8, 2013, Sitges, Spain.
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
18
15. Aggarwal A, Tennakoon S, Wohlgenannt M, Kallay E. Loss of the Calcium Sensing Receptor provides a growth advantage to colon cancer cells. ÖGMBT Meeting, Austria, September 25-27, 2013
16. Fetahu I S, Höbaus J, Aggarwal A, Hummel D, Tennakoon S, Mesteri I, Baumgartner Parzer S, Kallay E: Role of DNA methylation and histone modifications on calcium-sensing receptor expression in colorectal cancer. ÖGMBT Meeting, Austria, September 25-27, 2013
17. Tennakoon S, Hegedus L, Schmid J, Marian B, Kallay E. Regulation of mitogen activated protein kinase pathways by the calcium sensing receptor in colon cancer cells; ÖGMBT Meeting, Austria, September 25-27, 2013
18. Pali-Schöll I, Szöllösi H, Starkl P, Scheicher B, Stremnitzer C, Hofmeister A, Roth-Walter F, Lukschal A, Diesner SC, Zimmer A, Jensen-Jarolim E. Protamine-nanoparticles with CPG-ODN prevent an allergen-induced Th2 response in BALB/c mice rotamine-nanoparticles with CpG-ODN prevent an allergen-induced Th2-response in BALB/c mice. 3rd Conference on Innovation in Drug Delivery: Advances in Local Drug Delivery. Pisa, Italy. September 22-25, 2013.
19. Schoos A, Fazekas J, Muhr M, Panakova L, Singer J, Jensen-Jarolim E. Generation and characterization of recombinant soluble feline FcεRIα for diagnosis of allergic diseases in cat patients. 31st World Veterinary Congress, Prague, Czech Republic, Sept. 17-20, 2013
20. Svoboda M, Pils D, Heinze G, Meshcheryakova A, Tong D, Thalhammer T, Jensen-Jarolim E, Jaritz M, Zimmermann P, Zeillinger R, Mechtcheriakova D AID/APOBEC-associated gene signature: prognostic power for overall survival of patients with primary ovarian carcinoma. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
21. Scharf* E, Meshcheryakova A*, Wöhrer S*, Bajna E, Heiden D, Svoboda M, Jensen-Jarolim E, Birner P, Mechtcheriakova D, Microscopy-based algorithm for qualitative and quantitative analysis of immune cell populations within complex ovarian carcinoma tissues. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
22. Meshcheryakova A*, Tamandl D*, Bajna E, Svoboda M, Heiden D, Stift J, Mittlboeck M, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D. Degree and organization pattern of lymphocyte populations within the active border of human colorectal cancer liver metastases: association between immunological imprint and survival. . Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
23. Stremnitzer C*, Szalai K*, Starkl P, Willensdorfer A, Pieper M, König P, Mildner M, Jensen-Jarolim E. The cysteine protease papain induces skin barrier impairment and has strong sensitization capacity via the skin. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
24. Lukschal A, Bublin M, Wallmann J, Breiteneder H, Pali-Scholl I, Jensen-Jarolim E. Characterization of an epitope crossreactive between high moleclar birch pollen allergens and the celery allergen Api g 5. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
25. Satorina J, Szalai K, Lukschal A, Willensdorfer A, Mothes-Luksch N, Jensen-Jarolim E. Different production of major cat allergen Fel d 1 in normal versus hypoallergenic cat breeds? Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
19
26. Fazekas J, Singer J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E. Generation of a recombinant anti-EGFR antibody for a proof of concept comparative oncology study in canine cancer patients. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
27. Diesner SC, Schultz C, Pfitzner B, Assmann VE, Krishnamurthy D, Kreiner K, Weichselbaumer M, Starkl P, Eiwegger T, Szepfalusi Zs, Fehrenbach H, Jensen-Jarolim E, Hartmann A, Pali-Schöll I, Untersmayr E. Factors influencing anaphylactic responses in an oral OVA food allergy model under gastric acid suppression. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
28. Aggarwal A, Tennakoon S, Wohlgenannt M, Kallay E. Loss of the Calcium Sensing Receptor provides a growth advantage to colon cancer cells. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
29. Höbaus J, Tennakoon S, Gröschl C, Hummel D M, Aggarwal A, Thiem U,. Fetahu ISh,. Manhardt T, Kallay E. Consequences of the overexpression of the vitamin d degrading enzyme cyp24a1 in vivo and vitro, Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
30. Tennakoon S, Aggarwal A, Hegedus L, Wohlgenannt M, Gröschel C, Hummel D, Fetahu I, Höbous J, Gober L, Kallay E. Involvement of calcium sensing receptor on downstream signalling pathways in colon cancer cells; Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
31. Diesner SC, Schultz C, Wang XY, Assmann VE, Ratzinger G, Roth-Walter F, Starkl P, Eiwegger T, Szepfalusi Z, Pali-Scholl I, Jensen-Jarolim E, Gabor F, Untersmayr, E. Neuraminidase is a safe functionalization substance of allergen-loaded microparticles for oral immunotherapy of food allergy. Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria, September 17, 2013
32. Roth-Walter F, Willensdorfer A, Stremnitzer C, Schultz C, Diesner S, Szalai K, Fazekas J., Birnleiter H. and Jensen-Jarolim E. Acrolein impedes allergic sensitization by suppressing antibody-formation and promotes tumor growth in BALB/c mice. 15th International Congress of Immunology, Milan, Italy, Aug 22-27, 2013
33. Schultz C, Diesner SC, Wang XY, Roth-Walter F, Eiwegger T, Szepfalusi Z, Pali-Schöll I, Jensen-Jarolim E, Gabor F, Untersmayr E. Safety evaluation of Neuraminidase as a targeting substance of allergen-loaded microparticles for oral food allergy treatment. 15th International Congress of Immunology, Milan, Italy, Aug 22-27, 2013
34. Moskovskich A, Gomez-Casado C, Willensdorfer A, Singer J, Fuchs H, Roth-Walter F, Jensen-Jarolim E. Immune-modulatory properties of Cinnamaldehyde are associated with the induction of apoptosis in immune cells. 15th International Congress of Immunology, Milan, Italy, Aug 22-27, 2013
35. Bindke GM, Roth-Walter F, Brunthaler R, Köhler K, Jäger K, Singer J, Jensen-Jarolim E. Properties, binding & stability of Aleuria Aurantia Lectin on mucosal sites in Canis familiaris.15th International Congress of Immunology, Milan, Italy, Aug 22-27, 2013
36. Meshcheryakova A*, Tamandl D*, Svoboda M, Bajna E, Stift J, Sachsenmaier M, Grünberger T, Jensen-Jarolim E, Bergmann M, Mechtcheriakova D. Degree and organization pattern of lymphocyte populations within the active border of human colorectal cancer liver metastases: association between immunological imprint and survival. 15th International Congress of Immunology, Milan, Italy, Aug 22-27, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
20
37. Singer J, Lukschal A, Willensdorfer A, Achatz-Straussberger G, Achatz G, Jensen-Jarolim E. Proof of concept studies in low- (ΔM1M2), normal- (wt BALBc) and high- (KN1) IgE expressing mice. Inaugural Croucher Summer Course on Cancer Biology, Hongkong, August 14-18, 2013.
38. Gatault S, Stremnitzer C, Delbeke M, Legrand F, Kahn JE, LefèvreG, Jensen-Jarolim E, CapronM. Implication Of Innate Immune Receptors In Eosinophil Tumoricidal Activity. 8th International Eosinophil Society's Biennial Symposium. Oxford, England, July 13-17, 2013
39. Lukschal A, Wallmann J, Mari A, Harwanegg C, Mittlböck M, Hantusch B, Szalai K, Pali I, Jensen-Jarolim E. Prevalence estimation of IgE, IgG and IgG4 recognition of a single epitope of grass pollen allergen Phl p 5 in an Italian allergic population by a mimotope approach. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, June 22-26, 2013
40. Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Jensen-Jarolim. E. Passive anti-EGFR immunotherapy in canine cancer patients – a comparative medicine study. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, June 22-26, 2013
41. Singer J, Lukschal A, Willensdorfer A, Achatz-Straussberger G, Achatz G, Jensen-Jarolim E. IgE antibodies participate in innate and adaptive anti-cancer immunity in transgenic KN1 hyper-IgE mice. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, June 22-26, 2013
42. Singer J, Schopoff S, Lexmond W, Platzer B, Jensen-Jarolim E, Fiebiger E. Human recombinant soluble FcεRIα interacts with murine IgE. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, June 22-26, 2013
43. Lukschal A, Bublin M, Wallmann J, Hantusch B, Breiteneder H, Pali-Schöll I, Jensen-Jarolim E. Characterization of a coss-reactive epitope of birch pollen allergens and celery allergen Api g 5 by a mimotope approach. European Academy of Allergy and Clinical Immunology & World Allergy Organization & World Allergy & Asthma Congress, Milan, Italy, June 22-26, 2013
44. Stremnitzer C, Szalai K, Starkl P, Willensdorfer A, Pieper M, König P, Mildner M, Jensen-Jarolim E. The cysteine protease papain induces skin barrier impairment and has strong sensitization capacity via the skin.
45. Gómez-Casado C, Tordesillas L, Kinkel J, Starkl P, Cuesta-Herranz J, Roth-Walter F, Díaz-Perales A, Jensen-Jarolim E. Reduction and unfolding of Pru p 3 decreases its allergenic potential. 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
46. Singer J, Thell K, Lukschal A, Heffeter P, Willensdorfer A, Szalai K, Fazekas J, Knittelfelder R, Horvat R, Penichet ML, Berger W, Jensen-Jarolim E. Human BT474 ductal carcinoma cells as xenotransplants in immunocompetent BALB/c mice – refinement of mouse models for anticancer vaccines. 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
47. Satorina J, Lukschal A, Willensdorfer A, Jensen-Jarolim E, Szalai K. Validation of hypoallergenic cat breed by determination of the major allergen Fel d 1. 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
21
48. Fazekas J, Weichselbaumer M, Willmann M, Singer J, Pagitz M, Starkl P, Knittelfelder R, Thell K, Willensdorfer A, Thalhammer JG, Jensen-Jarolim E. A phase I/II study with xenogeneic antigen vaccination of canine CEA-overexpressing cancer patients. 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
49. Moskovskich A, Gomez-Casado C, Willensdorfer A, Singer J, Fuchs HC, Roth-Walter F, Jensen-Jarolim E. Anti-inflammatory properties of cinnamaldehyde can be associated with the induction of apoptosis and inhibition of proliferation of immune cells. 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
50. Meshcheryakova A*, Tamandl D*, Svoboda M, Bajna E, Stift J, Grünberger T, Jensen-Jarolim E, Bergmann M, Mechtcheriakova D. B lymphocytes at the border of colorectal cancer metastases in liver: passengers, drivers and/or prognostic marker for clinical outcome? 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
51. Aggarwal A, Tennakoon S, Wohlgenannt M, Gröschel C, Hummel D, Fetahu I, Höbaus J, Gober L, Boudot C, Mentaverri R, Baumgartner-Parzer S, Kállay E. Calcium mediated growth control in normal and transformed colon cells: Role of the CaSR . 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
52. Höbaus J, Thiem U, Hummel D, Fetahu I, Gober L, Manhardt T, Kallay E. Overexpression of the vitamin D catabolizing enzyme CYP24A1 is caused by gene amplification and results in highly proliferative colorectal tumors 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
53. Tennakoon S, Hegedus L, Schmid J, Marian B, Kallay E. Regulation of signalling pathways by the calcium sensing receptor in colon cancer cells; 9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
54. Gröschel Ch, Hummel D, Nittke T, Manhardt T, Kállay E. The impact of serine/threonine phosphorylation in regulating expression of the vitamin D metabolizing enzyme CYP24A1 in colon cancer9th PhD-Symposium of the Medical University of Vienna, Vienna, Austria, June 19-20, 2013
55. Fetahu I S, Hummel D M, Manhardt T, Aggarwal A, Baumgartner-Parzer S, Kallay E: Regulation of the calcium-sensing receptor expression by 1,25-dihydroxyvitamin D3, interleukin-6, and tumor necrosis factor alpha in colon cancer cells. 16th Vitamin D workshop, June 11-14, 2013, San Francisco, CA, USA.
56. Aggarwal A,.Höbaus J,. Fetahu I Sh, Mesteri I.& Kállay E: The mechanism behind the antiproliferative effect of calcium in colonocytes. 18th ÖGES Annual meeting of the Austrian Society for Endocrinology and Metabolism, April 18-19, 2013, Linz, Austria
57. Fetahu I S, Höbaus J, Aggarwal A, Hummel D, Mesteri I, Baumgartner-Parzer S, Kallay E: Role of epigenetic alterations in regulating the expression of the calcium-sensing receptor in colorectal cancer. 18th ÖGES Annual meeting of the Austrian Society for Endocrinology and Metabolism, April 18-19, 2013, Linz, Austria.
58. Aggarwal A, Tennakoon S, Wohlgenannt M, Höbaus J, Boudot C, Mentaverri R, Baumgartner-Parzer S, Kallay E: Loss of the Calcium Sensing Receptor provides a growth advantage to colon cancer cells. 18th ÖGES Annual meeting of the Austrian Society for Endocrinology and Metabolism, April 18-19, 2013, Linz, Austria
59. Aggarwal A, Wohlgenannt M, Tennakoon S, Höbaus J, Boudot C, Mentaverri R, Baumgartner-Parzer S, Kallay E: Calcium mediated growth control in normal and
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
22
transformed colon cells: A possible role of the CaSR. American Association for Cancer Research Annual Meeting, USA April 6-10, 2013
60. Höbaus J, Aggarwal A, Hummel D, Thiem U, Fetahu I, Mesteri I, Kallay E. Overexpression of the vitamin D catabolizing enzyme CYP24A1 is caused by gene amplification and results in highly proliferative colorectal tumors, American Association for Cancer Research Annual Meeting, USA April 6-10, 2013
61. Fetahu I S, Höbaus J, Aggarwal A, Hummel D, Tennakoon S, Mesteri I, Baumgartner-Parzer S, Kallay E: Epigenetic modulators and calcium-sensing receptor expression in colorectal cancer cells. American Association for Cancer Research Annual Meeting, USA April 6-10, 2013
62. Tennakoon S, Schmid J, Marian B, Kallay E. Influence of extracellular calcium on MAPK signalling cascade in colon cancer cells; American Association for Cancer Research Annual Meeting, USA April 6-10, 2013
63. Singer J, Weichselbaumer M, Stockner T, Mechtcheriakova D, Sobanov Y, Bajna E, Wrba F, Horvat R, Thalhammer JG, Willmann M, Jensen-Jarolim E. ErbB-1 and ErbB-2 in canine mammary cancer – promising targets for comparative oncology. Annual Meeting of VIA 2013 (Veterinär-immunologischer Arbeitskreis) of the German Society of Immunology, Vienna, Austria, April 5-6, 2013.
64. Szalai K, Satorina J, Willensdorfer A, Jensen-Jarolim E. Do hypoallergenic cats exist? Fel d 1 secretion in normal versus hypoallergenic cats. Annual Meeting of VIA 2013 (Veterinär-immunologischer Arbeitskreis) of the German Society of Immunology, Vienna, Austria, April 5-6, 2013.
65. Oida K, Hadzijusufovic E, Panakova L), Roth-Walter F, Singer J, Fazekas J, Willmann M, Valent P, Sazalai K, Tanaka A, Matsuda H, Jensen-Jarolim E. House dust mite allergens induce IgE-independent activation of canine mast cells NI-1. Annual Meeting of VIA 2013 (Veterinär-immunologischer Arbeitskreis) of the German Society of Immunology, Vienna, Austria, April 5-6, 2013.
66. Fazekas J, Singer J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E. Comparative oncology: generation of a passive EGFR-targeted immunotherapy in dogs. Annual Meeting of VIA 2013 (Veterinär-immunologischer Arbeitskreis) of the German Society of Immunology, Vienna, Austria, April 5-6, 2013.
67. Zimmer A, Szöllösi H, Starkl P, Scheicher B, Stremnitzer C, Hofmeister A, Roth-Walter F, Lukschal A, Diesner SC, Jensen-Jarolim E, Pali-Schöll I. Protamine-nanoparticles with CpG-ODN prevent an allergen-induced Th2-response in mice. 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Istanbul, Turkey. March 19-22, 2013.
68. Singer J, Fazekas J, Weichselbaumer M, Wang W, Mader A, Steinfellner W, Sobanov Y, Mechtcheriakova D, Matz M, Spillner E, Kunert R, Jensen-Jarolim E. Generation of a canine anti-ErbB-1 antibody for proof of concept studies of immunotherapy of cancer in veterinarian medicine.1st International symposium of the Cancer Research Center of Lyon (CRCL), February 13 - 15, 2013, Lyon, France.
g) Teaching Scripts and Books: n = 0
h) Articles in Medical Journals: n = 0
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
23
i) Public activity: n = 14 Erika Jensen-Jarolim 1. derstandard.at, Was mich nicht umbringt, macht mich stärker, November 13, 2013
2. News.at red. ROTE PFOTE Charity Event für die Krebsforschung: Die Volkskrankheit Krebs macht auch vor unseren vierbeinigen Lieblingen nicht Halt. November 13, 2013
3. Forschen und Entdecken. Mensch und Tier. Wiener Forscherinnen definieren vergleichende Forschung neu und erzielen damit erste Erfolge. September 2, 2013
4. OTS0273 17:37 RotePfote Travel Award für drei junge WissenschafterInnen der Komparativen Medizin. May 8, 2013
5. Profil, No 17 Aus für Allergien,part 2.By Alwin Schönberger, April 22, 2013
6. Profil, No 16. Aus für Allergien, part 1.Durchbruch im Kampf gegen die quälenden Überempfindlichkeiten. ByAlwin Schönberger, April 15, 2013
7. Labormedizin Austria, 1/2013. Biomarker relevant für die Komparative Medizin. Von Durchbruch im Kampf gegen die quälenden Überempfindlichkeiten, April 15, 2013
8. Heureka, Falter.at, Ausgabe: Sport und Gesellschaft (3/13) Was sagen S‘, Frau Doktor, i soll zu an Tierarzt geh‘n? Anfang Mai eröffnete das Labor für Komparative Medizin an der Vetmeduni Wien. BySonja Dries
9. "New Scientist" Wissenschaftsmagazin. Kristin Hüttmann. March 2013. Eva Untersmayr-Elsenhuber 1. Interview Gesünder Leben 10/2013, S.12-16
2. Interview Gesundheit - einfach gut leben “Ganz schön stark, dieses Immunsystem” August 2013
Diana Mechtcheriakova
1. IPA Impuls Seminar, Activation-induced cytidine deaminase (AID): AIDing in B-cell
immunity, chronic inflammation and cancer, Medical University of Vienna, November 2013
2. Immunology Research Cluster, December 2013
3. summer students (n=2) from FH Campus Vienna j) Radio and TV interviews: n = 6 Erika Jensen-Jarolim 1. ORF2: Die Tricks der Pharmaindustrie. Aus Menschen und Mächte. A Film by Kurt
Langbein and Elisabeth Tschachler. 60 min. November 27, 2013
2. Russia-2 TV channel, by United Media Group: October 26, 2013. http://russia.tv/brand/show/brand_id/48303.
3. Arte, X:enius, Allergien bei Kindern – Neue Hoffnung für die Betroffenen? 27 min, September 26, October 11, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
24
4. Poddoktor: Die Histamin Intoleranz http://www.poddoktor.at/aktuell, October 3, 2013
5. 3sat. Die Akte Aluminium. A film by Bert Ehgartner. 60 min. September 25, 2013.
6. ARD/MDR "Hauptsache Gesund", Sodbrennen. By Dirk Heinemann. August 15, 2013
k) Lay Information: Brochures and Workshops: n = 14 1. Der Hund – Das Fachmagazin für Hundefreunde 12/2013: „Neue Krebsmedikamente
für den Hund“, page 42-44, December 2013
2. Newsletter Medical Unversity Vienna, „Satellite-Meeting to ISMA“ für komparative und veterinäre Allergologie am 5. Dezember. Printed December 4, 2013
3. Mein Haustier – Health Magazine for pets,: „Vergleichende Krebsforschung – Tier und Mensch als gleichberechtigte Partner“, page 46/47, November/December 2013
4. Mein Haustier–Health Magazine for pets, 5/2013, Lisa-Maria Glenk: Tiergestu tzte Therapie aus der Hundeperspektive. Wie ergeht es Hunden im Dienst der menschlichen Gesundheit? September 9, 2013
5. Mein Haustier– Health Magazine for pets,: „Allergietext heute und morgen – Verschiedene Testverfahren und die Entwicklung neuer Möglichkeiten“, page 14/15, July/August 2013
6. Public Day in Schönbrunn: Komparative Medizin: Allergien. June 15, 2013. Lecture.
7. Unser Hund (6/2013). Pressecorner. Rote Pfote Travel Award fu r drei junge WissenschafterInnen der Komparativen Medizin. By Katja Wolf. June 2013
8. Mein Haustier– Health Magazine for pets, Max/: „EINE Medizin für Tier und Mensch – Wegweisende Impulse aus Wien für vergleichende Forschung“, page 44/45, June 2013
9. MedUnique 04/2013. Von Tieren lernen. By Marianne Kitzler. April 2013
10. Rhodesian Ridgeback Club Österreich – Clubzeitung, 3/2013: „Die EINE Medizin für Mensch und Tier. Tumorerkrankungen und Allergien – Schwerpunkte der vergleichenden Forschung in Wien, page 16 - 18. March 2013
11. BreederSpecial 3/2013: „Zielgerichtete Therapien – Neue Wege in der tiermedizinischen Onkologie“, Seite 4–13, March 2013
12. Vetmagazin. Messerli Forschungsinstitut eröffnet neues Labor für Komparative Medizin, by Heike Hochhauser.
13. Your Dog. (?) Rote Pfote – Krebsforschung zum Wohle von Mensch und Tier. By Viola Windsteig.
14. Tierfestival Donauinsel, Vienna. Komparative Medizin: Allergien.Lecture.
1.1.2. Research Awards: n = 22
Franziska Roth-Walter 1. Poster presentation Award at ISMA - International Symposium on Molecular Allergy,
Vienna, December 5th, 2013.
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
25
Anna Moskovich 1. EFIS travel grant to attend the International Congress of Immunology, ICI 2013 in
Milan;
Josef Singer 1. Travel Award to attend the EAACI-WAO Congress in Milan, Italy, June
Judit Fazekas 1. 2013 Research Award of the ÖKV – Austrian Association of Kynology
2. Rote Pfote – Cancer Research for Pets - Science Communication Award
3. Poster presentation Award at EAACI-WAO Congress 2013
4. EFIS Travel Grant to attend the International Congress of Immunology, ICI 2013 in Milan
Eva Untersmayr-Elsenhuber 1. Thesis Award of the Dr. Maria Schaumayer Stiftung
2. Abstract Award at EAACI/WAO Congress 2013 Cornelia Schultz (AG EUE): 1. ÖGAI Travel Grant für ICI Meeting 2013
2. Exzellenz-Stipendium der Industriellenvereinigung Kärnten
3. Stipendium der Marshall Plan Foundation
Charlotte Gröschel (AG EK) 1. Poster Presentation Award at the retreat of the CEPII, Medical University of Vienna,
2013.
Irfete Fetahu(AG EK) 1. Youth Travel Fund from the Federation of Biochemical Societies (FEBS) to attend the
workshop on: "Translating epigenomes to function: a next generation challenge to human disease" in Capri, Italy, 13-16 October 2013.
2. Young Investigator Award by the Austrian Society for Endocrinology and Metabolism, Linz, 18-19 April 2013.
Abhishek Aggarwal(AG EK) 1. Poster Presentation Award at CEPII retreat of Medical University of Vienna, 2013.
2. 3. Science Communication Award RotePfote – Cancer Research for pets.
Martin Svoboda (AG DM) 1. Poster Presentation Award at CEPII retreat of Medical University of Vienna, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
26
Elfi Scharf (AG DM) 1. Poster Presentation Award at CEPII retreat of Medical University of Vienna, 2013
Anastasia Meshcheryakova(AG DM) 1. Poster Presentation Award at CEPII retreat of Medical University of Vienna, 2013
2. EFIS travel grant to attend the International Congress of Immunology, ICI 2013 in Milan;
3. Poster Award, 9th YSA-PhD-Symposium, Medical University of Vienna, June 19-20, 2013.
Travel Grants n=4 1. EFIS travel grant to Anastasia Meshcheryakova to attend the International Congress of
Immunology, ICI 2013 in Milan. (600 Eur)
2. Travel grant and stay abroad to Martin Svoboda to cover mobility sponsored by Nebion, Zürich, Switzerland (10.785 Eur)
3. Comprehensive Cancer Center Travel Grant to Samawansha Tennakoon to attend the Annual Meeting of the American Association for Cancer Research in Washington D.C., 6-10 April 2013. (2000 Euro)
4. Comprehensive Cancer Center Travel Grant to Irfete Fetahu to attend the cell Symposia on Cancer Epigenomics in Melia, Spain, 6-8 October 2013.(2000 Euro)
1.1.3. Invited lectures: n = 13 Erika Jensen-Jarolim 1. Comparative oncology: Development of xenogenic vaccines and recombinant
antibodies for dog mammary cancer patients. Cold Spring Harbor Asia Conference: Tumour Immunology and Immunotherapy. Suzhou, China. October 31, 2013.
2. From tumor vaccines to IgG and IgE anti-cancer therapies.Agricultural Universoty Tokyo, Japan. Oct. 4, 2013
3. „Komparative Medizin: Von der Allergologie zur Onkologie“, Annual Meeting of the Austrian Small Animal Veterinarians (VÖK), Salzburg, September 20-21, 2013
4. Allergien im Wechselspiel mit anderen Erkrankungen: Komorbiditäten, Jahrestagung der Deutschen Gesellschaft für Allergologie, Bochum, September 6, 2013
5. Von der Nahrungsmittelallergie zur AllergoOnkologie. In: Netzwerk Schweres Asthma, Stuttgart, Germany, Juli 4, 2013
6. „Neues aus der Komparativen Medizin“, Impulse-Seminar, Medizinische Universität Wien, May 3, 2013
7. Comparative Allergology and Oncology: approaches to Allergo-Oncology“. Research Meeting, Institut für Medizinische Genetik, Medizinische Universität Wien, April 30,2013
8. News in allergy & food allergy: from molecules to clinic. In: International Comparative Medicine Symposium: Comparative allergolog. April 19, 2013, Vienna, Austria
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
27
Franziska Roth-Walter 1. Impact of food processing on the allergenic potential of dietary antigens. International
Comparative Medicine Symposium, April 19, Vienna, Austria
Eva Untersmayr-Elsenhuber 1. Medikamentöse Unterdrückung der Magensäure und Nahrungsmittelallergien.
AllergyClub Seminar (March 19, 2013, Vienna, Austria)
2. Neue Therapiestrategien bei Nahrungsmittelallergien. Drug targeting lecture series, University Vienna, Department of Pharmaceutical Technology and Biopharmaceutics (November 27 2013, Vienna, Austria)
Enikö Kallay
1. E. Kallay: 2013, October 31. Semmelweis University, Budapest, 2nd Department of
Medicine: “Vitamin D, a powerful weapon in the war against cancer (hype or reality?)”
2. E. Kallay: 2013, October 9. Chirurgie (MeduniWien) : „Vitamin D und Karzinomentstehung“
1.1.4. Congress organization
Division member Name:
National congress
Name, date
Function
Intern. congress, Name, date
Function
Jensen-Jarolim Intern. Comparative
Medicine Symposium,
April 19, 2013
Host
Jensen-Jarolim Satellite Symposium to ISMA, Decemper 5th,
2013
Host
1.1.5. Hosting speakers
division member Speaker´s name Affiliation Date
Jensen-Jarolim Rainer Ehmann, MD Center for Asthma, Stuttgart, Germany
Nov 8, 2013
Jensen-Jarolim Dr. Jozef Janda Academy of Sciences of Czech Republic
April 19, 2013
Jensen-Jarolim Dr. Luis Fernandez Pacios, Polytechnic Univ. Madrid, Spain
April 19, 2013
Jensen-Jarolim Prof. Araceli Diaz-Perales, PhD, Polytechnic Univ. Madrid April 19, 2013
Jensen-Jarolim Prof. Ines Swoboda FH Campus Vienna April 19, 2013
Jensen-Jarolim Prof. Ralf Müller Center of Animal health, Munich, Germany
December 6, 2013
Jensen-Jarolim Prof. Eliane Marti Vetsuisse Faculty, University of Berne,
Switzerland
December 6, 2013
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
28
Jensen-Jarolim Dr. Jozef Janda Academy of Sciences of Czech Republic
December 6, 2013
Jensen-Jarolim Dr. Claudio Rhyner SIAF, Swiss Institute of Allergy and Asthma
Research
December 6, 2013
Jensen-Jarolim Prof. Hiroshi Matsuda Agricultural University Tokyo, Japan
December 6, 2013
1.1.6. Mobility
Name Program University, Land Time frame Div In Out
Martin Svoboda Ad hoc Univ. Zürich 2 months DM X
Caroline Stremnitzer
Exchange INSERM, Université Lille 2; Faculté de Médecine; Lille, France
6 months in 2013
30.October 2012 - 1.May
2013
Franziska Roth-Walter
Thesis examin. of C. Gomez-
Casado
Madrid, Spain. 1-2 dec 2013 X
Kumiko Oida, DVM, PhD stud.
SFB Agricultural University, Tokyo, Japan 12 months X
Anna Moskovskich, MSc student
Erasmus Karolinska . FH Vienna 9 months X
Alexandra Schoos, Dipl. student
Vetmed Uni Vienna
Germany 8 months X
Judit Fazekas MSc, FH Vienna
Hungary 6 months X
Emilie Blixt Erasmus Karolinska . FH Vienna 2 months X
Josef Singer Croucher Summer Course in Cancer
Biology by the AACR& University of Hongkong
Hongkong, China, August 14-18, 2013
<1month, 3 days
X
Martin Svoboda FWF + travel grant
ETH/Nebion, Zürich, Switzerland 07.2013 -08.2013
1 X
1.1.7. Activities in Advisory Boards
Name Society/Institute/Journal Function
Erika Jensen-Jarolim WWTF – Viennese Fund fort eh Promotion of Technology and Research
Member of board of trustees
Erika Jensen-Jarolim Research Center Borstel Member of Scientific Advisory Board
Erika Jensen-Jarolim Senate of Medical University Vienna Member
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
29
Erika Jensen-Jarolim Senate of University of Veterinary Medicine, Vienna
Member
Erika Jensen-Jarolim Steering Committee for the Research Strategy of Lower Austria
Steering Committee member
Erika Jensen-Jarolim Center for Regenerative Medicine and Orthopedics, Donau- Universität Krems
Member of Advisory Board
Erika Jensen-Jarolim Verein RotePfote President
Erika Jensen-Jarolim Österr. Gesellschaft für Allergologie und Immunologie
Delegate to World Allergy Organization
Erika Jensen-Jarolim European Academy of Allergy and Clinical Immunology
Board Member of Interest Group for Comparative and Veterinary Allergology
1.1.8. Editorial Activities
Name Journal Function
Erika Jensen-Jarolim World Allergy Organization Journal
Editor
Erika Jensen-Jarolim Wiener Medizinische Wochenschrift
Scientific Council
Erika Jensen-Jarolim Allergo Journal Scientific Council
Erika Jensen-Jarolim Immunology Letters Editorial Board member
Erika Jensen-Jarolim The Open Allergy Journal Editorial Board member
Erika Jensen-Jarolim Journal of Biorepository Science for Applied Medicine, Dove Press;
Editorial Board member
1.1.9. Review Activities Name Grants/Thesis/Habilitation
Erika Jensen-Jarolim
In Commissions of the Senate of the Medical University Vienna
Member of Appointment commission for professorships
Chemical Safety and Cancer Prevention
Experimental and Applied Oncology
Mouth-, Jaw- and Face-Surgery
Teeth-, Mouth- and Jaw Surgery of Children
Transgenic Models
Erika Jensen-Jarolim
In Commissions of the Senate of the Medical University Vienna and of the University of Veterinary Medicine, Vienna
Member of commission for the double appointment professorships
Laboratory Animal Pathology
Translational Models in Cancer Research
Erika Jensen-Jarolim,
Wiener Med. Wochenschrift: WMWO-D-13-00097
Gerontology.: 201302017, 201302017
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
30
Reviews for journals Clinical and Developmental Immunology 385615
Cancer Immunology, Immunotherapy CIIM-D-13-00195
Clin. Exp. Allergy: CEA-2013-0238-AJW.R1
CEA-2013-0238-AJW
CEA-2013-0070-ROH
CEA-2012-0657-AJW
Allergy: ref number ALL-2013-00464
International CONsensus (iCON) on drug allergy
Expert Review of Vaccines, ms
World Allergy Organization Journal: WAO-ARIA-GA2LEN Consensus Document
Erika Jensen-Jarolim Coordinator of “fachbereichsnahe” Professors”; Habilitation Franziska Roth-Walter, ongoing.
Erika Jensen-Jarolim Member of Habil. Committee of Gorji Marzban, Boku Vienna. Closed.
Erika Jensen-Jarolim Member of Habilitation Committee of Dr. Michael Leschnik, Vetmeduni Vienna. Closed.
Erika Jensen-Jarolim Member of Habilitation Committee of Dr. Friederike Range, Vetmeduni Vienna. Closed.
Erika Jensen-Jarolim Reviewer of Animal studies submitted for approval to the City of Vienna, Magistratsabteilung 58; n=4
Erika Jensen-Jarolim Reviewer for the disposition of the title “Univ.Prof“ at the Medical University Vienna, n=1
Erika Jensen-Jarolim Reviewer of the Diploma thesis of Anna Matiasek at the University of veterinary Medicine Vienna
Erika Jensen-Jarolim Co-Supervisor of the Diploma Work of Ms. Helen Szöllösi, CCC, Medical University Vienna
Erika Jensen-Jarolim Reviewer of the PhD thesis and examinator of Barbara Bachler at the University of Veterinary Medicine Vienna
Erika Jensen-Jarolim Reviewer of the Diploma thesis of Susanne Bergmann at the University of veterinary Medicine Vienna
Beatrix Pfanzagl Reviews for Journals
Biochemistry
Cell Communication and Signaling
Eva Untersmayr-Elsenhuber
Reviews for Journals
Journal of Allergy and Clinical Immunology
Clinical and Experimental Allergy
Pediatric Research
Journal of Allergy
Allergy and Asthma Proceeding
Eva Untersmayr-Elsenhuber
Reviewer of Animal studies submitted for approval to the City of Vienna, Magistratsabteilung 58; n=3
Enikö Kallay Reviewer for EU:
REA-FP7-PEOPLE-2013-ITN
Enikö Kallay Reviewer for EU:
REA-FP7- PEOPLE-2013-IEF; REA-FP7- PEOPLE-2013-IIF; REA-FP7-
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
31
PEOPLE-2013-IOF
Enikö Kallay Reviewer of the PhD thesis and examiner of Mr. Thomas Davies, of Cardiff University, UK.
Enikö Kallay Reviewer for the disposition of the title “Assoc. Prof“ at the Tel- Aviv University for Dr. Amiram Ravid
1.1.10. Filed and granted patents not disclosed
Name Patent
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
32
1.1.11. Grants Uni Funding agency Title of project Principal investigator
Vet WWTF, LS12-060 Life Sciences 2012 - Food and Nutrition
Epidemiology of food allergy in and around Vienna and the impact of filaggrin gene loss-of-function mutation on food allergy.
Tamar Kinaciyan & Isabella Pali-Schöll
Vet Deutsches Umwelt-Bundesamt
Das Gefährdungspotenzial des Eichenprozessionsspinners Maier H, et al, et
Erika Jensen-Jarolim
Med FWF (Austrian Science Fund) doctoral college, MCCA – Molecular, Clinical and Cellular Allergology, W 1248-B13, part I: Students employed: Einhorn
Comparing allergic mechanisms in humans & dogs to promote the development of immunotherapeutical strategies.
Erika Jensen-Jarolim, Co-Applicant Franziska Roth-Walter
Vet FWF (Austrian Science Fund) doctoral college, CCHD - Cell Communications in Health and disease W1205-B09, part III: Students employed: Stremnitzer, Singer, Fazekas, 1 to be recruited 2014
Cellular interactions decisive for immune response to oral antig.
Erika Jensen-Jarolim
Med FWF P23398-B11
Targeting ERbB-1 and ERbB-2 overexpressed in cancer of dog by passive immunotherapy with lgG versus lgE antibodies.
Erika Jensen-Jarolim
Med FWF F4606-B19
Development of mimotope vaccines for preclinical and comparative medicine studies.
Erika Jensen-Jarolim, Co-Applicant Isabella Pali-Schöll
Mes Medical part in the Messerli Joint project (Socio-cognitive Abilities of pigs, ethical implications, medical Indicators for Wellfare)
Erika Jensen-Jarolim, Co-Applicant Lisa-Maria Glenk
Med FWF (Austrian Science Fund), KLIF 284
Sphingosine-1-phosphate as a biomarker for disease severity of food adverse
reaction.
Eva Untersmayr-Elsenhuber
Med FWF (Austrian Science Fund), B21884-B11
Microparticles for oral immunotherapy of type I food allergy.
Eva Untersmayr-Elsenhuber
Med FWF P22200-B11
Is cyp24a1 a proto-oncogene? A novel role for the catabolic vitamin D3 hydroxylase in tumourigenesis.
Enikö Kallay
Med Herzfelder’sche Familienstiftung AP00422OFF
Is calcium sensing receptor a tumour suppressor in colorectal cancer?
Enikö Kallay
Med FP7-264663
Dietary Vitamin Da powerful weapon in the war against colorectal cancer.
Enikö Kallay
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
33
Med WWTF FA648A0407
Dietary Vitamin Da powerful weapon in the war against colorectal cancer.
Enikö Kallay
Med Herzfelder’sche Familienstiftung AP00563OFF
Modulating the Wnt-pathway in Premalignant Colorectal Adenoma in collaboration with B. Marian (Innere Med. I. Inst Cancer Research)
Enikö Kallay
Med FWF APP22441FW
AID-gene regulatory network in cancer.
Diana Mechtcheriakova
Med FWF APP23228FW
Sphingolipid-related genes in cancer.
Diana Mechtcheriakova
1.1.12. Career Developments a) Habilitations: n = 0 b) Habilitations in progress: n = 1 c) Professorships: n = 0 d) Qualification Agreement: n = 0 e) Expert status: n = 2 1. Cornelia Schultz (completed),
2. Erika Bajna (ongoing)
1.1.13. Teaching a) Bachelor students: n = 2 Erika Jensen-Jarolim 1. Sarah Meitz: characterisation of a canine anti-EGFR IgG antibody in
immunohistochemistry.
Diana Mechtcheriakova 1. Nadja Seidl: “Assessment of the role of activation-induced cytidine deaminase, AID,
during the epithelial-to-mesenchymal transition program” (2012-2013). University of Vienna
b) Diploma, MDiploma and Master students: n =15 Erika Jensen-Jarolim 1. Martina Muhr (iMHAi): Generation and characterization of a recombinant, soluble form
of feline FcεRIα for chip diagnosis of feline allergy
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
34
2. Alexandra Schoos (Vetmed): Generation and characterization of a recombinant, soluble form of canine FcεRIα for chip diagnosis of canine allergy
3. Emilie Blixt: Immunological properties of the lipocalin allergen ?-lactoglobulin
4. Anna Moskovskich: NF-?B inhibition, induction of apoptosis and inhibition of proliferation in immune cells by cinnamaldehyde
5. Julia Satorina: „Do hypoallergenic cats exist? - Secretion of Fel d 1 in the Neva Masquarade versus domestic cat breeds.“
6. Gesa Bindke: Immunological assessment of Aleuria aurantia lectin
7. Helen Szöllösi: Protamine based nanoparticles with CpG-oligodeoxynucleotides as a suitable carrier system for the induction of a TH1 mediated immune response
Eva Untersmayr-Elsenhuber 1. Vera Elisabeth Assmann: MSc Thesis. "Factors influencing food allergy elicited by
gastric acid suppression in a murine model“ (start 2011 – 09/2013) University of Vienna
2. Katharina Beitl: MSc Thesis “Functionalized allergen-loaded PLGA microparticles for oral immunotherapy of type I food allergy in a murine food allergy model of oral immunizations under gastric acid suppression” (start 2013 – ongoing) University of Vienna
3. Anna Ondracek: MSc Thesis “The immunostimulatory capacity of nitrated food proteins” (start 2013 – ongoing) University of Vienna
Enikö Kallay 1. Lukas Gober: Role of microRNAs in regulating the vitamin D
2. Maximilian Wohlgennannt: Impact of the extracellular calcium sensing receptorin regulating proliferation and differentation of normal and neoplastic intestinal cells
Diploma students from University of Vienna (AG DM): 1. Tamara Kaufmann: Diploma Thesis „Activation-induced cytidine deaminase (AID):
potential novel biomarker and/or target during epithelial-to-mesenchymal transition program in cancer” (2011-2013). University of Vienna
2. Susi Wöhrer: Diploma Thesis “The TissueFAXS-based algorithm to assess the prognostic significance of tumor-infiltrating immune cells in ovarian carcinoma” (2012-ongoing). University of Vienna
3. Elfi Scharf: Diploma Thesis “The distribution pattern and prognostic power of tumor-infiltrating macrophages in ovarian carcinoma” (2012-ongoing). University of Vienna
c) PhD, MDSci, MD students: n =14 Erika Jensen-Jarolim 1. Caroline Stremnitzer (CCHD): “The molecular requirements of house dust mite
allergens to induce allergic skin inflammation”
2. Josef Singer (CCHD): IgE-based Immunotherapies of Cancer - a Comparative Oncology approach
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
35
3. Judit Fazekas (CCHD): IgE-based Immunotherapies of Cancer - a Comparative Oncology approach
4. Lukas Einhorn (MCCA): Recombinant species-specific FcεRIα for molecular diagnosis and comparative study of allergic diseases in veterinary patients
5. Kumiko Oida: A study on molecular mechanisms of breast cancer tumorigenesis
6. Galateja Jordakieva: Blutzelldynamik nach Allergenexposition bei Sensibilisierten Diana Mechtcheriakova 1. Anastasia Meshcheryakova: PhD thesis; start 2011 - ongoing. Medical University
Vienna Enikö Kallay 1. Julia Höbaus: Mechanisms of 25-Hydroxyvitamin D3-24-Hydroxylase Overexpression
in Colorectal Cancer
2. Doris Hummel: Is the vitamin D 25 hydroxylase an oncogene?
3. Irfete Fetahu: Regulators of the Calcium Sensing Receptor in colorectal cancer
4. Samawansha Tennakoon: Ligand-dependent CaSR signalling in colonocytes
5. Abishek Aggarwal: Role of CaSR in proliferation of Colon Cancer Cells"
6. Charlotte Gröschel: Modulating the Wnt-Pathway in Colorectal Adenoma Cells, role of Vitamin D.
7. Ursula Thiem: Vitamin D and the immune system: Evaluation of the effects of high-dose vitamin D3 therapy in the immune response in vitamin D deficient kidney transplant recipients.
1.1.14. Exams a) Oral examinations: n = 0 b) Bachelor, Diploma and Thesis-Examinations:n=1 1. Vera Elisabeth Assmann. 25.09.2013, 15:00 c) Exam supervising: n= 0
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
36
1.1.15. Lectures, Seminars, Lab courses SWST pro-rata LV Nr.
SS 2013
Jensen-Jarolim Erika 2.00 0.67 648.010 Progress Report in Comparative Allergology, Oncology and Immunology
Jensen-Jarolim Erika 2.00 0.67 860.059 TS: New Developments and comparative aspects in allergology, oncology and immunology Jensen-Jarolim Erika 2.00 0.35 860.079 JC New Developments and comparative aspects in allergology, oncology and immunology Jensen-Jarolim Erika 2.00 0.15 860.940 CCHD Journal Club - SS 2013 Jensen-Jarolim Erika 5.00 5.00 648031 Wissenschaftliche Arbeiten (Wahlfachausbildung für Dissertanten gem. § 13/1 lit. a StG) Kallay Enikö 2.00 0.67 648.010 Progress Report in Comparative Allergology, Oncology and Immunology Kallay Enikö 1.00 0.34 860.014 Creative and critical Journal Club IV
Kallay Enikö 2.00 0.67 860.059 TS: New Developments and comparative aspects in allergology, oncology and immunology Kallay Enikö 2.00 0.23 860.300 Basic Seminar Malignant Diseases II Mechtcheriakova Diana 2.00 0.66 648010 Progress Report in Comparative Allergology, Oncology and Immunology Mechtcheriakova Diana 2.00 0.66 860.059 TS: New Developments and comparative aspects in allergology, oncology and immunology Mechtcheriakova Diana 2.00 0.20 860.079 JC New Developments and comparative aspects in allergology, oncology and immunology Pfanzagl Beatrix 2.27 2.00 802.001 BL 4 - Funktionssysteme und biologische Regulation Pfanzagl Beatrix 2.27 6.78 802.001 BL 4 - Funktionssysteme und biologische Regulation Singer Josef 2.00 0.60 860079 JC New Developments and comparative aspects in allergology, oncology and immunology
Sum 19.65
WS 2013/14 Jensen-Jarolim Erika 2.00 0.18 562019 BVo: Immunologie Jensen-Jarolim Erika 5.00 2.50 648013 Wissenschaftliche Arbeiten (Wahlfachausbildung für Dissertanten gem. § 13/1 lit. a StG) Jensen-Jarolim Erika 2.00 0.67 648802 Progress Report in Comparative Allergology, Oncology and Immunology Jensen-Jarolim Erika 2.00 0.33 860060 JC New Developments and comparative aspects in allergology, oncology and immunology Jensen-Jarolim Erika 2.00 0.50 860061 TS: New Developments and comparative aspects in allergology, oncology and immunology Jensen-Jarolim Erika 4.00 0.10 860116 Basic Seminar: CCHD - WS 2013 Jensen-Jarolim Erika 6.00 0.15 860585 TS: CCHD Doctoral Seminar - WS 2013 Jensen-Jarolim Erika 2.00 0.05 860925 JC: CCHD - WS 2013 Jensen-Jarolim Erika 2.00 0.13 861007 MCCA Journal Club Kallay Enikö 1.13 0.27 801001 BL 1 - Gesunde und kranke Menschen Kallay Enikö 1.00 1.00 801011 Problemorientiertes Lernen - 1. Semester
Performance Report 2013 – Division 1
Comparative Immunology and Oncology
37
Kallay Enikö 5.80 0.27 803002 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder Kallay Enikö 1.00 0.33 860013 JC: Creative and critical Journal Club V Kallay Enikö 2.00 0.50 860061 TS: New Developments and comparative aspects in allergology, oncology and immunology Kallay Enikö 2.00 0.20 860966 Basisseminar: Zelluläre Signaltransduktion - WS 2013 Kallay Enikö 5.00 5.00 514051 Wachstumsregulation humaner Kolontumorzellen - (Wahlfachausbildung gem. § 13 StG) Kallay Enikö 2.00 0.67 648802 Progress Report in Comparative Allergology, Oncology and Immunology Mechtcheriakova Diana 2.00 0.33 860060 JC New Developments and comparative aspects in allergology, oncology and immunology Mechtcheriakova Diana 2.00 0.50 860061 TS: New Developments and comparative aspects in allergology, oncology and immunology Mechtcheriakova Diana 2.00 0.66 648802 Progress Report in Comparative Allergology, Oncology and Immunology Pfanzagl Beatrix 1.13 0.27 801001 BL 1 - Gesunde und kranke Menschen Pfanzagl Beatrix 1.00 1.00 801011 Problemorientiertes Lernen - 1. Semester Pali-Schöll Isabella 3.00 0.07 805000 BL 13 - Ernährung und Verdauung Pali-Schöll Isabella 2.00 0.33 860060 JC New Developments and comparative aspects in allergology, oncology and immunology Pali-Schöll Isabella 2.00 0.50 860061 TS: New Developments and comparative aspects in allergology, oncology and immunology Singer Josef 1.13 0.53 801001 BL 1 - Gesunde und kranke Menschen Singer Josef 2.20 0.27 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder Untersmayr-Elsenhuber Eva 3.00 3.00 648011
Immunpathologische Laboratoriumstechnik - mit Demonstrationen (Wahlfachausbildung gem. § 13/1 lit. a StG)
Untersmayr-Elsenhuber Eva 5.00 2.50 648013 Wissenschaftliche Arbeiten (Wahlfachausbildung für Dissertanten gem. § 13/1 lit. a StG) Untersmayr-Elsenhuber Eva 3.00 0.21 896014 Basics in Gender Medizin 1 Hummel Doris 2.20 0.27 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder Gröschel Charlotte 2.20 0.27 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Sum 23.56
Total sum SS+WS 43.21
Performance Report 2013– Division 2
Cellular and Molecular Pathophysiology
38
1.2. Division for Cellular and Molecular Pathophysiology Head: Peter Pietschmann, MD, Associate Professor
1. Publications5
IF Number Top/Std/Subst
Isabella Ellinger 3.711 1 xx St
Renate Fuchs 2.163 1 xxTop, xx St
Peter Pietschmann 7.441 2.6 xx Top, xx St, xx SSt
Theresia Thalhammer 5.011 5 xx St
Division-Sum 18.326 9.6
Top point score 2 - among top 20 % of journal in field
Standard point score 1 - between 21-60 %, Substandard point score 0,2
2. Supervision of diploma and doctoral students
Bachelor st. Diploma st. Doctoral st.
Isabella Ellinger 0 6 1 Renate Fuchs 0 3 1 Peter Pietschmann 1 5 4
Theresia Thalhammer 1 15 3
Sum 2 29 9
3. Teaching SS* WS* total W+S oral Exams
Isabella Ellinger 5.58 8.81 14.39 0 Renate Fuchs 3.41 12.82 16.23 0 Peter Pietschmann 6.92 18.82 25.74 0
Theresia Thalhammer 3.26 0.43 3.69 0
Jürg Graf 0.60 1.00 1.60 0
Sum 19.77 41.88 61.65 0
5 For working groups IFs of all publications including joint publications with other working groups are presented. In contrast, the
given sum of the division represents the net value of IFs without overlaps due to joint publications.
Performance Report 2013– Division 2
Cellular and Molecular Pathophysiology
39
1.2.1. Publications a) Peer-reviewed original articles: n = 6
Nr. Article IF Class pro-rata
IF
1. Heindl, A., A.K. Seewald, T. Thalhammer, G. Bises, M. Schepelmann, H. Uhrova, S. Dekan, I. Mesteri, R. Rogojanu, and I. Ellinger. Automated recognition of tissue-associated erytrhocytes (ARETE) – a new tool in tissue cytometry. Cytometry A 2013; 83:363-374
3.711 Std
3.711
2. Ruiz de Garibay, A.P., MA Solinís Aspiazu, A. Rodríguez Gascón, H. Ganjian, and R. Fuchs. Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors. J Gene Med 2013;15:427-440
2.163 Std 2.163
3. Maier-Salamon A., M. Böhmdorfer, J. Riha, T. Thalhammer, T. Szekeres, and W. Jäger. Interplay between metabolism and transport of resveratrol. Ann N Y Acad Sci 2013;1290:98-106
4.364 Top 0.873
4. Aust, S., A. Bachmayr-Heyda, D. Pils, L. Zhao, W. Tong, A. Berger, M. Fogel, T. Thalhammer, J. Sehouli, R. Horvat, R. Zeillinger, D.C. Castillo-Tong. Determination of tumor-infiltrating CD8+ lymphocytes in human ovarian cancer. Int J Gyneocol Pathol 2013;32:269-276
1.413 Subst
0.283
5. Bachmayr-Heyda, A, S. Aust, G. Heinze, S. Polterauer, C. Grimm, E.I. Braicu, J. Sehouli, S. Lambrechts, I. Vergote, S. Mahner, D. Pils, E. Schuster, T. Thalhammer, R. Horvat, C. Denkert, R. Zeillinger, and D.C. Castillo-Tong. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients – a study of the OVCAD consortium. BMC Cancer 2013;13:422-429
3.333 Std 0.667
6. Haisan A, Rogojanu R, Croitoru C, Jitaru D, Tarniceriu C, Danciu M, Carasevici E. Digital Microscopy assessment of angiogenesis in different breast cancer compartments. BioMed Research Int 2013;Article ID 286902, 1-10
2.880 Std 0.576
sum 14.984 8.273
b) Invited Articles & Reviews with IF: n = 9 Nr. Article IF Class pro-rata
IF
1. Rauner, M., W. Sipos, S.Thiele, and P. Pietschmann. Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities. Int Arch Allergy Immunol 2013;160:114-125
2.248
Std 2.248
2. Pietschmann, P, U. Föger-Samwald, W. Sipos, and M. Rauner. The role of cathepsins in osteoimmunology. Critical ReviewsTM in Eukaryotic Gene Expression 2013;23:11-26
2.065 Std 2.065
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
40
3.
4.
5.
6.
7.
8.
9.
Lechleitner, M., K. Pils, R. Roller-Wirnsberger, E. Beubler, R. Gasser, P. Mrak, F. Hoppichler, and P. Pietschmann. Diabetes und Osteoporose – Pathophysiologische Interaktionen und klinische Bedeutung für geriatrische Pathienten. Z Gerontol Geriat 2013;46:390-397
Kerschan-Schindl, K, J. Haschka, B. Obermayer-Pietsch, R.W. Gasser, H.P. Dimai, A. Fahrleitner-Pammer, H. Dobnig, P. Roschger, E. Preisinger, K. Klaushofer, H. Resch, and P. Pietschmann. How long women with postmenopausal osteoporosis should be treated with a bisphosphonate? Horm Metab Res 2013;45:621-628
Föger-Samwald, U, and P. Pietschmann. Gene expression analyses for osteoporosis research. Osteologie 2013;1:25-31
Tzakos, A.G., E Briasoulis, T. Thalhammer, W. Jäger, and V. Apostolopoulos. Editorial: Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer. J Drug Deliv 2013;Article ID 918304:1-5
Apostolopoulos, V., T. Thalhammer, A.G. Tzakos, and L. Stojanovska. Targeting antigens to dendritic cell receptors for vaccine development. J Drug Deliv 2013; Article ID 869718:1-22
Secky, L., M. Svoboda, L. Klameth, E. Bajna, G. Hamilton, R. Zeillinger, W. Jäger, and T. Thalhammer. The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors. J Drug Deliv 2013; Article ID 957605, 1-13
Buxhofer-Ausch, V., L. Secky, K. Wlcek, M. Svoboda, V. Kounnis, E. Briasoulis, A.G. Tzakos, W. Jäger, and T. Thalhammer. Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. J Drug Deliv 2013; Article ID 863539, 1-12
0.736
2.145
0.247
1.088
1.088
1.088
1.088
Subst
Subst
Subst
Subst
Subst
Subst
Subst
0.736
2.145
0.247
0.218
0.218
1.088
1.088
sum 10.705 10.053
c) Invited Articles & Reviews without IF: n = 1
1. Pietschmann, P. Editorial: Hyperparathyroidism. Wien Med Wochenschr 2013; 163:389-390
d) Book contributions: n = 5
1. Pietschmann P. Pathophysiologie des Alterns. In: Dorner TE (ed.) Public Health. Von den Gesundheitsbedürfnissen der Gesellschaft zu klinischen Implikationen. (MCW Block 22/23) Facultas WUV 2013, pp. 251-254
2. Pietschmann P, K. Kerschan-Schindl, K. Redlich, M. Aringer. Osteoporose und weitere metabolische Osteopathien. In: Stummvoll G, Pretterklieber ML, Kainberger F (eds). Bewegung und Leistung, Schmerz (MCW Block 21, 10. Auflage). Facultas Verlag 2013, pp. 148-162
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
41
3. Pietschmann P. Autoimmunendokrinologie. In: Ludvik B, Bischof M, Kraupp M, Luger A (eds). Endokrinologie und Stoffwechsel (MCW Block 10). Facultas 7. Auflage, Facultas Verlag 2013, pp. 18-25
4. Pietschmann P, Nanoff C, Dudczak R, Kainberger F. Knochen- und Kalzium-Stoffwechsel. In: Ludvik B, Bischof M, Kraupp M, Luger A (eds). Endokrinologie und Stoffwechsel (MCW Block 10).7. Auflage, Facultas Verlag 2013, pp. 204-217
5. Patsch J, Pietschmann P. Degenerative und altersassoziierte Erkrankungen. In: Marian B (ed). Krankheit, Krankheitsursachen und –bilder (MCW Block 8). Facultas 7. Auflage, Facultas Verlag 2013, pp.422-430
e) Abstracts, printed in periodicals: n = 8
1. Dorfer S., Kapfenberger A, Föger-Samwald U, Kudlacek S, Dovjak P, Pietschmann P. (2013) Serum levels of sclerostin and dickkopf-1 in geriatric patients with osteoporotic hip fractures. J Bone Miner Res 28 (Suppl 1) SU0291
2. Dovjak P, Föger-Samwald U, Dorfer S, Kapfenberger A, Kudlacek S, Pietschmann P (2013) Serum levels of sclerostin and dickkopf-1 in geriatric patients with osteoprotic hip fractures. Journal für Mineralstoffwechsel 20 (Sonderheft 2), p. 4
3. Föger-Samwald, Alaghebandan A, Patsch JM, Schamall D, Salem S, Mousavi M, Pietschmann P (2013) Bone microstructure in men with osteoporotic hip fractures. Journal für Mineralstoffwechsel 20 (Sonderheft 2), p 5
4. Kuessel L, Pietschmann P, Zeisler H. (2013) Datenmanagement und Plattformbildung für Osteoporose. Journal für Mineralstoffwechsel 20 (Sonderheft 2), p 8
5. Lamm C, Dockner M, Pospischek B, Patzak B, Pretterklieber M, Weber GW, Pietschmann P (2013) Micro-CT analyses of historical osteomyelitic bone samples from the “Narrenturm” (NHM). Journal für Mineralstoffwechsel 20 (Sonderheft 2), p 8
6. Nebot E, Aparicio VA, Föger-Samwald U, Wahl K, Camiletti-Moiron D, Martinez R, Kapravelou G, Porres JM, Lopez-Jurado M, Aranda P, Pietschmann P (2013) Do dietary protein amount, sourcer of protein, high-intensity exercice, and anabolic androgenic steroid administration affect bone microarchitecture in rats? Journal für Mineralstoffwechsel 20 (Sonderheft 2), p 11
7. Eric B, Geissler N, Erdenetsetseg R, Bajna E, Klameth L, Hamilton G, Thalhammer T, Geissler K (2013) Activated NOTCH-1 in cholangiocyte-derived hepatic tumors. Onkologie 36 (7), p 65.
8. Geissler N, Eric B, Rentsen E, Bajna E, Klameth L, Hamilton G, Thalhammer T, Geissler K (2013) GLI-1 is highly expressed in the tumor stroma in patients with liver malignancies. Onkologie 36 (7), p 65-66.
f) Abstracts, in congress proceedings or abstract books: n = 32
1. Buxhofer-Ausch V, Ausch C.A., Bauer H, Mollik Marina, Larijani A, Bajna E., Svoboda M, Kallay E, Reiner A, Kriwanek S, Sebesta C, Hamilton G, Zeillinger R, Thalhammer T. The prostaglandine E2 transporting organic anion transporting polypeptide OATP4A1: A potential prognostic marker in colorectal cancer? Gastrointestinal Cancers Symposium 2013, San Francisco, USA, 24. – 26. 1.2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
42
2. Thalhammer T, Svoboda M, Aust S, Klameth L, Secky L, Cacsire Castillo-Tong D. The prognostic value of estrogen-metabolizing enzymes (steroid sulfatase and estrogen sulfotransferase) and estrogen receptor alpha/beta in patients with advanced serous ovarian cancer. 2nd Congress on Steroid Research, Chicago, USA, 10. – 12. 3.2013
3. Föger-Samwald U, Patsch J, Deutschmann J, Hornek L, Salem S, Becker Ph, Pail P, Schamall D, Mousavi M, Becker S, Kainberger F, Resch H, Pietschmann P. Genexpression und Knochenmikrostruktur in Männern mit osteoporotischen Hüftfrakturen. Geriatriekongress “Altern – Chance und Herausforderung”, Wien, 21.-23.3.2013
4. Ndue L, Allinger P, Aust S, Svoboda M, Klameth L, Secky L, Castillo-Tong DC, Zeillinger R, Van Gorp T, Vergote I, Braicu I, Sehouli J, Mahner S, Fogel M, Thalhammer T. The estrogen sulfatase pathway: a potential target in ovarian cancer treatment. Joint Scientific Symposium of the Austrian Societies of Toxicology (ASTOX), Pharmacy (ÖPhG), Analytical Chemistry (ASAC) and Forensic Medicine (ÖGGM), and the Comprehensive Cancer Center Vienna (CCC), Wien, 21.-22.3.2013.
5. Zotter S, Larijani A, Buxhofer-Ausch V, Ausch C, Bauer H, Mollik M, Bajna E, Sebesta C, Reiner-Cocin A, Zeillinger R, Thalhammer T. The organic anion transporting polypeptide OATP4A1 may contribute to immunactivation in colorectal cancer and inflammatory colon disease. Joint Scientific Symposium of the Austrian Societies of Toxicology (ASTOX), Pharmacy (ÖPhG), Analytical Chemistry (ASAC) and Forensic Medicine (ÖGGM), and the Comprehensive Cancer Center Vienna (CCC), Wien, 21.-22.3.2013.
6. Gajdzik L, Jungmann D, Blaas D, Fuchs R. The sodium-proton exchange inhibitor EIPA affects multiple steps in the replication cycle of human rhinovirus 2 (HRV2). Viruses and Cells Conference, Il Ciocco, Italien, 5.-10.5.2013
7. Molcan L, Zeman M, Ellinger I. Melatonin and blood pressure modulation expression level and localization of melatonin receptors is different in aorta and mesenteric artery. 9th YSA PhD- Symposium, Vienna, 20. and 21.6.2013, P73
8. Itariu B, Marculescu R, Pietschmann P, Stulnig T. Markers of glycemic regulation and bone turnover correlate in severely obese non-diabetic individuals. 9th YSA PhD- Symposium, Vienna, 20. and 21.6.2013, P73
9. Föger-Samwald U, Rauner M, Kurz M, Brünner-Kubath C, Kapfenberger A, Höger H, Pietschmann P. Cathepsin deficient mice exhibit a bone and fat phenotype. 9th YSA PhD- Symposium, Vienna, 20. and 21.6.2013, P232
10. Nebot Valenzuela E, Aparicio Garcia-Molina V, Erben R, Camiletti-Moiron D, Kapravelou G, Lopez-Jurado M, Pietschmann P, Aranda P. Do high intensity exercise and anabolic androngenic steroids administration affect bone mineral density and structural parameters of rat femur? 9th YSA PhD- Symposium, Vienna, 20. and 21.6.2013, P237
11. Gajdzik L, Edlmayer J, Valenta R, Blaas D, Fuchs R. Entry pathways and genome release of human rhinoviruses. 3rd World Congress of Microbes, Wuhan, China, 29.7.-1.8.2013
12. Gajdzik L, Edlmayer J, Valenta R, Blaas D, Fuchs R. Analysis of uncoating of human rhinoviruses. Meeting “Virus Cell Interactions”, Seili, Finnland, 19.-22.8.2013
13. Dorfer S, Föger-Samwald U, Kapfenberger A, Kudlacek S, Dovjak P, Pietschmann P. Serum levels of sclerostin and dickkopf-1 in geriatric patients with osteoporotic hip
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
43
fractures. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
14. Föger-Samwald U, Alaghebandan A, Patsch JM, Schamall D, Salem S, Mousavi M, Pietschmann P. Gene expression and bone microarchitecture in men with osteoporotic hip fractures. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
15. Ashjaei K, Lengger N, Bublin M, Palmberger D, Ellinger I, Breiteneder H, Hoffmann-Sommergruber K. Allergen uptake characterization by dendritic cells: specificity and relevant factors. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
16. Kemper J, Voss A, Reiter M, Scheinast M, Uhrova H, Zeisler H, Knöfler M, Salzer H, Ellinger I, Gundacker C. Exploring canditate proteins involved in methylmercury (MeHg) transfer at the human materno-fetal barrier: expression of amino acid transporter LAT1 and LAT2 and organic anion transporter OAT4. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
17. Molcan L, Ellinger I, Zeman Michal. Melatonin receptor type 1 is expressed in thoracic aorta and mesenteric artery. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
18. Mytsko Y, Uhrova H, Fuchs R, Helmer H, Ellinger I. Human neonatal FC-receptor-mediated transplacental immuno-globulin G transport. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
19. Reiter M, Voss A, Kemper J, Scheinast M, Uhrova H, Zeisler H, Knöfler M, Salzer H, Ellinger I, Gundacker C. Exploring canditate proteins involved in methylmercury (MeHg) transfer at the human materno-fetal barrier: expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2). 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
20. Sheikh M, Zotter S, Larijani A, Buxhofer-Ausch , Ausch C, Bauer H, Mollik M, Bajna E, Reiner-Concin A, Thalhammer T. The organic anion transporting polypeptide OATP4A1 may contribute to immunactivation in colorectal cancer and inflammatory colon disease. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
21. Svoboda M, Pils D, Heinze G Meshcheryakova A, Tong D, Thalhammer T, Jensen-Jarolim E, Jaritz M, Zimmermann P, Zeillinger R, Mechtcheriakova D. AID/APOBEC-associated gene signature: prognostic power for overall survival of patients with primary ovarian carcinoma. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
22. Kucinska M, Szczolko W, Kaczmarek M, Goslinski T, Thalhammer T, Murias M. Biological activity of non-peripherally substitued phthalocyanine-in vitro evaluation for photodynamic therapy. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
23. Klameth L, Svoboda M, Thalhammer T, Olszewski U, Geissler K, Jäger W, Hamilton G. Influence of chemotherapeutic drugs, cisplatin, etoposide and topotecan, on PH regulating transporters and enzymes. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, Vienna, 17.9.2013
24. Klameth L, Svoboda M, Thalhammer T, Olszewski, Geissler K, Jäger W, Hamilton G. Expression of pH regulatory proteins may influence drug resistance. 10th International ISSX Meeting, Toronto, Kanada, 29.9. – 3.10.2013
25. Riha J, Brenner S, Mungenast F, Sultan S, Grünsteidel J, Cacsire Castillo-Tong D, Zeillinger R, Speiser P, Horvat R, Jäger W, Thalhammer T. Expression of organic
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
44
anion-transporting polypeptides (OATP) 2A1, 4A1, 5A1, and 6A1, as possible biomarkers for human ovarian cancer. 10th International ISSX Meeting, Toronto, Kanada, 29.9. – 3.10.2013
26. Brenner S, Riha J, Schölm M, Buxhofer-Ausch V, Ausch C, Bajna E, Reiner-Concin A, Hamilton G, Klameth L, Jäger W, Thalhammer T. Specific OATP expression pattern in primary small cell lung cancer (SCLC) cell lines: impact on diagnosis and therapy. 10th International ISSX Meeting, Toronto, Kanada, 29.9. – 3.10.2013
27. Dovjak P, Föger-Samwald U, Dorfer S, Kapfenberger A, Kudlacek S, Pietschmann P. Serum levels of sclerostin and dickkopf-1 in geriatric patients with osteoporotic hip fractures. Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
28. Föger-Samwald U, Alaghebandan A, Patsch JM, Schamall D, Salem S, Mousavi M, Pietschmann P. Bone microarchitecture in men with osteoporotic hip fractures. Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
29. Küssel L, Pietschmann P, Zeisler H. Datenmanagement und Plattformbildung für Osteoporose. Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
30. Lamm C, Dockner M, Pospischek B, Patzak B, Pretterklieber M, Weber G, Pietschmann P. Micro-CT Analyses of Historical Osteomylitic bone samples from the “Narrenturm” (NHM). Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
31. Nebot Valenzuela E, Aparicio VA, Föger-Samwald U, Wahl K, Camiletti-Moirón D, Martinez R, Kapravelou G, Porres JM, López-Jurdado M, Aranda P, Pietschmann P. Do dietary protein amount, source of protein, high intensity exercise and anabolic androgenic steroid administration affect bone microarchitecture in rats? Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
32. Weilner S, Schraml E, Keider V, Redl H, Pietschmann P, Grillari-Voglauer R, Grillari J. Galectin 3 is a component of circulating microvesicles and boosts osteogenetic differentiation of mesenchymal stem cells. Wissenschaftliche Herbsttagung der Österreichischen Gesellschaft für Knochen und Mineralstoffwechsel, TechGate Vienna, 16.11.2013
g) Teaching Scripts and Books: n = 0 h) Articles in Medical Journals: n = 0 i) Public activity n = 5 Isabella Ellinger:
1. Science – Education for kids: “I feel good. Exploring the in-door climate”. Primary School Project, 1160 Vienna, 18.2.-2.3.2013
2. “Cell City – was geht ab in der Zelle”. (zusammen mit Prof. Adolf Ellinger) Kinder Uni
Wien, 16.7.2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
45
Isabelle Ellinger und Ursula Föger-Samwald:
3. Was tut Daniel Düsentrieb? So werkt ein Forscher. Kinder Uni Wien, 18.7.2013
Peter Pietschmann:
4. Interview: “Interdisziplinarität bereichert den Diskurs”. Ärztemagazin, Ausgabe 20, 12.9.2013, S. 26-27.
5. Interview: “Osteoporose: Vorsorgeuntersuchung kann Leben retten”, Themenzeitung „Orthopädie“ Nr. 3 /2013
1.2.2. Research Awards: n = 4 Mag. Ursula Föger-Samwald: - Felix Bronner Dissertationsstipendium of the Austrian Society for Bone and Mineral
Research - Posterpreis: “Cathepsin S deficient mice exhibit a bone and fat phenotype””, 4th
Retreat of the Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna - Posterpreis: “Cathepsin S deficient mice exhibit a bone and fat phenotype”, 9th YSA PhD Symposium of the Medical University of Vienna
Leonard Ndue, Patricia Allinger:
Posterpreis: “ The estrogen sulfatase pathway: a potential target in ovarian cancer treatment”. Joint Scientific Symposium of the Austrian Societies of Toxicology (ASTOX), Pharmacy (ÖPhG), Analytical Chemistry (ASAC) and Forensic Medicine (ÖGGM), and the Comprehensive Cancer Center Vienna (CCC), Vienna, 21-22.3.2013.
1.2.3. Invited lectures: n = 34 Isabella Ellinger:
1. “Tissue FAXS, a high end technology”. Comparative Medicine Lab Opening, Messerli Research Institute, VetMedUni Vienna, 7.5.2013
2. “Melatonin and blood pressure modulation: expression and localization of melatonin
receptors MT1 and MT2 in rat thoratic aorta and mesenteric artery”. International Symposium of the Institute for Heart Research, Slovak Academy of Sciences, Smolenice Castle, Slovakia, 24.5.2013
3. “A Janus view on the human materno-fetal barrier: Placental research in transition
from methods to function”. Seminar at Pathophysiology and Repair/Neuroscience Division Seminar Series, Cardiff School of Biosciences, University of Cardiff, GB, 29.10.2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
46
Renate Fuchs:
4. “Entry pathways and genome release of human rhinoviruses”. 3rd Annual World
Congress of Microbes, Wuhan, China, 29.7.2013 5. “Analysis of uncoating of human rhinoviruses”. Meeting “Virus-Cell Interactions”, Seli,
Finnland, 20.8.2013 Peter Pietschmann:
6. „Pathophysiologie der renovaskulären Knochenerkrankung“. Osteologie 2013, Weimar, Deutschland, 8.3.2013
7. „Epidemiologie und Pathophysiologie“. Osteoporoseseminar 2013, Keutschach, Kärnten, 15.3.2013
8. „Zukünftige Osteoporosetherapien“. Osteoporoseseminar 2013, Keutschach,
Kärnten, 16.3.2013
9. „Core Curriculum Geriatrie: Osteoporose“. Geriatrie Kongrss – Alter(n) – Chance und Herausforderung. Wien, 20.3.2013
10. „Osteoporose: Pathophysiologie – was gibt es Neues?“ Geriatrie Kongrss – Alter(n) –
Chance und Herausforderung. Wien, 22.3.2013
11. „Osteoporose“. III. Novartis Geriatrieforum. Wien, 13.4.2013
12. „Bewegungsseffekte auf den Knochen - Molekulare Mechanismen“. 21. Osteoporoseforum, St. Wolfgang, 25.4.2013
13. „Metabolische Knochenerkrankungen beim geriatrischen Patienten“. 5.
Masterlehrgang Geriatrie SS 2013, Wien, 6.6.2013
14. „Vitamin D-Update“. 32. Rheumatologische Fortbildungstagung, Saalfelden, 22.6.2013
15. „140 years of pathophysiology“. 4th Retrat of the Center for Pathophysiology,
Infectiology and Immunology, Vienna, 17.9.2013
16. „Interaktion Muskel & Knochen aus pathophysiologischer Sicht“. Management der Osteoporose 2013, Vienna, 17.10.2013
17. „Gibt es die Low-turnover-Osteoporose?“ Fachtag Polypharmazie und Geriatrie,
Vienna, 19.10.2013
18. „Die Renovaskuläre Knochenerkrankung“. Fortbildungen der 6. Med. Abteilung m. Nephrologie und Dialyse. Wien, 13.11.2013
19. „Osteoimmunology“. Tri-National CEE Workshop on Bone Diseases, Vienna,
Krankenhaus Barmherzige Schwestern, 15.11.2013
20. „Gefäße & Knochen: Pathophysiologische Relationen“. Wissenschaftliche Herbsttagung der ÖGKM, Tech Gate Vienna, Vienna, 16.11.2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
47
21. „Pathophysiologie und Risikofaktoren“. Ausbildungskurs“Osteoporose“ der österr. Gesellschaft für Orthopädie und orthopädische Chirurgie, Vienna, AKH, 23.11.2013
22. „Sekundäre Osteoporosen und Osteopathien“. Ausbildungskurs“Osteoporose“ der
österr. Gesellschaft für Orthopädie und orthopädische Chirurgie, Vienna, AKH, 23.11.2013
23. „Bone physiology“. La Facultad de Farmacia y el Departamento de Fisiologia les
invitan a las Conferencias, Universidad de Granada, Spain, 3.12.2013
24. „Pathophysiology of bone diseases: osteoporosis and osteomalacia“. La Facultad de Farmacia y el Departamento de Fisiologia, Universidad de Granada, Spain, 3.12.2013
25. „Bone histomorphometry and osteoimmunology“. La Facultad de Farmacia, el
Programa de Doctorando y el Master en Nutricion Humana, Universidad de Granada, Spain, 3.12.2013
26. „History of the Department of Pathophysiology“. Wissenschaftliche Sitzung „140
Years Department of Pathophysiology“, Gesellschaft der Ärzte Wien, 10.12.2013
27. „Osteoporosis – an inflammatory disease?“ Impulsseminar, Hörsaalzentrum AKH Wien, 13.12.2013
Theresia Thalhammer:
28. „Transport proteins - ABC-efflux pumps and SLCO uptake transporters, part 1“ Lecture series PhD Program, Wroclaw Medical University, Polen, 17.3.2013
29. Transport proteins - ABC-efflux pumps and SLCO uptake transporters, part 2“
Lecture series PhD Program, Wroclaw Medical University, Polen, 18.3.2013
30. „ Nuclear receptors and their role in the exrection of drugs/xenobiotics“, Lecture series PhD Program, Wroclaw Medical University, Polen, 19.3.2013
31. „Drug hormone and xenobiotics metabolizing enzymes phase I and II“, Lecture series
PhD Program, Wroclaw Medical University, Polen, 20.3.2013
32. “Organic anion transporting polypeptides (OATPs) in liver, hepatic and extrahepatic tumors. Nuclear Receptor Symposium, Olomouce, Czech Rep, 3.4.2013
33. “Transport proteins and their role in the uptake of drugs hormones and xenobiotics”,
Lecture series PhD Program, Olomouc, Tschechien, 4.-6.11.2013
34. “Automatisierte Zelldetektion in der Osteoimmunologie”, Gesellschaft der Ärzte, Wien, 20.11.2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
48
1.2.4. Congress organization
Division member Name:
National congress Name, date
Function
Intern. congress,
Name, date
Function
Peter Pietschmann
Geriatriekongress – Altern – Chance und Herausforderung,
21.-23.3.2013
Organizing committee
Isabella Ellinger 12th WISIA Symposium, 21-22.6.2013
Co-Organizer
Peter Pietschmann
Jahrestagung der Österreichischen Gesellschaft
für Rheumatologie & Rehabilitation, 28.-30.11.2013
Session
organisation
Peter Pietschmann
Wissenschaftliche Herbsttagung der Österreichischen
Gesellschaft für Knochen und Mineralstoffwechsel, 16.11.2013
Conference president
1.2.5. Hosting speakers
division member Speaker´s name Affiliation Date
Theresia Thalhammer
Laczka Özvegy Csilla, PhD
Hungarian Academy of Sciences, National Center, Institute of
Hematology and Immunology, Budapest, Hungary
19/04/2013
Isabella Ellinger Prof. Michal Zeman Comenius University , Facultiy of Sciences, Department of Animal
Physiology and Ethnology, Bratislava, Slovakia
03/05/2013
Peter Pietschmann Dr. Elena Nebot Valenzuela
University of Granada, Department of Physiology, Spain
10/05/2013
Isabella Ellinger Dr. Andrea Nussbaumer
University of Vienna, Department of Marine Biology
24/05/2013
Theresia Thalhammer
Mag. Anna Bachmayr-Heyda
Medical University of Vienna, Department of Gynecology
24/05/2013
Isabella Ellinger Lubos Molcan Comenius University, Facultiy of Sciences, Department of Animal
Physiology and Ethnology, Bratislava, Slovakia
07/06/2013
Theresia Thalhammer
Ewa Marcinkowska, MD, PhD
University of Wroclaw, Faculty of Biotechnology, Poland
21/06/2013
Peter Pietschmann Georg Dorffner, PhD, Assoc. Prof.
Institute of Artifical Intelligence, Austria, Vienna
20/12/2013
Peter Pietschmann Lisa Gfrerer, MD Harvard Medical School, Center of Regenerative Medicine, Harvard
Stem Cell Institute, USA
20/12/2013
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
49
1.2.6. Mobility
Name Program University, country Time frame
Division
In Out
Isabella Ellinger / Michal Zeman
bzw. Lubos Molcan
WTZ- Austria Slovakia
Comenius University, Faculty of Sciences,
Department of Animal Physiology
and Ethnology, Bratislava, Slovakia
1.1.2013-31.12.2014
2 x x
Eva Kratz Wroclaw Medical University Foundation (ISO 9001:2009) and
APVV 0291-2012 (Slovakia Academia of
Sciences)
Wroclaw Medical University,
Department of Chemistry and
Immunochemistry, Wroclaw, Polen
10.6.-29.6.2013
2 x
Malgorzata Kucinska
WTZ Polen Poznan University of Medical Sciences,
Polen
18.8.-20.9.2013
2 x
Elena Nebot Valenzuela
Cooperation Agreement – Doctoral
Thesis supervision
Universidad Granada,
Department of Physiology, School of Pharmacy and School of Sports Sciences, and
Institute of Nutrition and Food
Technology, Granada Spain
1.4.-30.6.2013
and 18.9.-
2.10.2013
2 x
Monika Kaminska
Erasmus Poznan University of Medical Sciences,
Polen
2.9.-30.11.2013
Felicitas Mungenast
WTZ Polen Poznan Univeristy of Medical Sciences,
Department of Pharmacology and Toxicology, Polen
4.11. – 9.11.2013
2 x
1.2.7. Activities in Advisory Boards
Name Society/Institute/Journal Function
Peter Pietschmann Habilitationskommission “konservativ” (Interne, Pädiatrie,
Dermatologie, Radiologie)
Mitglied der Kommission
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
50
1.2.8. Editorial Activities
Name Journal Function
Peter Pietschmann Wiener Medizinische Wochenschrift
Associate Editor
Peter Pietschmann Hormone Metabolic Research Member Editorial Board
Peter Pietschmann Zeitschrift für Gerontologie und Geriatrie
Member Editorial Board
Peter Pietschmann Journal für Mineralstoffwechsel Member Editorial Board
Theresia Thalhammer Journal of Drug Targeting Guest Editor
1.2.9. Review Activities
Name Grants/Thesis/Habilitation
Peter Pietschmann Österreichische Nationalbank – Jubiläumsfonds (Grant)
Peter Pietschmann Deutsche Forschungsgemeinschaft “Immunobone” SPP 1468 (Grant)
1.2.10. Filed and granted patents
Name Patent
Isabella Ellinger Austrian Patent (A1444/210) by Tissue Gnostics “Metastrukurerkennung in Geweben”
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
51
1.2.11. Grants Funding agency Title of project Principal investigator
Wissenschaftlich-Technische Zusammenarbeit (WTZ) Österreich – Slowakei SK-AT- 0006-12
Melatonin und Blutdruckkontrolle: Identifizierung und Charakterisierung von Melatonin-Rezeptoren in Rattengefäßen.
Kooperationsprojekt: Prof. Michal Zeman Comenius University Bratislava (Projektleiter) and Isabella Ellinger
Forschungsförderungs-gesellschaft (FFG) Nr. 841847 (FA648A1010)
Hg-Transport Teil III - generation innovation Praktika (Talente-Praktika für Schülerinnen und Schüler.
Isabella Ellinger
Forschungsförderungs-gesellschaft (FFG) Nr. 841848 (FA648A1012)
Hg-Transport Teil IV - generation innovation Praktika (Talente-Praktika für Schülerinnen und Schüler.
Isabella Ellinger
Forschungsförderungs-gesellschaft (FFG) FFG 841861 (FA648A1011)
Fc Rezeptor Plazenta - generation innovation Praktika (Talente-Praktika für Schülerinnen und Schüler.
Isabella Ellinger
Forschungsförderungs-gesellschaft (FFG) FFG 841862 (FA648A1009)
Fc Rezeptor Plazenta II - generation innovation Praktika (Talente-Praktika für Schülerinnen und Schüler.
Isabella Ellinger
Hochschuljubiläums-stiftung der Stadt Wien H-2490/2009, (AP00410OFF)
RAGE (Rezeptor für “advanced glycated endproducts) und die Schwangerschaftserkrankung Präeklampsie.
Isabella Ellinger
Felix Bronner Dissertations-stipendium AP00604OFF
Local gene expression in bone samples from eldery women with osteoporotic hip fractures.
Ursula Föger-Samwald
Springer Verlag GmbH AP00243OFF
Unterstützung er Errichtung und Betreibung eines Editorial Office für die Wiener Medizinische Wochenschrift und der Publikationstätigkeit der Arbeitsgruppe Knochen-, Gender- und Altersforschung.
Peter Pietschmann
Institute de Recherches Internationales SERVIER & ADIR PHA-12911-152-AUT/001 (FA648A0601)
Strontium ranelate effect on osteoblast-induced differentiation and activity through the modulation of RANKL.
Peter Pietschmann
Roche Austria GmbH AP00369OFF
Errichtung eines Forschungsnetzwerks auf dem Gebiet der Gerontologie.
Peter Pietschmann
MSD – Merck, Sharp & Dohme FA648A0604
Cathepsin K in Osteoimmunology.
Peter Pietschmann
Novartis Pharma GmbH FA6480606
Bone, Gender und Aging Research.
Peter Pietschmann
Ludwig Boltzmann-Institut für Altersforschung FA648A0607
Gene expression and bone microarchitecture in elderly women with osteoporotic hip fractures.
Peter Pietschmann
Mag. Ursula Föger-Samwald AP00570OFF
Gene expression in elderly women.
Peter Pietschmann
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
52
Amgen FA648A0608
Entwicklung und Validierung einer automatisierten Methode zur Feststellung von Sclerostin im Mausknochen.
Peter Pietschmann
Eli Lilly FA648A0609
Pathogenesis of fractures in diabetes mellitus.
Peter Pietschmann
Fresenius Kabi Austria GmbH FA 648A0610
Automated Cell Detection in Osteoimmunology.
Peter Pietschmann
Medahead FA648A0611
Bone, Gender and Aging Research.
Peter Pietschmann
Medizinisch- Wissenschaftlicher Fonds des Bürgermeisters der Stadt Wien Nr. 10004
Proteins of the family of “organic anion transporters (OATP) and their potential role in lung and colon cancer therapy.
Principle Investigator: T. Thalhammer (Cooperation:Dr. Buxhofer-Ausch, SMZ-Ost)
Medizinisch- Wissenschaftlicher Fonds des Bürgermeisters der Stadt Wien Nr. P110016
Identifikation und Validation therapeutischer Targets beim kleinzelligen Lungenkarzinom.
Principle Investigator: T. Thalhammer (Cooperation: Univ.Prof.Dr. Primar Klaus Geissler, Ludwig Boltzmann Institut, KH Hitzing, 5. Med. Abt. mit Onkologie
Ludwig-Boltzmann Institut für Translationale Onkologie
Investigation of genetic and molecular biological characteristics of the tumor cells....
Principle Investigator: T. Thalhammer Koordinator Prof. Robert Zeillinger, Prof. G. Hamilton
Wissenschaftlich Technisches Abkommen mit Polen 2012-13 Nr. PL 20/2012
Evaluierung neuer photosensibilisierender Verbindungen für eine verbesserte Phototherapie an soliden Tumoren mit Licht nahe dem Infrarotspektrum.
Kooperationsprojekt: Prof. Marek Murias, Poznan, und T. Thalhammer
Performance Report 2013– Division 2
Cellular and Molecular Pathophysiology
53
1.2.12. Career Developments a) Habilitations: n = 0 b) Habilitations in progress: n = 0 c) Professorships: n =0
1.2.13. Teaching a) Bachelor students: n = 2 Peter Pietschmann: Knollmüller Petra: FH Campus Wien. Etablierung einer semiautomatisierten Methode zur Osteozytenquantifizierung in histologischen Gewebeschnitten (01/2013 – 07/2013) Theresia Thalhammer: Allinger Patricia: FH Campus Wien, Biotechnologie. Estrogen aktivierende und inaktivierende Enzyme bei Ovarialkarzinomen (01/2013-06/2013 b) Diploma, MDiploma and Master students: n = 29 Renate Fuchs: Jalali Manuel: MDiploma Thesis. Mechanismus von Virusinfektionen: Einfluß von Ethylisopropylamilorid auf die Infektion von HRB89. (07/2011 – in progress). Medical University of Vienna Otto Julian: MDiploma Thesis: Rolle der Clathrin-abhängigen Endozytose im Infektionsmechanismus des humanen Rhinovirus 89 (06/2012 – in progress), Medical University of Vienna Spanberger Thomas: MDiploma Thesis. Mechanismus von Virusinfektionen. (05/2009 – in progress), Medical University of Vienna. Isabella Ellinger: Habringer Pia: MDiploma Thesis: Studying the effects of the RAGE-ligands advanced glycation end products (AGEs) on the expression level of the RAGE-variants full length RAGE and soluble RAGE (flRAGE and sRAGE) in trophoblast-like BeWo cells. (05/2012 – in progress) Medical University of Vienna
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
54
Kemper Jost: MDiploma Thesis: Mercury transport across the placental barrier: Expression and localization of OAT4 (05/2013 – in progress ) Medical University of Vienna Mytsko Yuliya: Diploma (Master) Biology: Localization of the neonatal IgG Fc-receptor (FCRN) in the sycytiotrophoblast and fetal endothelial cells of human term placental chorionic villi in situ and in isolated placental endothelial cells ((05/2013 – in progress), University of Vienna Reiter Martin: MDiploma Thesis: Quecksilbertransport über die Plazentaschranke. Untersuchung der Funktion der Kandidatenproteine MRP 1 – 5 (ABCC 1 – 5) und OATP 4 (SLC22A11) mittels Knockdown-Versuchen in HepG2 und fetalen Fruchtwasserstammzellen (07/2013 – in progress) Medical University of Vienna Schaffhauser Martin: MDiploma Thesis. Investigating the contribution of the receptor for advanced glycation end products (RAGE) to the gestational disorder pre-eclampsia: do RAGE-ligands S100 calcium-binding and High Mobility Group Box 1 affect the expression of RAGE-protein variants flRAGE and sRAGE in trophoblast-like BeWo cells? (05/2012 – in progress) Medical University of Vienna Voss Agnes: MDiploma: Quecksilbertransport über die Plazentaschranke: Expression und Lokalisation von MRP2. (05/2013 - in progress) Medical University of Vienna Peter Pietschmann: Alaghebandan Afarin: MDentDiploma Thesis: Knochen-Histomorphometrie bei Männern mit osteoporotischen Hüftfrakturen (03/2012 –06/2013) Medical University of Vienna Kapfenberger Andrea: Diploma (Master) Bioverfahrenstechnik: Einfluss von Cathepsin S auf Knochenstruktur und adipozytäre Differenzierung. (10/2012 –04/2013 University of Applied Sciences (FH Campus Vienna) Körbler Florian: MDiploma thesis: Der Einfluss des Makrophagen-Kolonie-stimulierenden-Faktors (M-CSF) auf die Frkaturheilung durch Stimulation der Osteoklasten. (7/2013 – in progress) Medical University of Vienna Lamm Christiane: Diploma Biology: Mikro-CT Analyse morphologischer Strukturveränderungen bei Osteomyelitis anhand historischer Präparate aus dem „Narrenturm (02/2013 – in progress) University of Vienna Umar Zahra: MDiploma: Wirkung von Osteoprotegerin-Fc auf Knochenstruktur und Knochenumbau beim Schwein (Sus scrofa) (08/2012 – in progress). Medical University of Vienna
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
55
Theresia Thalhammer: Durmaz Yasemin: DiplomaPharm Thesis. Expression von Enzymen und Transportproteinen in Tumorzellen und Geweben: Bedeutung für die Therapie. (09/2011 –in progress). University of Vienna Eric Branislava: Diploma Biology: Relation between Abcg2 transporter expression and NOTCH-1 in solid tumors (liver, lung, ovary) (05/2013 – in progress) University of Vienna Eskandari Hamidreza: MDiploma thesis: Transmembrane transporter der OATP-Familie in Tumorzellen: Mögliche Relevanz für die Chemotherapie (11/2008 –12/2013), Medical University of Vienna. Gründsteidel Johann: MDiploma thesis: Expression of OATP4A1 proteins with potential relevance for prostaglandin transport in ovarian cancer. (10/2010 – 08/2013). Medical University of Vienna Katic Ana: Diploma Pharm: Expression von OATPs in Lungenkarzinomzellinien (09/2013 – in progress) University of Vienna Klameth Lukas: Diploma Biology: pH- regulation in tumors. (03/2012 – 06/2013) University of Vienna Larijani Aida: DiplomaPharm: OATP Transporter in soliden Tumoren. (03/2012 – in progress) University of Vienna Mungenast Felicitas: Diploma Biology: Organic anion transporting polypeptides as potential tumor markers in ovarian carcinoma (03/2013 – in progress) Ndue Leonard: MDiploma.Cyclooxygenase-2 Expression beim fortgeschrittenen Ovarialkarzinom. Korrelation mit klinischen Daten (07/2011 –06/2013). Medical University of Vienna Ocko Katharina: DiplomaPharm: Expression von OATPs in Tumorproben von Patienten (09(2013 – in progress) University of Vienna Sheikh Maidah: DiplomaPharm: Expression von OATP-Transportern im Tumorgewebe: Einfluß auf die Therapie (05/2013 – in progress) Sultan Sirag: MDiploma: Prostaglandin-transportierende OATPs als potentielle Tumormarker beim Ovrarialkarzinom (07/2011 –08/2013). Medical University of Vienna Türkay Emel: MDiploma thesis: Expression of OATP transporter: possible relevance on anticancer therapy. 11/2008 – 12/2013), Medical University of Vienna
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
56
Zhang Wenyi: MDiploma thesis: MRP4 und Ovarialkarzinom (05/2011 – in progress). Medical University of Vienna Zotter Simone: DiplomaPharm: Expression von Transportproteinen in Tumorproben von Patienten (10/2012 -08/2013) University of Vienna c) PhD, MDSci, MD students: n = 9 Isabella Ellinger: Föger-Samwald Ursula: PhD thesis (N790): Gene expression, bone turnover markers, and microarchitecture in metabolic bone diseases (02/2013 – in progress) Medical University of Vienna Klameth Lukas: PhD thesis (N094): Expression of pH-regulators NHE1 (sodium-proton exhchanger 1), MCTs (monocarboxylate transporters) and CAIX (carbonic anhydrase IX) in small cell lung cancer (SCLC) and ovarian cancer cell lines and their role in chemoresistance. (07/2013 – in progress). Medical University of Vienna Renate Fuchs. Ganjian Haleh: PhD thesis (N790): Rhinovirus infections of airway epithelial (02/2013 – in progress) Medical University of Vienna Peter Pietschmann: Föger-Samwald Ursula: PhD thesis (N790): Gene expression, bone turnover markers, and microarchitecture in metabolic bone diseases (02/2013 – in progress) Medical University of Vienna Gfrerer Lisa: PhD thesis(N094): Functional analysis of IRF6 and SPECC1l in Zebrafish models of orofacial cleft (12/2012 – in progress) Medical University of Vienna Maldonado-Gonzalez Eduardo: PhD thesis (N790). The role of Serotonin transporter (5-HTT) and insulin degrading enzyme (IDE) Polymorphism in vascular diseases (05/2011 – in progress) Medical University of Vienna. Raimann Adalbert: PhD thesis (N790): Impact of FGF23 on growth plate chondrocytes. (12/2013 – in progress) Medical University of Vienna
Theresia Thalhammer: Rentsen Erdentetsetseg: PhD Thesis. Identifikation und Validation therapeutischer Targets beim kleinzelligen Lungenkarzinom. (11/2011 – in progress) Medical University of Vienna
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
57
Riha Juliane, Mag.pharm: PhDPharm thesis. Metebolismus und Transport neuer Zytostatika in humanen Tumorzelllinien in Gewebe (10/2009 – in progress), University of Vienna.
Rogojanu Radu: PhD thesis. Automatic recognition of tumor areas in colon cancer (03/2009 – in progress). d) practical training for other diploma thesis:
Isabella Ellinger: Pozdena Christoph, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 2.1.2013 bis 31.5.2013 Krstic Denis, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, , 2.1.2013 bis 31.5.2013
Grbic Stefan, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie,
Rosensteingasse, 24.9. bis 31.12.2013 Hofer Renate, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 24.9. bis 31.12.2013 e) summer practical training:
Isabella Ellinger: Grbic Stefan, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 1.7. bis 26.7.2013 Hofer Renate, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 1.7. bis 26.7.2013 Jungmann Michaela, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 1.7. bis 26.7.2013 Birkner Jennifer, Höhere Technische Bundeslehr- und Versuchsanstalt für chemische Industrie, Rosensteingasse, 1.7. bis 26.7.2013 f) coordination of doctoral programs: Peter Pietschmann: Coordinator of the doctoral program “Regeneration of Bone and Joints”
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
58
1.2.14. Exams a) Oral examinations: n = 0 b) Diploma and Thesis-Examinations: n = 4
Renate Fuchs:
- Dr. Outi Heikkilä, Doctoral Examination Biotechnology and Food Technology, University of Applied Sciences, Turku, Finland
Peter Pietschmann:
- Dr. Martina Winkler-Krottmaier, Doctoral Examination (N790), 28.1.2013 - Dr. Markus Hof, Doctoral Examination (N094), 25.6.2013 - Felix Knöbel, MD Diploma Examination, 12.6.2013 - Roland Kraxner, MD Diploma Examination, 12.6.2013
Theresia Thalhammer:
Leonard Ndue, MD Diploma Examination, 13.5.2013 Sultan Sirag, , MD Diploma Examination, 22.8.2013 Johann Gründsteidel, , MD Diploma Examination, 22.8.2013 Emel Türkay, , MD Diploma Examination, 17.12.2013 Hamidreza Eskandari, , MD Diploma Examination, 17.12.2013
c) Exam supervising: n = 3 Peter Pietschmann: - SIP, 16.4.2013, 12.00 – 17.00 h Isabella Ellilnger: - SIP 3, 26.9.2013, 8.15 – 14.00 h - SSM 3, 17.10.2013, 7.35 – 10.00 h d) Reviewing of Doctoral Thesis: n = 2 Isabella Ellinger: - University of Salamanca, Spain Theresia Thalhammer: - University of Salamanca, Spain
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
59
1.2.15. Lectures, Seminars, Lab courses SWST pro-rata LV Nr.
SS 2013
Ellinger Isabella 1.00 1.00 800000 Senior-Mentoring Humanmedizin
Ellinger Isabella 2.27 1.60 802001 BL 4 - Funktionssysteme und biologische Regulation
Ellinger Isabella 2.27 0.75 806021 SSM 2 - Methoden der zellulären Pathophysiologie
Ellinger Isabella 4.00 1.50 808004 SSM 3-Projektstudie (Wahlpflichtteil)
Ellinger Isabella 2.00 0.14 850101 Basic Lectures
Ellinger Isabella 1.00 0.34 860014 Creative and critical Journal Club IV
Ellinger Isabella 1.00 0.25 860015 Stimulating Friday Seminar
Fuchs Renate 2.27 2.40 802001 BL 4 - Funktionssysteme und biologische Regulation
Fuchs Renate 2.27 0.76 806021 SSM 2 - Methoden der zellulären Pathophysiologie
Fuchs Renate 1.00 0.25 860015 Stimulating Friday Seminar
Graf Jürg 3.00 0.60 840053 Medizinisches Propädeutikum Teil 2
Pietschmann Peter 2.53 0.40 804000 BL 10 - Endokrinologie und Stoffwechsel
Pietschmann Peter 2.27 0.76 806021 SSM 2 - Methoden der zellulären Pathophysiologie
Pietschmann Peter 4.00 0.50 808004 SSM 3-Projektstudie (Wahlpflichtteil)
Pietschmann Peter 2.00 0.14 850101 Basic Lectures
Pietschmann Peter 1.00 0.12 850103 Journal Club (JC Bones and Joint Regeneration SS 2013)
Pietschmann Peter 1.00 0.34 860014 Creative and critical Journal Club IV
Pietschmann Peter 1.00 0.25 860015 Stimulating Friday Seminar
Pietschmann Peter 2.00 0.25 860220 Basisvorlesung Immunologie
Pietschmann Peter 2.00 0.70 860302 Dissertantenseminar: Durchflusszytometrie - Methodik und immunologische Anwendungsmöglichkeiten
Pietschmann Peter 2.00 0.18 870012 Medical Propedeutics III - Anatomy & Physiology - SS 2013
Pietschmann Peter 2.00 1.07 881005 Pathophysiology for Biotechnologists
Pietschmann Peter 3.00 0.21 896012 Gender - Basics in Gender Medizin 2
Pietschmann Peter 2.00 2.00 850102 Thesis Seminar (TS Bones and Joint Regeneration SS 2013)
Thalhammer Theresia 1.00 2.83 806009 Ärztliche Gesprächsführung B
Thalhammer Theresia 1.00 0.25 860015 Stimulating Friday Seminar
Thalhammer Theresia 2.00 0.06 860025 JC Endocrinology and Metabolism "SS 2013" (Pflichtfach)
Thalhammer Theresia 2.00 0.06 860026 TS Endocrinology and Metabolism - SS 2013 (Wahlpflichtfach)
Thalhammer Theresia 2.00 0.06 860027 PS: "Clinical Endocrinology, Metabolism and Nutrition II (Wahpflichtfach, compulsatory optional
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
60
course (SS 2013)
Sum 19.77
WS 2013/14
Ellinger Isabella 1.13 2.13 801001 BL 1 - Gesunde und kranke Menschen
Ellinger Isabella 1.07 1.20 801004 BL 2 - Der menschliche Körper
Ellinger Isabella 1.73 1.87 801006 BL 3 - Vom Molekül zur Zelle
Ellinger Isabella 0.50 0.53 803001 BL 7 - Wissenschaft und Medizin (SSM 1)
Ellinger Isabella 2.50 2.50 803074 SSM 1 - Entstehung von AGEs und ihre Rolle bei chronischen Erkrankungen
Ellinger Isabella 1.00 0.33 860013 Creative and critical Journal Club V
Ellinger Isabella 1.00 0.25 860014 TS: Stimulating Friday Seminar
Fuchs Renate 1.13 3.87 801001 BL 1 - Gesunde und kranke Menschen
Fuchs Renate 6.27 1.33 801005 BL 3 - Vom Molekül zur Zelle
Fuchs Renate 1.73 4.27 801006 BL 3 - Vom Molekül zur Zelle
Fuchs Renate 2.50 2.50 803051 SSM 1 - Mechanismus von Virusinfektionen
Fuchs Renate 2.27 0.27 805002 BL 14 - Niere und Homöostase
Fuchs Renate 2.00 0.18 562019 BVo: Immunologie
Fuchs Renate 2.00 0.15 618003 Journal Club/Progress Reports IV : Molecular Mechanisms in Cell Biology
Fuchs Renate 1.00 0.25 860014 TS: Stimulating Friday
Graf Jürg 2.27 0.27 805002 BL 14 - Niere und Homöostase
Graf Jürg 3.00 0.73 840052 Medizinisches Propädeutikum Teil 1
Pietschmann Peter 2.00 0.70 653346 Dissertantenseminar: Durchflusszytometrie - Methodik und immunologische Anwendungsmöglichkeiten
Pietschmann Peter 5.80 0.40 803002 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Pietschmann Peter 2.50 1.25 803069 SSM 1 - Knochenerkrankungen - Von der Wissenschaft in die Praxis
Pietschmann Peter 4.00 0.13 807002 BL 21 - Bewegung und Leistung, Schmerz
Pietschmann Peter 4.53 0.07 807009 BL 22/23 - Public Health
Pietschmann Peter 5.87 1.20 825001 BL Z-1 Kau- und Bewegungsapparat
Pietschmann Peter 1.00 0.14 850081 Journal Club (Doctoral Program N790 "Bones and Joint Regeneration")
Pietschmann Peter 2.00 1.00 850082 Thesis Seminar (Doctoral Program N790 "Bones and Joint Regeneration")
Pietschmann Peter 1,00 1.00 850085 Journal Club (Creative and Critical Journal Club)
Pietschmann Peter 2.00 0.17 850101 Basic Lectures
Pietschmann Peter 2.00 0.06 860000 TS Endocrinology and Metabolism WS 2013/14
Performance Report 2013 – Division 2
Cellular and Molecular Pathophysiology
61
Pietschmann Peter 2.00 0.06 860003 JC Endocrinology and Metabolism WS 2013/14
Pietschmann Peter 2.00 0.06 860004 Basic Seminar "Endocrinology and Metabolism I" (Wahlpflichtfach)
Pietschmann Peter 1.00 0.33 860013 JC: Creative and critical Journal Club V
Pietschmann Peter 1.00 0.25 860014 TS: Stimulating Friday
Pietschmann Peter 1.00 1.00 520419 Pathophysiologie und Klinik der metabolischen Osteopathien
Pietschmann Peter 1.00 1.00 561277 Pathophysiologie der rheumatischen Erkrankungen
Pietschmann Peter 10.00 10.00 520711 Wiss. Arbeiten: metabolische Osteopathien - Wissenschaftliche Arbeiten auf dem Gebiet der metabolischen Osteopathien
Thalhammer Theresia 2.00 0.06 860000 TS Endocrinology and Metabolism WS 2013/14
Thalhammer Theresia 2.00 0.06 860003 JC Endocrinology and Metabolism WS 2013/14
Thalhammer Theresia 2.00 0.06 860004 Basic Seminar "Endocrinology and Metabolism I" (Wahlpflichtfach)
Thalhammer Theresia 1.00 0.25 860014 TS: Stimulating Friday
Sum 41.88
Total sum SS+WS 61.65
Performance Report 2013 – Division 3
Immunpathology
61
1.3. Division for Immunpathology Head: Rudolf Valenta, MD, Professor
1. Publications6
pro-rata IF Number Top/Std/Subst
Flicker Sabine 14.861 0 1 Top/1 Std
Focke-Tejkl Margarete 5.081 4 2 Top/2 Std
Linhart Birgit 0 0 0 Valenta Rudolf 73.051 19 9 Top/8 Std/1Subst. 2 publications at
journals without Impact Factor
Vrtala Susanne 10.177 4 3 Top/1 Std
Division-Sum 78.519 10 Top, 9 Std/1Subst 2 publications at journals without Impact Factor
Top point score 2 - among top 20 % of journal in field
Standard point score 1 - between 21-60 %, Substandard point score 0,2
2. Supervision of diploma and doctoral students
Bachelor st. Diploma st. Doctoral st.
Flicker Sabine 0 0 2
Focke-Tejkl Margarete 0 0 1
Linhart Birgit 0 1 1
Valenta Rudolf 0 1 7
Vrtala Susanne 0 0 3
Sum 0 2 14
3. Teaching SS* WS* total W+S Exams
Flicker Sabine 0.5 0.0 0.5 4
Focke-Tejkl Margarete 4.0 3.31 7.31 2
Linhart Birgit 0.5 0.53 1.03 0 Valenta Rudolf 24.47 14.17 38.64 1
Vrtala Susanne 3.5 4.8 8.3 1
Sum 32.97 22.81 55.78 8
6 For working groups IFs of all publications including joint publications with other working groups are presented. In contrast, the
given sum of the division represents the net value of IFs without overlaps due to joint publications.
Performance Report 2013 – Division 3
Immunpathology
62
1.3.1. Publications a) Peer-reviewed original articles: n = 21 Nr. Article IF Class pro-rata IF
1. Baranyi, U., M. Gattringer, A. M. Farkas, K. Hock, N. Pilat, J. Iacomini, R. Valenta, and T. Wekerle. 2013. The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism. Eur. J. Immunol. 43: 2451-60; DOI: 10.1002/eji.201243277.
4.970 Top 0.994
2. Baranyi, U., R. Valenta, and T. Wekerle. 2013. Molecular chimerism in IgE-mediated allergy: B-and T-cell tolerance toward highly immunogenic exogenous antigens. Chimerism. 4: 29-31; DOI: 10.4161/chim.24071.
0 0.0
3. Canonica, GW, IJ Ansotegui, R. Pawankar, P. Schmid-Grendelmeier, M. van Hage, CE. Baena-Cagnani, G. Melioli, C. Nunes, G. Passalacqua, L. Rosenwasser, H. Sampson, J. Sastre, J. Bousquet, T. Zuberbier, K. Allen, R. Asero, B. Bohle, L. Cox, F. de Blay, M. Ebisawa, R. Maximiliano-Gómez, S. González-Diaz, T. Haahtela, S. Holgate, T. Jakob, M. Larché, PM. Matricardi, J. Oppenheimer, LK. Poulsen, HE. Renz, N. Rosário, M. Rothenberg, M. Sanchez-Borges, E. Scala, and R. Valenta. 2013. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 6(1):17; DOI: 10.1186/1939-4551-6-17.
0 0.0
4. Casset, A., R. Valenta, and S. Vrtala. 2013. Allergen content and in vivo allergenic activity of house dust mite extracts. Int. Arch. Allergy Immunol. 161: 287-288; DOI:10.1159/000347047.
2.248 Std 2.248
5. Gangl, K., V. Niederberger, and R. Valenta. 2013. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin Exp Allergy. 43: 1202-16; DOI: 10.1111/cea.12128.
4.789 Top 4.789
6. Garmatiuk, T., I. Swoboda, A. Twardosz-Kropfmüller, F. Dall'antonia, W. Keller, M.B. Singh, P.L. Bhalla, T. Okada, K. Toriyama, M. Weber, M. Ghannadan, W.R. Sperr, K. Blatt, P. Valent, B. Klein, V. Niederberger, M. Curin, N. Balic, S. Spitzauer, and R. Valenta. 2013. Characterization of mutants of a highly cross-reactive calcium-binding protein from Brassica pollen for allergen-specific immunotherapy. Immunobiology. 218: 1155-65; DOI: 10.1016/j.imbio.2013.04.006.
2.814 Std 2.814
Performance Report 2013 – Division 3
Immunpathology
63
7. Gattringer, M., U. Baranyi, N. Pilat, K. Hock, C. Klaus, E. Buchberger, H. Ramsey, J. Iacomini, R. Valenta, and T. Wekerle. 2013. Engraftment of retrovirally-tranduced Bet v 1-GFP expressing bone marrow cells leads to allergen-specific tolerance. Immunobiology. 218: 1139-46; DOI: 10.1016/j.imbio.2013.03.007.
2.814 Std 0.563
8. Hradetzky, S., H. Balaji, L. M. Roesner, A. Heratizadeh, I. Mittermann, R. Valenta, and T. Werfel. 2013. The human skin-associated autoantigen α-NAC activates monocytes and dendritic cells via TLR-2 and primes an IL-12-dependent Th1 response. J. Invest. Dermatol. 133: 2289-92; DOI: 10.1038/jid.2013.161.
6.193 Top 1.239
9. Marth, K., I. Breyer, M. Focke-Tejkl, K. Blatt, MH. Shamji, J. Layhadi, A. Gieras, I. Swoboda, D. Zafred, W. Keller, P. Valent, SR Durham, and R. Valenta. 2013. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG towards IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype. J. Immunol. 190: 3068-3078; DOI: 10.4049/jimmunol.1202441.
5.520 Top 5.520
10. Olivieri, M., C.A. Biscardo, P. Palazzo, S. Pahr, G. Malerba, R. Ferrera, D. Zennaro, G. Zanoni, L. Xumerle, R. Valenta, and A. Mari. 2013. Wheat IgE profiling and wheat IgE levels in bakers with allergic occupational phenotypes. Occup. Environ. Med. 70: 617-22; DOI: 10.1136/oemed-2012-101112.
3.215 Top 0.643
11. Pahr, S., C. Constantin, N. Papadopoulos, S. Giavi, M. Mäkelä, M. Pelkonen, C. Ebner, A. Mari, S. Scheiblhofer, J. Thalhamer, M. Kundi, S. Vrtala, I. Mittermann, and R. Valenta. 2013. α-Purothionin, a new wheat allergen associated with severe allergy. J. Allergy Clin Immunol. 132: 1000-1003.e.4; DOI: 10.1016/j.jaci.2013.05.016.
12.047 Top 12.047
12. Reginald, K., J. Eckl-Dorna, D. Zafred, M. Focke-Tejkl, C. Lupinek, V. Niederberger, W. Keller, and R. Valenta. 2013. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1-specific monoclonal IgE. Immunol. Cell. Biol. 91: 167-72; DOI: 10.1038/icb.2012.70.
3.925 Std 3.925
13. Selb, R., J. Eckl-Dorna, S. Vrtala, R. Valenta, and V. Niederberger. 2013. An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapy. Allergy. 68:1199-202; DOI: 10.1111/all.12204.
5.883 Top 1.177
Performance Report 2013 – Division 3
Immunpathology
64
14. Srinivasan, B., M. Focke-Tejkl, I. Swoboda, C. Constantin, I. Mittermann, S. Pahr, H. Vogelsang, W.D. Huber, and R. Valenta. 2013. A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens. Amino Acids. 45: 889-900; DOI: 10.1007/s00726-013-1537-6.
3.914 Std 3.914
15. Swoboda, I., N. Balic, C. Klug, M. Focke, M. Weber, S. Spitzauer, A. Neubauer, S. Quirce, N. Douladiris, N. G. Papadopoulos, and R. Valenta. 2013. A general strategy for the generation of hypoallergenic molecules for the immunotherapy of fish allergy. J. Allergy Clin. Immunol. 132: 979-981.e.1; DOI: 10.1016/j.jaci.2013.04.027.
12.047 Top 12.047
16. Valenta, R. 2013. Editor-in-Chief Rudolf Valenta. Int Arch Allergy Immunol. 162: 275; DOI: 10.1159/000355596.
2.248 Std 2.248
17. Valenta, R.*, and B. Bohle*. 2013. Who is who in the journal? Int. Arch. Allergy Immunol. 162:1; DOI:10.1159/000350968.
2.248 Std 2.248
18. Weghofer, M., M. Grote, Y. Resch, A. Casset, M. Kneidinger, J. Kopec, W.R. Thomas, E. Fernández-Caldas, M. Kabesch, R. Ferrara, A. Mari, A. Purohit, G. Pauli, F. Horak, W. Keller, P. Valent, R. Valenta, and S. Vrtala. 2013. Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J. Immunol. 190: 3059-3067; 190, DOI: 10.4049/jimmunol.1202288.
5.520 Top 5.520
19. Flicker, S., B. Linhart, C. Wild, U. Wiedermann, and R. Valenta. 2013. Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy. Immunobiol. 130: 1418-1420; DOI: 10.1016/j.imbio.2012.10.008
2.814
Std 2.814
20. Gadermaier, E., S. Flicker, C. Lupinek, P. Steinberger, and R. Valenta. 2013. Determination of allergen specificity by heavy chains in grass pollen allergen-specific IgE antibodies. J. Allergy Clin. Immunol. Nov. 30; DOI: 10.1016/jaci.2012.10.010
12.047
Top 12.047
21. Wagner, G. E., S. Gutfreund, K. Fauland, W. Keller, R. Valenta, and K. Zangger. 2013. Backbone resonance assignment of Alt a 1, a unique β-barrel protein and the major allergen of Atlernaria alternata. Biomol. NMR Assign. May 29.
0.636 SSt. 0.1272
sum 95.892 78.069
Performance Report 2013 – Division 3
Immunpathology
65
b) Invited Articles & Reviews with IF: n = 1
Nr. Article IF Class pro-rata IF
1. 1. Bousquet, J., J. Anto, J. Sunyer, M. Nieuwenhuijsen, M. Vrijheid, T. Keil; MeDALL Study Group; CHICOS Study Group; ENRIECO Study Group; GA²LEN Study Group. 2013. Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper. Int. Arch. Allergy Immunol. 161: 1-10; DOI: 10.1159/000343018.
2.248 Std 0.450
sum 2.248 0.450
c) Invited Articles & Reviews without IF: n = 0 d) Book contributions: n = 0 e) Abstracts, printed in periodicals: n = 0
f) Abstracts, in congress proceedings or abstract books: n = 28 1. A. Baar, S. Pahr, C. Constantin, S. Giavi, M. Alkisti, N.G. Papadopoulos, C. Ebner, A.
Mari, S. Vrtala, R. Valenta. Specific IgE reactivity to Tri a 36 in wheat food allergic children– 4th retreat of the Center for Pathophysiology, Infectiology and Immunology, September 17, 2013.
2. A. Baar, S. Pahr, C. Constantin, S. Giavi, M. Alkisti, N.G. Papadopoulos, C. Ebner, A. Mari, S. Vrtala, R. Valenta. Tri a 36 shows higher IgE-binding frequency than omega-5-gliadin in wheat food allergic patients– 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
3. A. Gstöttner: FAAM (Food Allergy and Anaphylaxis Meeting), “Antibodies induced by immunization with a hypoallergenic mutant of the major fish allergen Cyp c 1 inhibit allergic symptoms in a mouse model of fish allergy”, Nizza, Frankreich, February 7-9, 2013.
4. B. Linhart, Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy, 7 FAAM (Food Allergy and Anaphylaxis Meeting), Nizza, Frankreich, February 7-9. Februar 2013.
5. B. Linhart,: 2nd Meeting of Middle-European Societies for Immunology and Allergology, “Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy”, Opatija, Kroatien, October 10-13, 2013.
6. C. Lupinek, E. Wollmann, J. Bousquet, J. M. Antó, C. Harwanegg and R. Valenta. Development of the MeDALL allergy-chip, an allergen-micro-array comprising 176 components for sensitive detection of allergen-specific antibodies. 15th ICI-Congress, Milan, Italy, August 22-27, 2013.
7. C. Madritsch, E. Gadermaier, C. Lupinek, R. Valenta, S. Flicker. High density IgE recognition of the major grass pollen allergen, Phl p 1, revealed with single chain IgE
Performance Report 2013 – Division 3
Immunpathology
66
antibody fragments obtained by combinatorial cloning. Symposium of the Center for Pathophysiology; Infectiology and Immunology, Vienna, Austria, September 17, 2013.
8. C. Madritsch, E. Gadermaier, C. Lupinek, R. Valenta, S. Flicker. High density IgE recognition of the major grass pollen allergen, Phl p 1, revealed with single chain IgE antibody fragments obtained by combinatorial cloning. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
9. C. Madritsch, E. Gadermaier, C. Lupinek, R. Valenta, S. Flicker. High density IgE recognition of the major grass pollen allergen, Phl p 1, revealed with single chain IgE antibody fragments obtained by combinatorial cloning. International Symposium on Molecular Allergy (ISMA) meeting, Vienna, Austria, December 5-7, 2013.
10. CR Cabauatan, Campana R, Niespodziana K, Reinisch C, Lundberg U, Meinke A, Henning R, Neubauer A, Valenta R. Induction of allergen-specific blocking IgG using patch delivered recombinant Bet v 1 in guinea pigs. International Symposium of Molecular Allergy (ISMA) 2013. Vienna, Austria (Oral presentation). December 5-7, 2013.
11. CR Cabauatan, Campana R, Niespodziana K, Reinisch C, Lundberg U, Meinke A, Henning R, Neubauer A, Valenta R. Epicutaneous patch vaccination with recombinant major birch pollen allergen Bet v 1 induces allergen-specific blocking IgG antibodies in guinea pigs. 2nd Meeting of Middle-European Societies for Immunology and Allergology. Opatija, Croatia (Oral presentation with travel bursary). October 10-13, 2013.
12. E. Gadermaier, L. K. James, M. H. Shamji, T. Garmatiuk, R. Beavil, S. Flicker, S. R. Durham, H. J. Gould, R Valenta. A Phl p 7-specific IgG4 antibody inhibits allergic patients IgE cross-reactivity to allergens from the EF-hand family: Importance of affinity and degree of cross-reactivity. International Symposium on Molecular Allergy (ISMA) meeting, Vienna, Austria, December 5-7, 2013.
13. E. Wollmann, E. Sibanda, C. Hamsten, A. Onell, D. Gallerano, C. Lupinek, R. Valenta, M. van Hage; Natural tolerance towards peanuts in African allergic patients. 15th International Congress on Immunology, Milan, Italy, August 22-27, 2013.
14. E. Wollmann, E. Sibanda, C. Hamsten, A. Onell, D. Gallerano, C. Lupinek, R. Valenta, M. van Hage; African allergic patients show natural clinical tolerance to peanut. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013
15. L. James, E. Gadermaier, R. Beavil, T. Garmatiuk, H. Bowen, S. Flicker, S. Durham, R. Valenta, J. McDonell, H. Gould. Cross-reactivity of a Phl p 7-specific monoclonal IgG4 antibody. Annual meeting of the British Society for Allergy and Clinical Immunology, Great Britain. 2013.
16. N. Najafi, A. Stöcklinger, B. Linhart, C. Madritsch, C. Lupinek, J. Thalhammer, R. Valenta, S. Flicker. A molecular model system to examine the influence of distinct factors on basophil activation. Symposium of the Center for Pathophysiology; Infectiology and Immunology, Vienna, Austria, September 17, 2013.
17. N. Najafi, A. Stöcklinger, B. Linhart, C. Madritsch, C. Lupinek, J. Thalhammer, R. Valenta, S. Flicker. A molecular model system based on human monoclonal allergen-specific IgE antibodies to study basophil activation. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
18. N. Najafi, A. Stöcklinger, B. Linhart, C. Madritsch, C. Lupinek, J. Thalhammer, R. Valenta, S. Flicker. A molecular model system to examine the influence of distinct factors on basophil activation. International Symposium on Molecular Allergy (ISMA) meeting, Vienna, Austria, December 5-7, 2013.
Performance Report 2013 – Division 3
Immunpathology
67
19. S. Banerjee, I. Swoboda, M. Focke-Tejkl. M. Weber, K. Blatt, P. Valent, R. Valenta, S. Vrtala, A hypoallergenic vaccine of D p 23, a new major house dust mite allergen, for immunotherapy, 15th ICI-Congress, August 22-27, 2013, Milan, Italy.
20. S. Banerjee, I. Swoboda, M. Focke-Tejkl. M. Weber, K. Blatt, P. Valent, R. Valenta, S. Vrtala, A hypoallergenic vaccine of D p 23, a new major house dust mite allergen, for immunotherapy, 4th retreat of the Center for Pathophysiology, Infectiology and Immunology, September 17, 2013.
21. S. Pahr, C. Constantin, N.G. Papadopoulos, S. Giavi, M. Mäkelä, A. Pelkonen, S. Scheiblhofer, J. Thalhamer, M. Kundi, I. Mittermann, S. Vrtala, R. Valenta. The new wheat food allergen Tri a 37 contains non-conformational IgE-epitopes- 15th International Congress on Immunology, Milan, Italy, August 22-27, 2013.
22. S. Pahr, R. Selb, C. Constantin, N.G. Papadopoulos, S. Giavi, M. Mäkelä, A. Pelkonen, S. Scheiblhofer, J. Thalhamer, I. Mittermann, V. Niederberger, S. Vrtala, R. Valenta. Tri a 37, a potential diagnostic marker for severe wheat food allergy, comprises non-conformational IgE epitopes– 4th retreat of the Center for Pathophysiology, Infectiology and Immunology, September 17, 2013.
23. S. Pahr, R. Selb, C. Constantin, N.G. Papadopoulos, S. Giavi, M. Mäkelä, A. Pelkonen, S. Scheiblhofer, J. Thalhamer, I. Mittermann, V. Niederberger, S. Vrtala, R. Valenta. The wheat food allergen Tri a 37 which is associated with wheat-induced anaphylaxis contain non-conformational IgE-epitopes– 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
24. V. Garib, E.Wollmann, G. Gjambekova, R. Valenta; In-print of the environment on the molecular sensitization profile towards pollen allergens revealed by allergen micro-array, ISMA Vienna, Austria, December 5-7, 2013
25. Y. Resch, S. Michel, M. Kabesch, R. Valenta, S. Vrtala. Asthmatic and non-asthmatic mite-allergic patients show striking differences in their IgE- and IgG-reactivity profiles to house dust mite allergens – 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
26. Y. Resch, S. Michel, M. Kabesch, R. Valenta, S. Vrtala: Analysis of the IgE- and IgG-reactivity profiles of asthmatic and non-asthmatic HDM-allergic patients using the ISAC microarray system – International Symposium on Molecular Allergology, Vienna, Austria, December 5-7, 2013.
27. Y. Resch, S. Michel, M. Kabesch, R. Valenta, S. Vrtala: Differences in the IgE- and IgG-reactivity profile of asthmatic and non-asthmatic house dust mite-allergic patients revealed with micro-arrayed HDM allergens – 15th International Congress on Immunology, Milan, Italy, August 22-27, 2013.
28. Y. Resch, S. Michel, M. Kabesch, R. Valenta, S. Vrtala: Differrences in the IgE- and IgG-reactivity profile of asthmatic and non-asthmatic house dust mite-allergic patients revealed with micro-arrayed HDM allergens – 4th retreat of the Center for Pathophysiology, Infectiology and Immunology, September 17, 2013.
g) Teaching Scripts and Books: n = 0
h) Articles in Medical Journals: n = 0
Performance Report 2013 – Division 3
Immunpathology
68
i) Public activity: n = 52
1. P ahr Sandra, MedUnique, 3/2013, „Alpha Purothionin“ (Tri a 37),
2. Pahr Sandra, derStandard, 6.8.2013, Ein Auslöser für Weizenallergie entdeckt
3. Pahr Sandra, Studium.at, 6.8.2013, Weizen-Nahrungsmittelallergie: Für allergische
Reaktionen verantwortliches Protein identifiziert.
4. Pahr Sandra: APA science, 9.8.2013, Ein Weizen-Allergen identifiziert
5. Pahr Sandra: Der Standard, 7.8.2013, Wiener Medizinerin findet Ursache für
Weizenallergie.
6. Pahr Sandra: diepresse.com, 9.8.2013, Ein Auslöser für Weizenallergie entdeckt
7. Pahr Sandra: Kurier, 12.8.2013, Weizen-Allergie: Auslöser entdeckt
8. Pahr Sandra: MUW-news, 6.8.2013, Ein Auslöser für Weizen-Nahrungsmittelallergie
entdeckt.
9. Pahr Sandra: Oberösterreichische Nachrichten: 7.8.2013, Auslöser für Allergie gegen
Weizen entdeckt.
10. Pahr Sandra: ORF2 konkret, 3.12.2013, 18:30, Weizenallergie
11. Pahr Sandra: Pflanzenforschung.de, 13.8.2013, Weizen-Allergie: Ein Auslöser
entdeckt.
12. Pahr Sandra: Radiointerview Wissen aktuell, August 6.8.2013, Weizenallergen
13. Pahr Sandra: Salzburger Nachrichten, 7.8.2013, Weizenallergen entdeckt.
14. Pahr Sandra: SVZ, 7.8.2013, Wiener Allergieforscherin identifizierte Weizen-Allergen
15. Pahr Sandra: Tiroler Tageszeitung, 7.8.2013, Auslöser für Weizenallergie entdeckt.
16. Pahr Sandra: www.ots.at, 6.8.2013, Ein Auslöster für Weizen-Nahrungsmittelallergie
entdeckt.
17. Valenta Rudof: Servus TV: Pharmazieforschung - Bald Impfung gegen Schnupfen
möglich http://www.servustv.com/cs/Satellite/Article/Servus-Journal-
011259494957546, 3.4.2013, 18:00.
18. Valenta Rudolf, Science.orf.at,: Bald Impfung gegen Schupfen möglich:
http://science.orf.at/stories/1715437/, 2.4.2013.
19. Valenta Rudolf: Format Impfung gegen Schnupfen möglich, 5.4.2013.
20. Valenta Rudolf: APA science, 10.4.2013, Plasma Blutwäsche hilft immer mehr
Patienten.
21. Valenta Rudolf: APA science, Antikörpertest auf Rhinoviren, 2.4.2013.
http://science.apa.at/rubrik/medizin_und_biotech/MedUni-
Wien:_Antik%C3%B6rpertest_auf_Rhinoviren/SCI_20130402_SCI3937135121214257
4.
22. Valenta Rudolf: APA, Apherese - Blutwäsche: Hocheffiziente Therapieoption mit
enormem Potenzial, 2.4.2013
23. Valenta Rudolf: Ärzte Woche, 25.4.2013, Therapie mit Potenzial
24. Valenta Rudolf: Bald Impfung gegen Schnupfen möglich – science.ORF.at
http://science.orf.at/stories/1715437/, 2.4.2013
25. Valenta Rudolf: Bayrischer Rundfunk, Bayern 3, Gesundheit, Allergie Impfung, 3/2013
26. Valenta Rudolf: Der Kurier online, 10.4.2013, Krankheiten einfach „auswaschen“.
27. Valenta Rudolf: Der Kurier online, 10.4.2013, Wenn schädliche Stoffe aus dem Blut
gewaschen werden.
28. Valenta Rudolf: Der Standard, 3.4.2013, Neue Hoffnung für Impfung gegen
Schnupfen.
Performance Report 2013 – Division 3
Immunpathology
69
29. Valenta Rudolf: derStandard.at: http://derstandard.at/1363706648265/MedUni-Wien-
erforscht-Schnupfen-Immunisierung, 2.4.2013.
30. Valenta Rudolf: Die Presse am Sonntag, Der Kampf gegen den Schnupfen hat
begonnen, 7.3.2013
31. Valenta Rudolf: Fernsehbeitrag, 7.3.2013, Allergenchip
32. Valenta Rudolf: FOCUS 11/12, 11.3.2013, Schluss mit Allergie
33. Valenta Rudolf: Format trend, 23.4.2013, Blutwäsche bringt mehr
Therapiemöglichkeiten.
34. Valenta Rudolf: Format, 19.4.2013, Blutwäsche bringt mehr Therapiemöglichkeiten
35. Valenta Rudolf: Frankfurter Allgem. Tageszeitung, Eine Kur gegen den Niesreiz,
31.3.2013
36. Valenta Rudolf: Kronen Zeitung, 3.4.2013, Bald Impfung bei Schnupfen?
37. Valenta Rudolf: Kurier, 3.4.2013, Wiener Forscher arbeiten an Impfung gegen
Schnupfen.
38. Valenta Rudolf: Medianet, 12.4.2013, Neue Vereinigung für Blutwäsche,
39. Valenta Rudolf: med-reporter.at, Apherese - Blutwäsche: Hocheffiziente
Therapieoption mit enormem Potenzial, 11.4.2013
40. Valenta Rudolf: MedUnique 3/2013, Wussten Sie?
41. Valenta Rudolf: Oberösterreichische Nachrichten, 3.4.2013, Gegen Schnupfen
impfen?
42. Valenta Rudolf: ORF 2 Konkret. 11.4.2013, 18:30, Blutwäsche,
43. Valenta Rudolf: ORF/Ö1 Wissen aktuell: http://oe1.orf.at/programm/333093, 2.4.2013,
13:55.
44. Valenta Rudolf: ÖSTERREICH, 15.4.2013, Synthetische Impfung gegen Gräser-
Pollen.
45. Valenta Rudolf: Pressemeldungen.com, 10.4.2013, Apherese –Blutwäsche:
Hocheffiziente Therapieoption mit enormem Potenzial.
46. Valenta Rudolf: Profil, 15.4.2013, Aus für Allergien, Durchbruch im Kampf gegen die
quälenden Überempfindlichkeiten.
47. Valenta Rudolf: Radio Arabella, Allergie Impfstoff, 17.4.2013
48. Valenta Rudolf: Radiosendung Ö1, Wissen aktuell, 13:55, 10.4.2013, Prinzip der
Apharese,
http://pressespiegel.metacommunication.com/v3/clippings/pool/2013/04/03/13042_OE1
_WAK_Schnupfen.mp2
49. Valenta Rudolf: Salzburger Nachrichten, 3.4.2013, Impfung gegen Schnupfen möglich
50. Valenta Rudolf: Tiroler Tageszeitung, 3.4.2013, Impfung gegen Schnupfen denkbar
51. Valenta Rudolf: Wellness World Business 6/2013, Nr. 2, Therapieoption mit Potential,
52. Valenta Rudolf: www.profil.at, Abwehrschlacht gegen Allergien
1.3.2. Research Awards: n = 10 1. Gadermaier Elisabeth: Clemens von Pirquet-Preis der Österreichischen Gesellschaft
für Allergologie und Immunologie (ÖGAI).
2. Gadermaier Elisabeth: Förderungspreis der Dr. Maria Schaumayr-Stiftung.
3. Gstöttner Antonia: Travel Grant, EAACI FAAM (Food Allergy and Anaphylaxis Meeting) 7.-9. Februar 2013, Nizza, Frankreich).
Performance Report 2013 – Division 3
Immunpathology
70
4. Kuan-Wei Chen: Förderpreis für spezifische Immuntherapie; Deutsche Gesellschaft für Allergologie und klinische Immunologie (DGAKI).
5. Madritsch Christoph: Travel Grant, 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 2013
6. Marth Katharina: Forschungsförderungspreis der Erste Bank der Österreichischen Sparkassen AG.
7. Pahr Sandra: Travel Grant, 15th International Congress of Immunology, Milan, Italy, August 2013.
8. Valenta Rudolf: Würdigungspreis Wissenschaft 2013 des Landes Niederösterreich, 17.10.2013.
9. Resch Yvonne: ÖGAI travel grant for the 15th International Congress on Immunology, Milan, Italy, August 22-27, 2013:
10. Resch Yvonne: EFIS travel bursary for the 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013
1.3.3. Invited lectures: n = 55
1. Flicker Sabine; Pirquet Club, “Allergen-spezifische Antikörper- diagnostische und therapeutische Möglichkeiten“, November 30, 2013, Innsbruck, Austria.
2. Focke-Tejkl Margit: Rencontre francophone d`allergologie moleculaire. "Les proprietes du vaccin BM32 (vaccin peptidique des graminees combine une proteine virale)", January 26-27, 2013, Paris, France
3. Focke-Tejkl Margit: VIII World Congress on Immunopathology, Respiratory Allery & Asthma. "Preclinical characterization of the grass pollen vaccine BM32","Why is Phl p 5 such a potent elicitor of asthma?" October 12-15, 2013, Dubai, VAE
4. Linhart Birgit: “Rekombinante Allergene”, 6.Wiener Komponentenschule „Allergien besser verstehen“ August 30-31, 2013
5. Linhart Birgit: Open Medical Institute of the Austrian Academy of Sciences, “Recombinant Allergens”, September 23, 2013, Vienna, Austria.
6. Linhart Birgit: “Recombinant Allergens”,1st Training for Trainers” IN Uni MAI, Vienna, 3-5th Dec. 2013.
7. Lupinek Christian: “Vorteile der Komponentendiagnostik”, 6.Wiener Komponentenschule „Allergien besser verstehen“ August 30-31, 2013
8. Lupinek Christian: Application of chip technology for research and development. International Symposium on Molecular Allergology, December 5-7, 2013, Vienna, Austria.
9. Lupinek Christian: Characterisation of the MeDALL-chip. MeDALL Integration Workshop, June 3-4, 2013, Karolinska Institutet, Stockholm, Sweden.
10. Lupinek Christian: IgE molecular profiling: The first MeDALL results. 3rd annual MeDALL meeting, January 14-15, 2013, Berlin, Germany.
11. Lupinek Christian: Mechanisms of SIT. Open Medical Institute of the Austrian Academy of Sciences, September 23, 2013, Vienna, Austria.
12. Lupinek Christian: Molecular diagnosis, prescription and monitoring of SIT. 1st Training for Trainers of the International Network University for Molecular Allergology and Immunology, December 3-5, 2013, Vienna, Austria.
Performance Report 2013 – Division 3
Immunpathology
71
13. Marth Katharina: “Allergenkomponenten für die Indikationsstellung und Verlaufskontrolle der SIT” 6.Wiener Komponentenschule „Allergien besser verstehen“ August 30-31, 2013
14. Marth Katharina: Open Medical Institute of the Austrian Academy of Sciences, “Case reports of IgE-mediated allergies” September 23, 2013, Vienna, Austria.
15. Mittermann Irene: “Venom Allergy” 1st Training for Trainers of the International Network University for Molecular Allergology and Immunology, December 3-5, 2013, Vienna, Austria.
16. Pahr Sandra: MeDALL – Mechanisms of the Development of ALLergy. Annual meeting: “The wheat food allergen alpha purothionin, Tri a 37, belongs to a new allergen family of plant defense proteins”, January 14-15, 2013, Berlin, Germany
17. Valenta Rudolf: 15th ICI (Immunitas vis Nature) International Congress of Immunology: “From allergen genes to allergy vaccines”. August 21-28, 2013, Milan, Italy.
18. Valenta Rudolf: 1st International Ring Symposium “Skin in Inflammation and Allergy”: “Recombinant allergens for diagnosis and therapy”. December, 9, 2013, Münich, Germany.
19. Valenta Rudolf: 1st Training for trainers of International Network University for molecular allergology & immunology (IN Uni MA&I): “Current view of pathomechanisms of allergy”, “New strategies for therapy and prevention of allergy”, “ISAC Results Round table”. December 3-5, 2013. Vienna, Austria.
20. Valenta Rudolf: 2nd Meeting of Middl-European Societies for Immunology and Allergology, “Session VI on Allergology”. October 10-13, 2013, Opatija, Croatia.
21. Valenta Rudolf: 2nd SFB work-in-progress meeting, SFB Program Grant F46: “”Towards prophylactic vaccination of allergy”. November 4-5, 2013, Rastenfeld, Austria.
22. Valenta Rudolf: 3rd EFIS-EJI Summer School in Clinical Immunology, Innovative Therapies based on Immunology (ITI): “Engineered allergen-specific immunotherapy vaccines, from bench to bedside”. July 1-3, 2013, Cordeliers Research Center, Paris, France.
23. Valenta Rudolf: 3rd Pediatric Allergy and Asthma Meeting (PAAM 2013), “Monitoring the antibody response to rhinovirus: implications for asthma management”. October 18-19, 2013, Athens, Greece.
24. Valenta Rudolf: 5. Wiener Komponentenschule, Allergien besser verstehen: „Pathomechanismen der Allergie“, „Mechanismen der SIT“. August 30-31, 2013. Wien, Österreich.
25. Valenta Rudolf: AAA (Austrian Apheresis Association), Apherese-Gesellschaft, Gesellschaft der Ärzte in Wien - Billrothhaus, Pressekonferenz: “Zukunftsaussichten – Apherese gegen Asthma und schwere allergische Erkrankungen”. April, 10, 2013, Vienna, Austria.
26. Valenta Rudolf: AAAAI (American Academy of Allergy, Asthma & Immunology) Annual Meeting 2013: “Peptides and modified recombinants”. February, 22-26, 2013, San Antonio, Texas
27. Valenta Rudolf: AAF/OMI Open Medical Institute Symposium in topic “Current view to molecular allergology for personalize medicine”: “Current view to pathomechanisms of allergy”, “Innovative allergy diagnosis”, “New strategies for therapy and prevention of allergy”. September 18, 2013, Tashkent, Uzbekistan.
28. Valenta Rudolf: Advisory Board Meeting, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma. February 8, 2013, London, Great Britain
Performance Report 2013 – Division 3
Immunpathology
72
29. Valenta Rudolf: Allergieforschung – der Status quo, Gesellschaft der Ärzte in Wien - Billrothhaus: „Immuntherapie für Gräserpollenallergie mit rekombinanten Allergenderivaten“. April, 17, 2013, Vienna, Austria.
30. Valenta Rudolf: Allergologie im Kloster, Interdisziplinares Symposium und Workshops: “Molekulare Allergologie: von den wissenschaftlichen Anfängen bis zur Anwendung in der klinischen Routine”. May 25, 2013, Kloser Eberbach in Eltville, Rheingau, Deutschland.
31. Valenta Rudolf: Annual meeting of the Portuguese society of immunology, Coimbra SPI 2013: “From allergen genes to new forms of diagnosis and therapy of allergy”. November 13-15, 2013, Coimbra, Portugal.
32. Valenta Rudolf: Congress of the European Academy of Allergy and Clinical Immunology & World Allergy Organization (EAACI & WAO), World Allergy & Asthma Congress: “In vitro allergy diagnosis”. June 22-25, 2013, Mailand, Italy.
33. Valenta Rudolf: Congress of the Federation of Clinical Immunology Societies (FOCIS) 2013, AAAAI & NIAID FOCIS Symposium: “New forms of allergen immunotherapy”. June 27-30, 2013, Boston, Massachusetts, USA.
34. Valenta Rudolf: Else Kröner Fresenius Award Ceremony: “From allergen genes to new form of diagnosis and therapy of allergy”. June 5, 2013, Else Kröner-Fresenius-Stiftung, Deutsches Historisches Museum, Berlin, Germany
35. Valenta Rudolf: eMediqual – The end of a project, the beginning of structural changes in Romanian medical education: “From allergen genes to new forms of diagnosis and therapy of allergy”. University of Medicine and Pharmacy “Victor Babes”. November 20-22, 2013, Timisoara, Romania.
36. Valenta Rudolf: Emerging Societies Program (ESP), World Allergy Training School (WATS), Diagnostics tests of allergy: “Demonstation session I: Skin testing workshop”, “ Indications, Mechanisms and Treatment of Airway Allergy Diseasse: SCIT vs SLIT”. November 25-26, 2013, Harare, Zimbabwe.
37. Valenta Rudolf: FAST – EU-Projektmeeting, progress meeting, Golden Age of Athens hotel. November 11-12, 2013, Athens, Greece.
38. Valenta Rudolf: MeDALL FP7 Project Meeting, MeDALL Integration Workshop: „Concept and expected outcome of IgE Microarray“, „Time plan for further analysis of other cohorts“, „Expected outcomes – deliverables of WP5“. May 31- June 5, 2013, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden and Thermofischer, Uppsala , Sweden.
39. Valenta Rudolf: MeDALL Meeting, FP7: “Characterization of inhalant and food allergens”, “IgE molecular profiling: the first MeDALL results”, January 14-15, 2013, Berlin, Germany.
40. Valenta Rudolf: Neue Diagnose und Behandlung von Allergien und Asthma, Vortrag von Univ. Prof. Dr. Rudolf Valenta, May 29, 2013, Guntramsdorf am Tabor, Austria.
41. Valenta Rudolf: Open Medical Institute of the Austrian Academy of Sciences, “,Pathomechanisms of Allergy”, September 23, 2013, Vienna, Austria.
42. Valenta Rudolf: PreDicta (EU-Projekt) consortium meeting, Hotel Rydges Kensington. October 7-8, 2013, London, Great Britain.
43. Valenta Rudolf: PreDicta Consortium Meeting, FP7 Project, January 23-24, 2013, Vienna, Austria
44. Valenta Rudolf: Slovak and Czech Allergology and Clinical Immunology Congress (SSAKI): “Recombinant allergen-based forms of diagnosis and treatment for allergy”.
Performance Report 2013 – Division 3
Immunpathology
73
September 25, 2013, Bratislava, Slovakia.
45. Valenta Rudolf: Stallergenes´ Scientific advisory board meeting, April, 26, 2013, Paris, France.
46. Valenta Rudolf: The role of developmental determinants of chronic diseases and frailty in ageing: From science to value creation and policies. Workshop. December 2-3, 2013, Montpellier, France.
47. Valenta Rudolf: VI World Asthma, Allergy & COPD Forum: “Depletion of IgE for the treatment of allergic asthma”, “Mechanisms and clinical results obtained with a recombinant vaccine for grass pollen allergy”. April, 27-30, 2013, London, Great Britain.
48. Valenta Rudolf: WAO Symposium on Immunotherapy and Biologics: “Recombinant allergens: the present and the future”, “Passive immunization with allergen-specific IgG antibodies for the treatment and prevention of allergy”. December 13-14, 2013, Chicago, IL, United States.
49. Valenta Rudolf: Zimbabwe Allergy Society, NCD Symposium on Allergies and Asthma: “Immunotherapy and Immunomodulators in allergic airway disease”. November 26-27, 2013, Bronte Hotel, Harere, Zimbabwe.
50. Vrtala Susanne: Allergy Workshop Mainz „Towards new forms of diagnosis and therapy of house dust mite allergy”, March 7-8, 2013, Mainz, Germany
51. Vrtala Susanne: VI World Asthma, Allergy and COPD Forum, “Molecular markers for house dust mite-induced asthma”, “New immunotherapy strategies for house dust mite allergy”, April 27-30, 2013 in London, UK.
52. Vrtala Susanne: VIII World Congress on Immunopathology, Respiratory Allergy & Asthma, “Towards new forms of diagnosis of house dust mite allergy “,Recombinant house dust mite allergens for immunotherapy”,October 12-15, 2013, Dubai, VAE.
53. Vrtala Susanne: 1st Training for Trainers of the International Network University for Molecular Allergology and Immunology, “Animal and Mite Allergens”, December 3-5, 2013, Vienna, Austria.
54. Wollmann Eva: 1st Training for Trainers, “Molecular Allergology in Practice”, Vienna, 3-5th Dec. 2013.
55. Wollmann Eva: International Seminar on Modern Allergology. “Peanut Allergy”, September 15-19.2013, Tashkent, Uzbekistan.
1.3.4. Congress organization
Division member Name:
National congress Name, date
Function
Intern. Congress, Name, date
Function
Valenta Rudolf PreDicta Consortium Meeting, Vienna, January, 23-24, 2013
Organizer
Valenta Rudolf 6.Wiener Komponentenschule „Allergien besser verstehen“, Vienna August 30-31, 2013
Co-Organizer
Performance Report 2013 – Division 3
Immunpathology
74
Valenta Rudolf 2nd SFB work-in-progress meeting,
Rastenfeld/Ottenstein, November 4-5, 2013
Organizer
Valenta Rudolf 1st Training for Trainers
of International Network University for Molecular Allergology & Immunology, Vienna, December 3-5, 2013
Organizer
Valenta Rudolf ISMA 2013, International Symposium on Molecular Allergology, December 5-7, 2014, Vienna, Austria
Co-Organizer
1.3.5. Hosting speakers division member Speaker´s name Affiliation Date
Valenta Rudolf Dr. Trevor T. Hansel
BSc, MBBCh, MSc, FRCPath, PhD
St.Mary's Hospital Paddington, London , UK
05/10/2013
Valenta Rudolf Prof. Motohiro Ebisawa, MD, Ph.D
Dept. of Allergy, Clinical Research Center for Allergology and Rheumatology, Sagamihara National Hospital,Sagamihara, Japan
06/19/2013
Valenta Rudolf Prof. Detlef Schuppan, Dr. Dr.
Dept. of Medicine I, University of Mainz, Medicine Harvard Medical School, Molecular and Translational Medicine, Univ. of Mainz Medical Center, Mainz, Germany
07/11/2013
Valenta Rudolf Dr. Peter Socrates Creticos, M.D.
John Hopkins Univ. School of Medicine Div. of Allergy & Clin.Immunology, Director of Clin. Research Creticos Research Group
08/06/2013
Valenta Rudolf Prof. Peter JM Openshaw
Centre for Respiratory Infection, National Heart &Lung Inst. , Imperial College London, St. Mary's Campus, Paddington, London, UK
09/20/2013
Valenta Rudolf Prof. Ruby Pawankar, MD,
PhD, FRCP, FAAAAI
World Allergy Organisation, Allergy, Dept. of Pediatrics, Nippon Med. School, Japan
11/4-5/2013
Valenta Rudolf Prof. Allen Kaplan, MD
Med. Univ. of South Carolina, Charleston, USA
11/4-5/2013
Valenta Rudolf Prof. Wayne Thomas, PhD
Telethon Inst. for Child Health Research,Univ. of Western Australia, West Perth, Western Australia
11/4-5/2013
Valenta Rudolf Prof. Catherine Dept. of Immunology, Cancer & 11/08/2013
Performance Report 2013 – Division 3
Immunpathology
75
Sautes-Fridman
Inflammation, Cordeliers Research Center, Univ. Paris Descartes, Paris, France
Valenta Rudolf Prof. Wolf-Herve Fridman
Director Cordeliers Research Center, Univ. Paris Descartes, Paris, France
11/08/2013
Valenta Rudolf Prof. Hans-Uwe Simon
Inst. of Pharmacology, Med. Faculty, Univ. of Bern, Switzerland
11/15/2013
Valenta Rudolf Prof. Dr. rer. nat. Stephan Urban
Dept. of Infectious Diseases, Molecular Virology University Hospital Heidelberg, Heidelberg, Germany
12/19/2013
Valenta Rudolf David Artis, PhD Univ. of Pennsylvania, Perleman School of Medicine, Dept. of Microbiology, Inst. for Immunology, Philadelphia, USA
11/20/2013
Valenta Rudolf Prof. Dr. Heimo Breiteneder
Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
08/30/2013, 12/03/2013
Valenta Rudolf Dr. Birgit Linhart Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
08/30/2013, 12/03/2013
Valenta Rudolf Prof. Winfried Pickl Medical University of Vienna Department of Immunology Center of Pathophysiology, Infectiology & Immunology
12/04/2013
Valenta Rudolf Prof. Victoria Garib Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
12/04/2013
Valenta Rudolf Dr. Christine Hafner Medical University of Vienna Division of General Dermatology
08/30/2013, 12/04/2013
Valenta Rudolf Prof. Barbara Bohle Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
12/04/2013
Valenta Rudolf Dr. Stefan Wöhrl Floridsdorfer Center of Allergology 08/30/2013, 12/04/2013
Valenta Rudolf Prof.Zsolt Szepfalusi
Medical University of Vienna Center of Pedriatics
12/04/2013
Valenta Rudolf Ass.Prof.Susanne Vrtala
Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
12/04/2013
Valenta Rudolf Dr. Irene Mittermann
Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology,
12/04/2013
Performance Report 2013 – Division 3
Immunpathology
76
Infectiology & Immunology
Valenta Rudolf Prof. Dr. Verena Niederberger
Medical University of Vienna Department or Ear, Nose and Throat Diseases
08/30/2013, 12/05/2013
Valenta Rudolf Dr. Christian Lupinek
Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
08/30/2013, 12/05/2013
Valenta Rudolf Doz. Eleonora Dehlink
Medical University of Vienna Center of Pedriatics
08/30/2013
Valenta Rudolf Prof. Werner Aberer
Medical University of Graz Department or Ear, Nose and Throat Diseases
08/30/2013
Valenta Rudolf Dr. Katharina Marth Hospital Hietzing, Neurological Center Rosenhügel
08/30/2013
Valenta Rudolf Dr. Garmatiuk Tetjiana
Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
12/05/2013
Valenta Rudolf Dr. Eva Wollmann Medical University of Vienna Department of Pathophysiology and Allergy Research Center of Pathophysiology, Infectiology & Immunology
12/05/2013
1.3.6. Mobility
Name Program University, Country
Time frame Division In Out
Hochradl Monika
Trainee Austria 05/06/13 – 06/30/13
3 X
Billerhart Magdalena
Trainee Austria 07/01/13 – 08/02/13
3 X
Marth Katharina
Visiting scientist Austria 07/01/13 3 X
Lamplot Roman
Trainee Austria 09/02/13 – 09/27/13
3 X
Helmis Christina
Trainee Hamburg 09/09/13 – 10/18/13
3 X
Garib Victoria Visiting scientist Uzbekistan 11/07/12 - ongoing
3 X
Martins Luis Miguel
Lourenco
Visiting scientist Portugal 01/07/13 – 01/27/13
3 X
Ranftler Nadine
Trainee Austria 07/01/13 – 07/31/13
3 X
Performance Report 2013 – Division 3
Immunpathology
77
1.3.7. Activities in Advisory Boards
Name Society/Institute/Journal Function
Rudolf Valenta Iranian Journal of Allergy, Asthma and Immunology”
International Board Consultant
1.3.8. Editorial Activities
Name Journal Function
Rudolf Valenta International Archives of Allergy and Immunology
Editor in Chief
Rudolf Valenta International Archives of Allergy and Immunology
Editorial Board
Rudolf Valenta ACI International Editorial Board
Rudolf Valenta Allergo Journal Editorial Board
Rudolf Valenta Journal of Investigational Allergology & Clinical
Immunology
Editorial Board
Rudolf Valenta European Journal of Clinical Investigation
Editorial Board
Rudolf Valenta Calcium Binding Proteins Editorial Board
Rudolf Valenta International Journal of Immunorehabilitation
Editorial Board
Rudolf Valenta American Journal of Plant Sciences
Editorial Board
Rudolf Valenta Revista Alergia Mexico Editorial Board
Rudolf Valenta Clinical Reviews in Allergy and Immunology
Editorial Board
1.3.9. Review Activities
Name Grants/Thesis/Habilitation
Valenta Rudolf Review of the diploma thesis “Characterization and culture of primary human nasal epithelial cells” by Eva Waltl
1.3.10. Filed and granted patents
Name Patent
Valenta Rudolf USA, appliance No. 11/933498, 10.5.2001, Patent No. 8440200, Grant date: 14.5.2013
Valenta Rudolf China, appliance No. 200880125943.X, 28.11.2008, Patent No. ZL200880125943.X, Grant date: 30.10.2013
Valenta Rudolf Canada, appliance No. 2429636, 27.12.2001, Patent No. 2429636, Grant date: 5.2.2013
Valenta Rudolf Russian Federation, appliance No. 2010126590, 28.11.2008, Patent No. 2502742, Grant date: 27.12.2013
Performance Report 2013 – Division 3
Immunpathology
78
Valenta Rudolf ."Gräser Hybride" - notice of grant of patent in Europe: Europäische Patentanmeldung Nr. 10.752799.6 "Hypoallergenic hybrid
polypeptides for the treatment of allergy"
Valenta Rudolf European Patent Application, Short title: HIV DIAGNOSIS, EP 13159417.8,
Valenta Rudolf "Fish Parvalbumin" – granted in Canada: Kanadische Patentanmeldung Nr. 2,475,073 - "Hypoallergenic polypeptides
based on fish parvalbumin"
Valenta Rudolf "Allergen Carrier" - notice of grant of patent in Japan: Patent Application No 2009-513514
Valenta Rudolf . "Mosaic Antigens" -granted in Canada: Kanadische Patentanmeldung Nr. 2,513,711 "Process for the Preparation of
Hypoallergenic Mosaic Antigens"
Valenta Rudolf "Milbe Clon 30" - granted in China: Chinesische Patentanmeldung No. ZL200780014784.1 - Short title: HAUSSTAUBMILBENALLERGEN
Valenta Rudolf "HIV Diagnosis" - New European application filed : PCT Patent Application PCT/EP2014/055194 "HIV Diagnosis"
Valenta Rudolf "Allergen Carrier" - notice of grant of patent in Australia: Patent Application No. 2007257308
Vrtala Susanne Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity, international
Performance Report 2013 – Division 3
Immunpathology
79
1.3.11. Grants Funding agency Title of project Principal investigator
Biomay Produktions-und Handels-Aktiengesellschaft (RV), AP00085OFF
0Impfstoffe und Toleranzstrategien für Typ I Alllergie.
Rudolf Valenta
Phadia, AP00031OFF/ AS00000017
Utility of recombinant allergens, wheat and venom allergens.
Rudolf Valenta
EU-Kommission/FP7 „Health“, FA648A0304
EU Projekt MedAll - Mechanisms of the development of allergy.
Rudolf Valenta
EU-Kommission/FP7 „Health“, FA648A0303
EU Projekt Predicta - Post-infectious immune reprogramming and its association with persistence and chronicity of respiratory allergic diseases.
Rudolf Valenta
Fresenius Medical Care Deutschland GmbH., ESPIRA, FA648A0305
Extracorporal Specific IgE Removal from the plasma of allergic Asthma patients.
Rudolf Valenta
Karger Verlag, UE64801005
Editorial Office, Personalkosten, Sachkosten. Rudolf Valenta
Fonds zur Förderung Wissenschaftlicher Forschung (FWF)
PHD-Program „Inflammation and Immunity“. Rudolf Valenta
Fonds zur Förderung Wissenschaftlicher Forschung (FWF)
PhD-Program Molecular, Cellular and Clinical Allergology, MCCA.
Rudolf Valenta
Fonds zur Förderung Wissenschaftlicher Forschung (FWF)
PhD-Program Molecular, Cellular and Clinical Allergology, MCCA.
Susanne Vrtala
Fonds zur Förderung Wissenschaftlicher Forschung (FWF)
PhD-Program Molecular, Cellular and Clinical Allergology, MCCA.
Margarete Focke-Tejkl
FWF, 23318-B11, APP23318FW
Regulatory role of allergen-specific antibodies. Sabine Flicker
FWF, 23350-B11, APP23350FW
Recognition of allergen epitopes in secondary IgE response.
Birgit Linhart
Christian Doppler Research Association
Development of allergen chips. Susanne Vrtala
FWF-SFB F4605-B19, APF04605FW
“Towards prophylactic vaccination of allergy”. Rudolf Valenta
FWF-SFB F4602-B19, APF04602FW
“Strategies for diagnosis, treatment and prevention of house dust mite allergy “.
Susanne Vrtala
FWF-SFB F4607-B19, APF04607FW
Allergen specific antibodies for therapy and prevention of allergy.
Sabine Flicker
European Research Grant - FP7 – Seventh Framework, FA648A1101
Towards safe and effective immunotherapy of persistent life-threatening food allergies.
Birgit Linhart
Bundesministerium für Wissenschaft und Forschung, EU Zusatzfinanzierung für 7. Rahmenprogramm, FA648A1102
Towards safe and effective immunotherapy of persistent life-threatening food allergies.
Birgit Linhart
FWF, P 25921-B21, APP25921FW
New forms of diagnosis and treatment. Heidrun Hochwallner
Performance Report 2013 – Division 3
Immunpathology
80
1.3.12. Career Developments a) Habilitations: n = 0 b) Habilitations in progress: n = 2 1. Linhart Birgit: Molekulare Allergologie (filed)
2. Mittermann Irene: Molekulare Allergologie, "Molecular characterisation of allergens for diagnosis and therapy". (filed)
c) Professorships: n = 0
1.3.13. Teaching a) Bachelor students: n = 0
b) Diploma, MDiploma and Master students: n = 2
1. Borochova Kristina: Master thesis: Expression and purification of human respiratory
sxncytial virus recombinant surface proteins F and G (2013 – in progress).
2. Gstöttner Antonia: Diploma thesis, From mechanisms of food allergy to new forms of diagnosis and treatment (2012 – 2013).
c) PhD, MDSci, MD students: n = 15 1. Baar Alexandra: PhD thesis: Characterization of wheat allergens, (2009-2013).
2. Banerjee Srinita: PhD thesis: Production and evaluation of peptide vaccines for house dust mite immunotherapy (2009-in progress).
3. Cabauatan Clarissa: PhD thesis: Pollen Aerobiology and Pollen-Specific Immunoglobulin-E Levels of Selected Allergic Patients in the Philippines (2011 – 2013).
4. Cornelius Carolin: PhD thesis: Characterization of immune responses towards Hepatitis B virus antigens and epitopes (2012 – in progress).
5. Dzoro Sheron: PhD student: “Characterisation of antibody reactive microbial antigens”, (2013 – in progress).
6. Gallerano Daniela: PhD thesis, Towards the definition of HIV-related anitbody-signatures and new immunogens for vaccine design (2009 – in progress).
7. Huey-Jy Huang: PhD thesis: Identification of the dominant T cell and B cell epitopes of important HDM allergens (2013 – in progress).
8. Madritsch Christoph: PhD thesis: Isolation of grass pollen specific IgE variable regions to study mechanisms of effector cell degranulation (2009- in progress).
9. Narayanan Meena Balakumari: PhD thesis: Mechanisms underlying secondary antibody responses (12/16/2009 – in progress).
10. Nazanin Najafi: PhD thesis: IgE dependent activation of effector cells (2012- in progress).
Performance Report 2013 – Division 3
Immunpathology
81
11. Ochome Mary: PhD thesis: Identification of peptides from the major peanut allergens for the induction of allergen-specific protective IgG antibodies with diminished IgE or T-cell reactivity (2013 – in progress).
12. Pahr Sandra: PhD thesis: Characterization of wheat food allergens (2010-in progress).
13. Resch Yvonne: PhD thesis: Characterization of mite allergens (2010-in progress).
14. Srinivasan Barani: PhD thesis: Characterization of wheat allergens in celiac disease patients (2008 – in progress).
1.3.14. Exams: n = 8 a) Oral examinations: n = 1
1. Valenta Rudolf: Verdi Philip Martin, 30.9.2013 b) Diploma and Thesis-Examinations: n =6
1. Flicker Sabine: Debiasi Markus, diploma thesis examination, 24.9.2013
2. Flicker Sabine: Thien Phuong Mai Nguyen, diploma thesis examination, 19. 7.2013
3. Vrtala Susanne: Debiasi Markus, diploma thesis examination, 24.9.2013
4. Focke-Teijkl Margarete: Baar Alexandra, 20.12.2013
5. Flicker Sabine: Preyer Isabella, diploma thesis examination, 21.1.2013
6. Flicker Sabine: Pauer Sophie, diploma thesis examination, 21.10.2013
c) Exam supervising: n= 1 1. Focke-Teijkl Margarete: SIP2, 27.6.2013
Performance Report 2013 – Division 4
Medical Biotechnology
82
1.3.15. Lectures, Seminars, Lab courses SWST pro-rata LV Nr. SS 2013
Flicker Sabine 2.00 0.50 860037 Journal Club and Progress Report
Focke-Tejkl Margarete 2.00 0.50 860037 Journal Club and Progress Report
Focke-Tejkl Margarete 10.00 2.50 648022 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Focke-Tejkl Margarete 4.00 1.00 648033 Wissenschaftliches Arbeiten
Linhart Birgit 2.00 0.50 860037 Journal Club and Progress Report
Valenta Rudolf 5.00 5.00 648020 Hämathologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Valenta Rudolf 10.00 2.50 648022 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Valenta Rudolf 2.00 2.00 648024 Journal Club und Progress Report
Valenta Rudolf 5.00 2.00 648026 Molekulare Allergologie - Anleitung zum Wissenschaftlichen Arbeiten (Wahlfachausbildung gem. § 13 lit.a StG.)
Valenta Rudolf 4.00 4.00 648027 Pathologie des Herz- und Kreislaufsystems - Ausgewählte Kapitel aus funktioneller Pathologie
Valenta Rudolf 4.00 1.00 648033 Wissenschaftliches Arbeiten
Valenta Rudolf 2.00 0.20 860007 Special Course: Scientific Presentation
Valenta Rudolf 2.00 0.17 860201 IAI-Journal Club
Valenta Rudolf 2.00 0.20 860202 Special Course: Basic techniques in molecular and cellular biology
Valenta Rudolf 2.00 0.25 860220 Basisvorlesung Immunologie
Valenta Rudolf 2.00 0.15 901929 IAI-Basic Seminars
Valenta Rudolf 2.00 2.00 901931 Special Course: Advanced Molecular cloning techniques
Valenta Rudolf 2.00 1.00 901941 Special Course: Allergology
Valenta Rudolf 2.00 2.00 902276 TS Molekulare Allergologie
Valenta Rudolf 2.00 2.00 902277 Journal Club und Progress Report
Vrtala Susanne 10.00 2.50 648022 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Vrtala Susanne 4.00 1.00 648033 Wissenschaftliches Arbeiten
Sum 32.97
WS 2013/14
Focke-Tejkl Margarete 5.00 1.00 514034 Molekulare Allergologie - Anleitung zum Wissenschaftlichen Arbeiten (Wahlfachausbildung gem. § 13 lit.a StG.)
Focke-Tejkl Margarete 2.00 0.22 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Focke-Tejkl Margarete 2.00 0.13 861007 MCCA Journal Club
Performance Report 2013 – Division 4
Medical Biotechnology
83
Focke-Tejkl Margarete 4.00 1.30 648002 Wissenschaftliches Arbeiten
Focke-Tejkl Margarete 2.00 0.66 648005 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Linhart Birgit 2.20 0.53 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Valenta Rudolf 5.80 0,40 803002 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Valenta Rudolf 4.00 4.00 514002 Pathologie des Herz- und Kreislaufsystems - Ausgewählte Kapitel aus funktioneller Pathologie
Valenta Rudolf 5.00 2.00 514034 Molekulare Allergologie - Anleitung zum Wissenschaftlichen Arbeiten (Wahlfachausbildung gem. § 13 lit.a StG.)
Valenta Rudolf 2.00 0.22 861008 Lecture, Seminar and Course Series on Allergic Priming and Effector Phase
Valenta Rudolf 2.00 2.00 648001 Journal Club and Progress Report
Valenta Rudolf 4.00 1.30 648002 Wissenschaftliches Arbeiten
Valenta Rudolf 2.00 0.66 648005 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Valenta Rudolf 3.00 0.40 840052 Medizinisches Propädeutikum Teil 1
Valenta Rudolf 2.00 0.18 860008 Special Course: Scientific Presentation
Valenta Rudolf 2.00 0.18 870011 Medical Propedeutics II ¿ Linking Biology and Diseases - WS 2013
Valenta Rudolf 2.00 0.13 901929 IAI-Basic Seminars
Valenta Rudolf 2.00 2.00 901931 Special Course: Advanced Molecular cloning techniques
Valenta Rudolf 2.00 0.17 902241 IAI-Journal Club
Valenta Rudolf 2.00 0.18 902920 Special Course: Basic techniques in molecular and cellular biology
Valenta Rudolf 2.00 0.22 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Valenta Rudolf 2.00 0.13 861007 MCCA Journal Club
Vrtala Susanne 1.13 0.27 801001 BL 1 - Gesunde und kranke Menschen
Vrtala Susanne 1.00 1.00 801011 Problemorientiertes Lernen - 1. Semester
Vrtala Susanne 5.00 1.00 514034 Molekulare Allergologie - Anleitung zum Wissenschaftlichen Arbeiten (Wahlfachausbildung gem. § 13 lit.a StG.)
Vrtala Susanne 4.00 1.30 648002 Wissenschaftliches Arbeiten
Vrtala Susanne 2.00 0.66 648005 Immunologie - Ausgewählte Kapitel aus Funktioneller Pathologie
Vrtala Susanne 2.00 0.44 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Vrtala Susanne 2.00 0.13 861007 MCCA Journal Club
Sum 22.81
Total sum SS+WS 55.78
Performance Report 2013 – Division 4
Medical Biotechnology
84
1.4 Division of Medical Biotechnology Head: Heimo Breiteneder, Professor
1. Publications7
IF Number Top/Std/Subst
Heimo Breiteneder 31.356 7 6 Top, 1 Std
Karin Hoffmann-S. 28.903 6 3 Top, 2 Std, 1 Sst
Yan Ma 2.755 1 1 Top
Christian Radauer 12.047 1 1 Top
Division-Sum 36.165
Top point score 2 - among top 20 % of journal in field
Standard point score 1 - between 21-60 %, Substandard point score 0,2
2. Supervision of diploma and doctoral students Bachelor st. Diploma st. Doctoral st.
Heimo Breiteneder 0 4 Karin Hoffmann-S. 4 2 Yan Ma 6 2 Christian Radauer 1 1
Sum 11 9 3. Teaching SS* WS* total W+S oral Exams
Heimo Breiteneder Merima Bublin Christine Hafner
3.67 1.00 0.00
6.17 0.53 3.00
9.84 1.53 3.00
0 0 0
Karin Hoffmann-S. 3.00 6.58 9.58 22 Yan Ma 8.64 9.05 17.69 22 Christian Radauer 0.00 2.23 2.23 0 Sum 16.31 27.56 43.87 44
7 For working groups IFs of all publications including joint publications with other working groups are presented. In contrast, the
given sum of the division represents the net value of IFs without overlaps due to joint publications.
Performance Report 2013 – Division 4
Medical Biotechnology
85
1.4.1. Publications a) Peer-reviewed original articles: n = 10
Nr. Article IF Class pro-rata
IF 1. Le TM*, Bublin M*, Breiteneder H, Fernández-Rivas M, Asero
R, Ballmer-Weber B, Barreales L, Bures P, Belohlavkova S, de Blay F, Clausen M, Dubakiene R, Gislason D, van Hoffen E, Jedrzejczak-Czechowicz M, Kowalski ML, Kralimarkova T, Lidholm J, DeWitt AM, Mills CE, Papadopoulos NG, Popov T, Purohit A, van Ree R, Seneviratne S, Sinaniotis A, Summers C, Vázquez-Cortés S, Vieths S, Vogel L, Hoffmann-Sommergruber K, Knulst AC. Kiwifruit allergy across Europe: clinical manifestation and IgE recognition patterns to kiwifruit allergens. J Allergy Clin Immunol 2013;131(1):164-71. *These authors contributed equally to this paper
12.047 TOP 12.047
2. Caimmi D, Barber D, Hoffmann-Sommergruber K, Amrane H, Bousquet PJ, Dhivert-Donnadieu H, Demoly P. Understanding the molecular sensitization for Cypress pollen and peach in the Languedoc-Roussillon area. Allergy 2013;68 (2):249-51.
5.883 TOP 1.177
3. Berneder M, Bublin M, Hoffmann-Sommergruber K, Hawranek T, Lang R. Allergen chip diagnosis for soy allergic patients: Gly m 4 as a marker for severe food allergic reactions to soy. Int Archives Allergy Immunol 2013;161:229-33.
2.248
Std 2.248
4. Bublin M, Kostadinova M, Radauer C, Hafner C, Szépfalusi Z, Varga EM, Maleki SJ, Hoffmann-Sommergruber K, Breiteneder H. IgE cross-reactivity between the major peanut allergen Ara h 2 and the non-homologous allergens Ara h 1 and Ara h 3.J Allergy Clin Immunol 2013;132(1):118-24.
12.047 TOP 12.047
5. Vlieg-Boerstra BJ, van de Weg WE, van der Heide S, Skypala I, Bures P, Ballmer-Weber BK, Hoffmann-Sommergruber K, Zauli D, Ricci G, Dubois AE. Additional Indications for the low allergenic properties of the apple cultivars Santana and Elise. Plant Foods Hum Nutr 2013;68(4):391-5.
2.358 Std 0.472
6. De Swert L, Veereman G, Bublin M, Breiteneder H, Dilissen E, Bosmans E, Mattelaer C, Bullens D. Eosinophilic gastrointestinal disease suggestive of pathogenesis-related class 10 (PR-10) protein allergy resolved after immunotherapy. J Allergy Clin Immunol 2013;131(2):600-2.
12.047 TOP 2.409
7. Peter K, Schinnerl J, Felsinger S, Brecker L, Bauer R, Breiteneder H, Xu R, Ma Y. A novel concept for detoxification: Complexation between aconitine and liquiritin in a Chinese herbal formula ('Sini Tang'). J Ethnopharmacol 2013;16;149(2):562-9.
2.755 TOP 2.755
8. van den Driesche S, Iuliano F, Haiden C, Pucciarelli D, Breiteneder H, Pastorekova S, Hafner C, Vellekoop MJ. Cell membrane morphology analysis using an infrared sensor system. Sensor Actuat B Chem 2013;179:150-156.
3.535 TOP 0.707
Performance Report 2013 – Division 4
Medical Biotechnology
86
9. Chruszcz M, Ciardiello MA, Osinski T, Majorek KA, Giangrieco I, Font J, Breiteneder H, Thalassinos K, Minor W. Structural and bioinformatic analysis of the kiwifruit allergen Act d 11, a member of the family of ripening-related proteins. Mol Immunol 2013;56(4):794-803.
2.645 Std 0.529
10. Santos KS, Gadermaier G, Vejvar E, Arcuri HA, Galvão CE, Yang AC, Resende VM, Martins Cde O, Himly M, Mari A, Liso M, Pomponi D, Breiteneder H, Wagner S, Kalil J, Ferreira F, Castro FF. Novel allergens from ancient foods: Man e 5 from manioc (Manihot esculenta Crantz) cross reacts with Hev b 5 from latex. Mol Nutr Food Res 2013;57(6):1100-9.
4.310 TOP 0.862
sum 59.875 35.253 b) Invited Articles & Reviews with IF: n = 1
Nr. Article IF Class pro-rata IF
1. Hoffmann-Sommergruber, K. “Authentication of food allergens” J Serb Chem Soc 2013 Vol. 78, No. 3, p. 315-320 (2013).
0.912 Subst 0.912
sum 0.912 0.912 c) Invited Articles & Reviews without IF: n = 4 Bublin M. Kiwifruit allergies. Advances in food and nutrition research 2013; 68:321-40. 1. Silva DD, Panesar SS, Thusu S, Rader T, Werfel T, Muraro A, Hoffmann-
Sommergruber K, Roberts G, Sheikh A. The acute and long-term management of food allergy: protocol for a rapid systematic review. Clin Transl Allergy 2013;3(1):12.
2. Nwaru BI, Panesar SS, Hickstein L, Rader T, Werfel T, Muraro A, Hoffmann-Sommergruber K, Roberts G, Sheikh A. The epidemiology of food allergy in Europe: protocol for a systematic review. Clin Transl Allergy 2013;3(1):13.
3. Soares-Weiser K, Panesar SS, Rader T, Takwoingi Y, Werfel T, Muraro A, Hoffmann-Sommergruber K, Roberts G, Sheikh A The diagnosis of food allergy: protocol for a systematic review. Clin Transl Allergy 2013;3(1):18.
d) Book contributions: n = 1 Was sind Chinesische Medizin und Chinesische Kultur? Kinderuni Wien 2013. Studienbuch S99. Vienna General Hospital, Medical University of Vienna, July 15th-19th 2013 e) Abstracts, printed in periodicals: n = 5 1. Bublin, M., C. Radauer, N.M. Rigby, C. Hafner, B. Ballmer-Weber, H. Breiteneder, K.
Hoffmann-Sommergruber. IgE cross-reactivity between non-homologous allergens from hazelnut. Poster presentation at the the EAACI-WAO World Allergy and Asthma Congress 2013, 22–26 June, Milan, Italy. Abstract no. 1949. Allergy 68 Suppl. 97, 667
2. Ashjaei, K., N. Lengger, M. Bublin, I. Ellinger, S. Wagner, K. Hoffmann-Sommergruber. Visualization of allergen uptake by dendritic cells. Poster presentation
Performance Report 2013 – Division 4
Medical Biotechnology
87
at the the EAACI-WAO World Allergy and Asthma Congress 2013, 22–26 June, Milan, Italy. Abstract no. 436. Allergy 68 suppl. 97, 195
3. Pucciarelli, D., Weber, E., van den Driesche, S., N. Lengger, Vellekoop, MJ., Breiteneder, H., Hafner, C. Macromolecular changes in melanoma cells after treatment with Vemurafenib observes by a mid-infrareded sensor system. 2013 International Investigative Dermatology Meeting, May 8-11, 2013, Edinburgh, United Kingdom. J Invest Dermatol, 2013, 133, S238-S238
4. Gepp B., Ackerbauer, D., Lengger, N., Hemmer, W., Radauer, C., Breiteneder, H.: Distinct antibody reactivity patterns to Bet v 1 and its bacterial homologues from Staphylococcus aureus and Pseudomonas aeruginosa. Oral presentation at the the EAACI-WAO World Allergy and Asthma Congress 2013, 22–26 June, Milan, Italy, abstract no. 53. Allergy 2013, Volume: 68; Supp: 97: 24. Sep 2013
5. Guhsl, EE., G. Hofstetter, N. Lengger, C. Ebner, H. Breiteneder, C. Radauer. Comparing clinical data and allergen-specific immunoglobulin levels in the birch pollen plant food syndrome. EAACI-WAO World Allergy and Asthma Congress 2013, Milan, Italy June 22-26, 2013 (Poster presentation). Abstract no. 1948.Allergy 68 Suppl. 97, 667
6. Lukschal, A., M. Bublin, J. Wallmann, B. Hantusch, H. Breiteneder, I. Pali-Schöll , E. Jensen-Jarolim. Characterization of a coss-reactive epitope of birch pollen allergens and celery allergen Api g 5 by a mimotope approach. Poster presentation at the the EAACI-WAO World Allergy and Asthma Congress 2013, 22–26 June, Milan, Italy. Allergy 68 Suppl. 97, 174.
7. Smole U., Ackerbauer D., Lengger N., Radauer C., Wallner M., Svoboda M., Wills-Karp M., Mechtcheriakova D., Breiteneder H. (2013): Allergenicity of the major birch pollen allergen Bet v 1 might arise from molecular mimicry of homologous bacterial proteins. Poster presentation at the 100th Annual Meeting of the American Association of Immunologists, May 3-7, 2013, Honolulu, HI, USA. J. Immunol. 190 suppl., abstract 62.4.
8. Bublin, M., M. Kostadinova, C. Radauer, C. Hafner, Z. Szépfalusi, E. M. Varga, S.J. Maleki, H. Breiteneder, K. Hoffmann-Sommergruber. IgE cross-reactivity between the major peanut allergen Ara h 2 and the non-homologous allergens Ara h 1 and Ara h 3. Poster presentation at the Food Allergy and Anaphylaxis Meeting 2013, 7-9. February, Nice, France. Clin Transl Allergy 2013, 3 (Suppl 3): P85
9. Gadermaier, G., E. Vejvar , P. Briza, K. Hoffmann-Sommergruber, W. Hemmer, F. Ferreira. Molecule-based diagnosis of Apium graveolens allergy. Is there a need to increase the current allergen panel? Oral presentation at the Food Allergy and Anaphylaxis Meeting 2013, February 7-9, 2013, Nice, France. Clin Translat Allergy 2013, 3 (Suppl 3): O12.
10. Datema, M. R., L. Zuidmeer, C. Garino, J. Marsh, A. Lovegrove, M. Clausen, D. Gislason, R. Dubakiene, I. Reig, L. Barreales, A. C. Knulst, T.M. Le, M. L. Kowalski,M. Jedvzejczak, J. Lidholm, T. Kralimarkova, T. Popov, R. Asero, S. Seneviratne, N. Sinaniotis, N. Papadopoulos, A. Purohit, F. de Blay, P. Bures, S. Vieths, M. Fernández-Rivas, K. Hoffmann-Sommergruber, R. van Ree, B. Ballmer-Weber. Component Resolved Diagnosis in relation to severity of hazelnut allergy across Europe. Poster presentation at the Food Allergy and Anaphylaxis Meeting 2013, February 7-9, 2013, Nice, France. Clin Translat Allergy 2013, 3 (Suppl 3): P39
11. Datema, R., L. Zuidmeer-Jongejan, C. Garino, J. Marsh, A. Lovegrove, M. Clausen D. Gislason, R. Dubakiene, I. Reig, L. Barreales, A. C. Knulst, T.-M. Le, M. L. Kowalski, M. Jedvzejczak-Czechowicz, J. Lidholm, P. Bures ,T. Kralimarkova T. Popov, R. Asero, S.L. Seneviratne, S. Belohlavkova, A. Sinaniotis, N. Papadopoulos, A. Purohit, F. de Blay , S.
Performance Report 2013 – Division 4
Medical Biotechnology
88
Vieths, M. Fernández-Rivas, K. Hoffmann-Sommergruber, R. van Ree, B. Ballmer-Weber. Hazelnut allergy in outpatient clinics across twelve European countries (EuroPrevall study). Oral presentation at the the EAACI-WAO World Allergy and Asthma Congress 2013, 22–26 June, Milan, Italy. abstract no. 1843. Allergy 68 Suppl. 97,112.
f) Abstracts, in congress proceedings or abstract books: n = 29 1. Pucciarelli, D., E. Weber, S. van den Driesche, M. Vellekoop, H. Breiteneder, C.
Hafner. The CH2-stretch ratio as a method to determine membrane morphology alterations in melanoma cells treated with PLX4032. YSA-PhD Symposium, Medical University of Vienna; June 19-20, 2013;
2. Pucciarelli, D., L. Csaderova, F. Juliano, N. Lengger, H. Breiteneder, S. Pastorekova, C. Hafner: The Response to PLX4032 in V600E Mutated Melanoma Cells under Hypoxic Condition. 4rd Retreat of the Center of Pathophysiology, Infectiology & Immunology; September 17, 2013;
3. Pucciarelli, D., L. Csaderova, F. Juliano, N. Lengger, H. Breiteneder, S. Pastorekova, C. Hafner. Hypoxia influences the response to vemurafenib in V600E mutated melanoma cells. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
4. Gepp, B., N. Lengger, P. Briza, M. Hauser, U. Smole, F. Ferreira, C. Radauer, H. Breiteneder. Chimeras of Bet v 1 and its homologue Api g 1 show highly varying degrees of lysosomal stability. EAACI Winter School, Pichl, Austria, January 27-30, 2013.
5. Gepp, B., D. Ackerbauer, N. Lengger, W. Hemmer, C. Radauer, H. Breiteneder. Distinct antibody reactivity patterns to Bet v 1 and its bacterial homologues from Staphylococcus aureus and Pseudomonas aeruginosa. 9th YSA PhD Symposium at the Medical University of Vienna, Vienna, Austria, June, 19-20, 2013.
6. Gepp, B., D. Ackerbauer, N. Lengger, W. Hemmer, C. Radauer, H. Breiteneder. Distinct antibody reactivity patterns to Bet v 1 and its bacterial homologues from Staphylococcus aureus and Pseudomonas aeruginosa. 4th CePII Retreat, Vienna, Austria, September 17, 2013.
7. Gepp, B., J. Fuchs, C. Radauer, N. Lengger, M. Hauser, P. Briza, F. Ferreira, K. Liedl, H. Breiteneder. Chimeras of Api g 1 and Bet v 1 show highly differing proteolytic stabilities. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia, October 10-13, 2013.
8. Gepp, B., D. Ackerbauer, N. Lengger, W. Hemmer, C. Radauer, Z. Szepfalusi, H. Breiteneder. Distinct antibody reactivity patterns to Bet v 1 and its bacterial homologues from Staphylococcus aureus and Pseudomonas aeruginosa. SFB Work in Progress Meeting, Ottenstein, Austria, November 4-5, 2013.
9. Pfeifer, S., K. Ashjaei, K. Hoffmann-Sommergruber. Purification and characterization of hazelnut and sunflower seed allergens. SFB Work in Progress Meeting, Ottenstein, Austria, November 4-5, 2013
10. Guhsl, E., G. Hofstetter, C. Ebner, W. Hemmer, H. Breiteneder, C. Radauer. Random mutagenesis and phage display technology as a tool for identifying IgE epitopes of the birch pollen allergen Bet v 1. Oral presentation at the International Symposium on Molecular Allergology, Vienna, 5-7,2013 .
11. Guhsl, E., G. Hofstetter, N. Lengger, C. Ebner, W. Hemmer, H. Breiteneder, C. Radauer. Comparing allergen-specific IgE, IgG1, IgG4 and IgA levels with clinical data
Performance Report 2013 – Division 4
Medical Biotechnology
89
in birch pollen allergic patients with plant food allergies. 2nd Joint Meeting of Middle-European Societies for Immunology and Allergology, Opatjia, October 10-13, 2013 (Poster presentation)
12. Guhsl, E., G. Hofstetter, N. Lengger, C. Ebner, H. Breiteneder, C. Radauer. Comparing clinical data and allergen-specific immunoglobulin levels in the birch pollen plant food syndrome. YSA Symposium, Medical University of Vienna, June 19-20, 2013 (Poster presentation)
13. Guhsl, E., G. Hofstetter, C. Ebner, W. Hemmer, H. Breiteneder, C. Radauer. Identification of conformational IgE epitopes of the major birch pollen allergen Bet v 1 using directed in vitro evolution. EAACI Winter School, Pichl, Austria, January 27-30, 2013 (Poster presentation)
14. Bublin, M., M. Kostadinova, C. Radauer, C. Hafner, Z. Szépfalusi, E.M. Varga, H. Breiteneder. Engineering of hypoallergenic variants of the major peanut allergens for allergen specific immunotherapy. Poster presentation at the 2nd Meeting of Middle-European Societies for Immunology and Allergology 2013, 10-13 October, Opatija, Croatia.
15. Pfeifer, S., A. Spiller, M. Bublin, K. Ashjaei, C. Radauer, C. Hafner, K. Hoffmann-Sommergruber. Protein lipid interaction affects allergenic activity. Poster presentation at the 2nd Meeting of Middle-European Societies for Immunology and Allergology 2013, 10-13 October, Opatija, Croatia.
16. Varga, E.M., M. Bublin, E. Eber, H. Breiteneder. Anaphylaxis to topical Aloe vera in a birch pollen allergic child. Poster presentation at the International Symposium on Molecular Allergology 2013, 5-7 December, Vienna, Austria.
17. Ashjaei, K., N. Lengger, M. Bublin, I. Ellinger, K. Hoffmann-Sommergruber: Visualization of allergen uptake by dendritic cells. Is there a difference? YSA Meeting of the Medical University of Vienna, 2013; June 19-20
18. Peter, K., J. Schinnerl, S. Felsinger, L. Brecker, R. Bauer, H. Breiteneder, R. Xu, Y. Ma. A novel concept of detoxification. Complexation between aconitine and liquiritin in a Chinese herbal formula Sini Tang. 12th Meeting of Consortium for Globalization of Chinese Medicine in Graz, Austria, August 27-29, 2013
19. Peter, K., J. Liu, D. Shi, L. Zhang, G. Dong, D. Zhang, S. He, J. Jakowitsch, H. Breiteneder, Y. Ma. Improvement of Early Ventricular Remodeling after Myocardial Infarction by a Modified Traditional Chinese Medicine Sini Decoction. 2nd Annual Meeting of The Good Practice in Traditional Chinese Medicine Research Association. Graz, Austria, August 30, 2013
20. He, S., K. Peter, J. Schinnerl, S. Felsinger, L. Brecker, R. Bauer, H. Breiteneder, R. Xu, Y. Ma. A novel concept of detoxification: complexation between aconitine and liquiritin in the chinese herbal formula sini tang. CePII Retreat, Vienna, Austria. September 17th 2013
21. Peter, K., S. He, J. Schinnerl, S. Felsinger, L. Brecker, R. Bauer, H. Breiteneder, R. Xu, Y. Ma. Herbal interactions in the traditional Chinese medical formula Sini Tang - a novel concept of detoxification. China Academy of Chinese Medicine Sciences, Beijing, China. October 20th 2013
g) Teaching Scripts and Books, n = 47 Breiteneder Heimo: Med Biotech VO 881.004/791.363, SS 2013 1. The world of protein allergens, sources, structures and significance
Performance Report 2013 – Division 4
Medical Biotechnology
90
2. Recognition of microbes and damaged self (Innate Immunity 1) 3. Cell-associated pattern recognition receptors (Innate Immunity 2) 4. Soluble recognition and effector molecules (Innate Immunity 3) 5. Cells of the innate immune system (Innate Immunity 4) 6. IgE-mediated allergies 7. Allergens and the innate immune system Nahrungsmittelallergie VO 502.362 1. Nahrungsmittelallergene: Proteinfamilien und Kreuzreaktivitäten, Einleitung 2. Nahrungsmittelallergene: Proteinfamilien und Kreuzreaktivitäten, Teil A 3. Nahrungsmittelallergene: Proteinfamilien und Kreuzreaktivitäten, Teil B 4. Gentechnisch veränderte Nahrungsmittel und Allergie 5. Physikalisch-chemische Eigenschaften von Nahrungsmittelallergenen
Hoffmann-Sommergruber Karin: Lehrunterlagen f. d. Vorlesung NM-Allergien und Intoleranzen 514.074 gemeinsam mit Priv. Doz. Dr. Merima Bublin VO 2St. 1. Einführung Immunsystem, Grundlagen und Pathomechanismus der allerg. Reaktion 2. NM-Allergien: Symptome, Prävalenz 3. Allergene 4. Diagnostik von NM-Allergien und Fallbeispiele 5. NM-Intoxikationen, Immunmediierte NM-Allergien – Zöliakie, EOE 6. NM-Intoleranzen 7. NM-Allergien: Genetisch und epigenetische Aspekte; Umwelteinflüsse bei
Allergieentstehung, Hygienehypothese 8. Präventionsmaßnahmen: Allergenkennzeichnung, Leitlinien 9. NM-Allergien: Therapieansätze Lehrunterlagen f. d. Vorlesung NM-Allergien gemeinsam mit H. Breiteneder, C. Radauer: WS 2013/14: abgehalten: 1. Begriffsabklärung, Einführung: Immunsystem 2. Grundlagen, Pathomechanismus der allerg Reaktionen 3. Das mukosale Immunsystem: Anatomie, Physiologie, mukosale Toleranz 4. Nicht IgE-vermittelte Nahrungsmittelunverträglichkeiten (Laktoseintoleranz, Histamin-
intoleranz)
Lehrunterlagen: Masterlehrgang Med. Biotechnologie mit BOKU: VO Infectious Diseases and Vaccine development 1. Immunology 2. Molecular Biology 3. Bacterial Infections 4. Allergy Vaccines 5. Adjuvants 6. Alternative Vaccine development (plant-based) 7. Gene Therapy (Retrovirus) Ma Yan: 1. 890.048 13W 0,33 SSt SE Lebensqualität, Qualitätsmanagement, Management,
Wissenschaftliches Arbeiten 2. 891.050 W M5 0,17 SSt VB Tuina und Massage 3. 891.051 M5 2,00 SSt PR Klinische Observation oder Praktikum in Österreich 4. 891.052 M5 0,8SSt SE - Einführung in die Medizinische chinesische Fachsprache
und Kultur (5)
Performance Report 2013 – Division 4
Medical Biotechnology
91
5. 891.106 14S 0,5SSt SE M1 - Einführung in die medizinische chinesische Fachsprache
6. 891.108 14S 2,67SSt VO M1 - Grundlagen der Chinesischen Medizin 7. 891.109 14S 1,5SSt PR M1 - Clinical Observation in Austria 8. 891.110 14S 0,27SSt VO M1 - Philosophische Grundlagen und Denkweise von TCM 9. 891.009 14S 0,4SSt VO M1 - Abhandlung von exogenen fieberhaften Krankheiten 10. 891.104 13W 0,54SSt SE M2 - Forschung in der TCM 11. 891.105 13W 0,5SSt SE M2 - Einführung in die medizinische chinesische
Fachsprache und Kultur (2) 12. 891.107 13W 1,33SSt PR M2 - Klinische Observation in Österreich 13. 891.011 14S 2,67SSt PR M2 - Klinische Observation in Österreich 14. 891.017 14S 2,27SSt VO M2 - Chinesische Materia Medica 15. 891.018 14S 0,93SSt VO M2 - Einführung in die Rezeptkunde der TCM 16. 891.019 14S 0,27SSt VO M2 - Synopsis der Goldenen Kammer 17. 891.102 14S 0,54SSt SE M2 - Forschung in der TCM Radauer Christian: Unterlagen für die Vorlesung “Nahrungsmittelallergie” (502.362; 2013 W) 1. Genetische und umweltbedingte Ursachen allergischer Erkrankungen 2. IgE-vermittelte Nahrungsmittelallergien: Typen, Epidemiologie, Symptome, Diagnose,
Therapie, Prävention 3. Wichtige Allergenquellen und Kreuzreaktivitäten in der Nahrungsmittelallergie:
molekulare Ursachen, klinische Relevanz 4. Allergenität verarbeiteter Nahrungsmittel Unterlagen für die Vorlesung “Biological Therapeutics” (881.000; 2013 W) 1. Structure and function of immunoglobulins 2. Development and production of antibodies 3. Therapeutic full-length mAbs (1) 4. Therapeutic full-length mAbs (2) 5. Recombinant antibody derivatives (fragments, bivalent and bispecific antibodies) 6. Antibody conjugates h) Articles in Medical Journals: n = 0 i) Public Activity: n = 3 Hoffmann-Sommergruber Karin: Fernsehinterview: in „Konkret“, 4.3. 12. 2013 Hoffmann-Sommergruber Karin: Zeitungsartikel: Standard 4. 3. 2013: „Nahrungsmittelallergien sind eine Epidemie“ Yan Ma: Zeitungsartikel: „Wien Heute“. July 16th 2013: „Dani ließ sich die Chinesische Medizin und Kultur erklären“.
Performance Report 2013 – Division 4
Medical Biotechnology
92
1.4.2. Research Awards: n = 4 Pucciarelli Daniela: Travel award: sponsored by European Federation of Immunological Societies (EFIS), for the participation at the 2nd Meeting of Middle European Societies for Immunology and Allergology, 2013, Opatija, Croatia Ma Yan: Travel award from Österreichische Agentur für internationale Mobilität und Kooperation in Bildung, Wissenschaft und Forschung (ÖAD) for the meeting of TCM Research Cluster Austria and China Academy of Chinese Medicine Sciences. Oct 19-23 2013, Beijing, China Ma Yan: Travel award from Eurasia Pacific UNINET (EPU) for the 12th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), Aug 27-29. 2013, Graz, Austria Ma Yan: Best Poster Award: 2nd Annual Meeting of The Good Practice in Traditional Chinese Medicine Research Association, August 30. 2013, Graz, Austria
1.4.3. Invited lectures: n = 27 Breiteneder Heimo: 1. BOKU Meets MedUni; „Das Birkenpollenhauptallergen Bet v 1 und der Ursprung der
Birkenpollenallergie“. Vienna, Jan 08, 2013.
2. AAAAI 2013; 4306 Molecular Allergy: Emerging Concepts for the Practicing Allergist; „The World of Protein Allergens: Sources, Structures and Significance”. San Antonio, USA, February 25, 2013
3. Immunodays 2013; “Vom Urknall zum Allergen“. Vienna, April 25, 2013
4. Universidade Federal Da Bahia; “Protein evolution and the origins of allergens”. Salvador da Bahia, Brasil, August 22, 2013
5. Wiener Komponentenschule; Hotel Courtyard Marriott Wien Messe; „Allergene: Definition, Nomenklatur und Datenbanken“. Vienna, August 30 – 31, 2013
6. ImmunoDay 2013; “Vom Urknall zum Allergen“.Luzern, October 31, 2013
7. International Network University for Molecular Allergology & Immunology; “Nomenclature, Classification and Databases of Allergens”. Vienna, December 3-5, 2013
8. Menopausekongress 2013; „Die Bedeutung der Birkenpollenallergie für die Phytotherapie menopausaler Beschwerden“. Vienna, December 05-07, 2013
9. International Symposium on Molecular Allergology, ISMA 2013; “Allergy and the innate immune system”. December 5-7, 2013
Gepp Barbara: Epitope grafting: Eine neue Methode zur Charakterisierung des Bet v 1-spezifischen IgE Repertoires von Birkenpollenallergikern. Pirquet-Club organized by the Austrian Society of Allergology and Immunology (ÖGAI). Medical University of Vienna, Austria: December 2, 2013. Hoffmann-Sommergruber Karin:
What do we need to know about allergenic protein families? Oral Abstract Session; FAAM, Nice, February, 2013
1. Komponentengestütze Diagnostik der Nahrungsmittelallergien. Fortbildung f. Ärzte; AllergyCare, February 19, 2013.
Performance Report 2013 – Division 4
Medical Biotechnology
93
2. Authentication of Food Allergens. Inst. Seminar, (Impulsseminar, March 1, 2013)
3. Schwere Nahrungsmittelallergien – Wie berate ich meine Patienten? Pirquet Spezial: Schwer
behandelbare und lebensbedrohliche allergische Erkrankungen“ Vienna, May 25, 2013
4. EAACI: Business Meeting IG Food Allergy – Monday, June 24, 2013, Mailand, IT
5. Gentechnisch veränderte Lebensmittel: Vermeidbares Risiko oder Segen für den
Konsumenten? Akademie f. Ernährungsmedizin; Wien, January 26 and September 14, 2013;
6. “Schwere Nahrungsmittelallergien bei Kleinkindern und Jugendlichen: Was gibt es Neues zur
Prävention und Allergiediagnostik?” Fortbildung f. Kinderärzte der Ärztekammer Wien u Niederösterreich, Fachgruppe Kinder- u Jugendheilkunde, Fa. Milupa), September 15, 2013, Schloss Hernstein NÖ
7. Lebensmittelallergien – und Unverträglichkeiten, Toxikologie Kurs, Kaiserslautern, Oktober, 2013
8. Lebensmittelallergien – und Unverträglichkeiten; Fortbildung f. Lehrer, PH NÖ, Amstetten, December 4, 2013
9. Component resolved diagnosis: how allergen panels improve in vitro diagnosis, December 6, 2013
Ma Yan: 1. Health Communication: Einführung in die Traditionelle Chinesische Medizin (TCM) -
Akupunktur und Kräutermedizin. Vienna University, April 27, 2013
2. Was sind Chinesische Medizin und Chinesische Kultur? Kinderuni Wien 2013. Vienna General Hospital, Medical University of Vienna, July 15, 2013
3. Herbal interactions in the traditional Chinese medical formula Sini Tang - a novel concept of detoxification. Inst. Impulsseminars, October 4, 2013)
4. Herbal interactions in the traditional Chinese medical formula Sini Tang - a novel concept of detoxification. China Academy of Chinese Medicine Sciences, Beijing, China. October 20-23, 2013
5. Food Allergies: Molecular and Immunological Strategies for Prevention, Diagnosis and Therapy. Dongzhimen Hospital, Beijing University of Chinese Medicine. October 22,2013
Pucciarelli Daniela: Institute of Clinical Physiology, Consiglio Nazionale Ricerca, Pisa, Italy, April 16, 2013. Melanoma: Targeted Therapy and a New Detection System.
Radauer Christian: Allergene pflanzlicher und tierischer Nahrungsmittel, Kreuzreaktionen. Seminar Nahrungsmittelallergien, veranstaltet vom Verband der Diätologen Österreichs. September 19-21, 2013, Salzburg (Vortragsdatum: 19. 9. 2013)
Performance Report 2013 – Division 4
Medical Biotechnology
94
1.4.4. Congress organization
Division member Name:
National congress Name, date
Function Intern. Congress,
Name, date Function
Breiteneder Heimo
International Symposium on Molecular Allergology. December 5-7, 2013, Vienna
Member of Organizing Committee
Breiteneder Heimo
International Symposium on Molecular Allergology. December 5-7, 2013, Vienna
Chair of Session 4 of Oral Presentations
Hoffmann-Sommergruber Karin
Int. Congress on Food Allergy and Anaphylaxis FAAM, Feb. 7 – 9. 2013, Nice EAACI,
Chair of the Organizing Committee
Hoffmann-Sommergruber Karin
Int. Symposium on Molecular Allergology ISMA, Vienna, Dec. 5 – 7. 2013 EAACI
Chair of the Organizing Committee
Hoffmann-Sommergruber Karin
Food Allergy and Anaphylaxis Meeting FAAM Nice, Feb. 7 – 9. 2013 FR: Genetic, epigenetic and other early life influences on the development of food allergy
Chair of Plenary Session
Hoffmann-Sommergruber Karin
EAACI Annual Meeting Milan, 25.6. 2013
Chair of Session (Business Meeting Interest Group Food)
Hoffmann-Sommergruber Karin
Immunodays 25. 4. 2013: Vienna Vorsitz: Session Allergie
Chair of session
Ma Yan 12th Meeting of Consortium for Globalization of Chinese Medicine in Graz, Austria, August 27-29, 2013
Panelist
Radauer Christian
Retreat of the Center for Pathophysiology, Infectiology and Immunology. September 17, 2013, Vienna
Chair of poster workshop 1
Radauer Christian
International Symposium on Molecular Allergology. December 5-7, 2013, Vienna,
Chair of poster session 4
Performance Report 2013 – Division 4
Medical Biotechnology
95
1.4.5. Hosting speakers
division member Speaker´s name Affiliation Date
Ma Yan Prof. Dr. Chunyue Zhang
Beijing University of Chinese Medicine
March 19, 2013
Ma Yan Prof. Ma Shikun Peking Union Medical College & Chinese Academy of Medical
Sciences, Beijing
December 03, 2013
1.4.6. Mobility
Name Program University, Country
Time frame Division In Out
Zhang Chunyue Visiting scientist Humanity College, Beijing University of Chinese Medicine, China
March 19, 2013
4 X
Emanuel Weber EngCabra University of Bremen
Jan 28 – Feb 22, 2013
4 X
Valeria Fioravanti
EngCabra University of Bremen
Feb 18 – March 1, 2013
4 X
1.4.7. Activities in Advisory Boards
Name Society/Institute/Journal Function
Breiteneder Heimo AllFam database
Member of the scientific advisory board
Breiteneder Heimo
IUIS allergen nomenclature subcommitee
Head
Breiteneder Heimo
IUIS allergen database
Member
Breiteneder Heimo
SDAP database
Member of the scientific advisory board
Breiteneder Heimo
IGAV
Member
Bublin Merima AllFam Database of Allergen Families
Member of the scientific advisory board
Hoffmann-Sommergruber Karin
EAACI (European Academy of Allergy And Clinical Immunology)
ExCom Member (IG Representative)
Hoffmann-Sommergruber Karin Pirquet Clubs
Wissenschaftl. Sekretärin
Hoffmann-Sommergruber Karin ÖGAI (Österr. Gesellschaft f. Allergologie und Immunologie
Vorstandsmitglied (Schriftführerin)
Ma Yan Consortium for Globalisation of Chinese Medicine
Expert of Education Session
Performance Report 2013 – Division 4
Medical Biotechnology
96
Ma Yan World Federation of Chinese Medicine
Member
Ma Yan Eurasia-Pacific Uninet
Member
Ma Yan ASEAN-European Academic University Network
Member
Ma Yan Austrian Society for Medical Anthropology
Member
Ma Yan The World Federation of Chinese Medicine Societier
Member
Radauer Christian
IUIS Allergen Nomenclature Sub-Committee
Member
Radauer Christian
AllFam database Project leader and system administrator
1.4.8. Editorial Activities
Name Journal Function
Breiteneder Heimo International Archives of Allergy and Immunology
Member
Breiteneder Heimo Allergy Member
Hoffmann-Sommergruber Karin International Archives of Allergy and Immunology
Member
Ma Yan The international journal TANG Member
1.4.9. Review Activities
Name Grants/Thesis/Habilitation
Breiteneder Heimo Begutachtung eines Projektes des Life Science Calls.
Breiteneder Heimo Begutachtung Bachelor Thesis Johanna Wolfsberger: “Single chain variable fragments (scFvs) against SMU.440 from Streptococcus mutans gained from a human phage display library.”
Breiteneder Heimo Begutachtung Dissertation Frau Mag. Ulrike Pichler: “Development of novel tools for allergy diagnosis and therapy”
Hoffmann-Sommergruber Karin Begutachtung PhD Thesis Eva Vejvar,„Identification and molecular characterization of novel plant food and pollen allergens and their Impact on IgE cross reactivity”
Hoffmann-Sommergruber Karin Deutsche Forschungsgemeinschaft (Grant Review)
Hoffmann-Sommergruber Karin Medizinisch-Wissenschaftlicher Fonds des Bürgermeisters der Bundeshauptstadt Wien (Grant Review)
1.4.10. Filed and granted patents
Name Patent
Performance Report 2013 – Division 4
Medical Biotechnology
97
1.4.11. Grants Funding agency Title of project Principal investigator
Fonds zur Förderung der wissenschaftl. Forschung SFB F46 APF04603FW
Structure function relationship of food allergens.
Karin Hoffmann- Sommergruber
Fonds zur Förderung der wissenschaftl. Forschung, DK W 1248-B13
Doktoratskolleg Molecular, cellular and clinical Allergology, MCCA.
Karin Hoffmann- Sommergruber
Fonds zur Förderung der wissenschaftl. Forschung, DK W 1248-B13
Doktoratskolleg Molecular, cellular and clinical Allergology, MCCA.
Heimo Breiteneder
Fonds zur Förderung Wissenschaftlicher Forschung (FWF) Nr. P 22559-B11 APP22559FW
Identification of conformational immunoglobulin E epitopes of the major birch pollen allergen, Bet v 1: their cross-reactivities and clinical relevance in the birch pollen-plant food syndrome.
Christian Radauer
Fonds zur Förderung Wissenschaftlicher Forschung (FWF) Nr. # 08 in SFB F46 APF04608FW
Recombinant allergen derivatives and adjuvants to direct dendritic cells.
Heimo Breiteneder
European Community (FP7-PEOPLE-2010-ITN 264417-EngCaBra) FA648A0803
Biomedical engineering for cancer and brain disease diagnosis and therapy development.
Heimo Breiteneder
Roche Austria GmbH FA648A0804
The effect of mimotope vaccine induced antibodies specific for CSPG4 and BRAF inhibitor on melanoma cells.
Heimo Breiteneder
Bundesministerium für Gesundheit, Familie und Jugend (BMGFJ) / Bundesministerium für Wissenschaft und Forschung (BMWF) FA648A0901
TCM and Age Related Diseases. Yan Ma
Bundesministerium für Gesundheit, Familie und Jugend (BMGFJ) / Bundesministerium für Wissenschaft und Forschung (BMWF) FA648A0903
Prevention and early intervention of chronic diseases by TCM: Evaluation of immunomodulatory, anti-inflammatory and neuroprotective effects.
Yan Ma
Medizinische Universität Wien. LG15017010
Universitätslehrgang Grundlagen und Praxis der TCM.
Yan Ma
Eurasia-Pacific Uninet Joint Workshop on Evicence Based Traditional Chinese Medicine: Education and Training.
Yan Ma
Performance Report 2013 – Division 4
Medical Biotechnology
98
1.4.12. Career Developments a) Habilitations: n = 0 b) Habilitations in progress: n = 0 c) Professorships: n = 0 d) Qualification Agreement: n = 1
Ma Yan: QV- Succesfully finalised 31/12/2013, Assoc Prof.
1.4.13. Teaching Hoffmann-Sommergruber Karin: Ferialpraktikantin: Katharina Kienast (FH Studentin) 1 Monat (Juli 2013) a) Bachelor students: n = 0 b) Diploma, MDiploma and Master students: n = 11 Agreiter Christiane: Master Thesis: Purification of seed storage proteins from tree nuts and peanut and their range of cross-reactivity – implication for the nut allergic patient (November 2011 - 2. 5. 2013). Berneder Maria: Diploma thesis: From the allergic sensitization to the effector phase: Methods to follow allergen uptake by dendritic cells, allergen characterization and evaluation of allergen chips (January 2011- 8. 11. 2013). Duan Heying: Master Thesis: Comparison of Eastern and Western Medical Strategies for Prevention of Obesity Prevalence and its Related Diseases (August 2013 – in Progress). Feder Astrid: Master Thesis: Efficiency of Acupuncture as a Perioperative Pain Therapy after Total Knee Replacement - A prospective randomized controlled study (March 2013- in Progress). Huang Wenyu: Master Thesis: Garnoderma Lucidum for Prevention and Treatment of Pollen-induced Allergic Rhinitis (October 2013 – in Progress). Hofstetter Gerlinde: Diploma thesis: Development of an immunoassay for the detection of Bet v 1-related allergens in plant foods (November 2012 – in Progress).
Performance Report 2013 – Division 4
Medical Biotechnology
99
Kriehuber Michael: Diploma thesis: PatientInneninformation und TCM - Evaluation eines TCM-PatientInnen-Informationstextes in Hinsicht auf Relevanz, Verständlichkeit und Nutzen (January 2012 – 29.04.2013). Kühebacher Maria: Diploma thesis: “Component-resolved in vitro diagnosis of hazelnut allergy” (April 2011 - 16. July 2013). Mao Xinjun: Master Thesis: The clinical effect of sham acupuncture for analgesia of total knee replacement in the perioperative period (October 2013- in Progress). Spiller Alexandra: Diploma thesis: “Impact of food matrices on allergenic properties of food allergens” (April 2013-in Progress). Wang Xiaoxia: Master Thesis: Prävention und Therapie von koronaren Herzkrankheiten mit Traditionelle Chinesische Medizin (August 2013 – in Progress). c) PhD, MDSci, MD students: n = 9 Ackerbauer Daniela: PhD thesis. The interaction of inhalative and ingestive allergens and their lipid ligands with cells of the innate immune system (June 2012 – in progress). Ashjaei Kazem: PhD thesis. Influence of allergens on human dendritic and basophil cells (April 2010 – in progress). Dubiela Pawel: PhD thesis. Food Allergens: Their recombinant production and physicochemical characterization (1st Oct. 2013 – in progress). Gepp Barbara: PhD thesis. Identification of conformational immunoglobulin E epitopes of the major birch pollen allergen, Bet v 1: their cross-reactivities and clinical relevance in the birch pollen-plant food syndrome (Oct. 2010 – in progress). Guhsl Eva: PhD thesis. Identification of conformational Immunoglobulin E epitopes of the major birch pollen allergen Bet v 1: Their cross-reactivities and clinical relevance in the birch pollen-plant food syndrome (October 2010 – in progress). He Shan: PhD Thesis thesis: Anti-inflammatory effects of the Chinese herbal medicine Sini Tang and Ginseng (Panax quinquefolius) saponins (N094), (April 2012 – in progress). Palladino Chiara: PhD thesis: Biological and allergenic activities of peanut allergens (Oct. 2013 – in progress).
Performance Report 2013 – Division 4
Medical Biotechnology
100
Pucciarelli Daniela: PhD thesis. Melanoma cell detection and identification in biopsies by IR spectroscopy (July 2011 – in process). Peter Karoline: PhD thesis: “Analysis of the effective components of a Chinese herbal formula and its effects on post-infarction ventricular remodeling in rats”. Faculty of Life Sciences at the University of Vienna (Oct. 2012 - April 29 2013).
1.4.14. Exams a) Oral examinations n = 44 Hoffmann-Sommergruber Karin: n = 22 Ma Yan: n = 22 b) Diploma and Thesis-Examinations: n = 5 Hoffmann-Sommergruber Karin: Defensio Master Thesis: Christiane Agreiter: 2. 5. 2013. Diploma examination (medicine): Maria Kühebacher, 16. 7. 2013. Diploma examination (Microbiology and Genetics): Maria Berneder, 8. 11. 2013. Ma Yan: Diploma examination: Michael Kriehuber, 07.11.2013. PhD Thesis examination: Karoline Peter, 29.04.2013. c) Exam supervising: n = 1
Breiteneder Heimo: SIP-3 Saalleiter HS 3, 28. 6. 2013
Performance Report 2013 – Division 4
Medical Biotechnology
101
1.4.15. Lectures, Seminars, Lab courses SWST pro-rata LV Nr.
SS 2013 Breiteneder Heimo 2.00 0.67 881004 Immunobiology and Vascular Diseases
Breiteneder Heimo 2.00 2.00 514057 Dissertanten- und Diplomandenseminar: Anleitung zu Wissenschaftlichen Arbeiten
Breiteneder Heimo 1.00 1.00 514073 Neueste molekularbiologische Techniken - (Privatissimum)
Bublin Merima 2.00 1.00 514074 Nahrungsmittelallergien und -Intoleranzen
Hoffmann-Sommergruber Karin 2.00 1.00 514074 Nahrungsmittelallergien und -Intoleranzen
Hoffmann-Sommergruber Karin 2.00 2.00 648037 Journal Club und Progress Report
Ma Yan 0.33 890.048 Lebensqualität, Qualitätsmanagement, Management, Wissenschaftliches Arbeiten
Ma Yan 0.17 891.050 Tuina und Massage
Ma Yan 2.00 891.051 Klinische Observation oder Praktikum in Österreich
Ma Yan 0.80 891.052 Einführung in die Medizinische chinesische Fachsprache und Kultur (5)
Ma Yan 0.50 891.106 Einführung in die medizinische chinesische Fachsprache
Ma Yan 2.67 891.108 Grundlagen der Chinesischen Medizin
Ma Yan 1.50 891.109 Clinical Observation in Austria
Ma Yan 0.27 891.110 Philosophische Grundlagen und Denkweise von TCM
Ma Yan 0.40 891.009 Abhandlung von exogenen fieberhaften Krankheiten
Sum 16.31
WS 2013 Breiteneder Heimo 2.00 0.60 502362 Nahrungsmittelallergie
Breiteneder Heimo 2.00 2.00 514057 Dissertanten- und Diplomandenseminar
Breiteneder Heimo 1.00 1.00 514073 Anleitung zum wissenschaftlichen Arbeiten
Breiteneder Heimo 2.00 2.00 648007 Journal Club and Progress Report
Breiteneder Heimo 2.00 0.44 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Breiteneder Heimo 2.00 0.13 861007 MCCA Journal Club
Bublin Merima 2.20 0.53 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Hafner Christine 3.00 3.00 881002 Stem Cells and Tissue Engineering
Hoffmann-Sommergruber Karin 2.20 0.53 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Hoffmann-Sommergruber Karin 2.00 0.70 502362 Nahrungsmittelallergie
Hoffmann-Sommergruber Karin 2.00 2.00 648008 Journal Club und Progress Report
Hoffmann-Sommergruber Karin 2.00 2.00 648009 Anleitungen zu wiss. Arbeiten
Hoffmann-Sommergruber Karin 2.00 0.22 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Performance Report 2013 – Division 4
Medical Biotechnology
102
Hoffmann-Sommergruber Karin 2.00 0.13 861007 MCCA Journal Club
Hoffmann-Sommergruber Karin 2.00 1.00 881001 Infectious Diseases and Vaccines
Radauer Christian 2.20 0.53 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Radauer Christian 2.00 0.70 502362 Nahrungsmittelallergie
Radauer Christian 2.00 1.00 881000 Biological Therapeutics
Ma Yan 0.54 891.104 Forschung in der TCM
Ma Yan 0.50 891.105 Einführung in die medizinische chinesische Fachsprache und Kultur (2)
Ma Yan 1.33 891.107 Klinische Observation in Österreich
Ma Yan 2.67 891.011 Klinische Observation iin Österreich
Ma Yan 2.27 891.017 Chinesische Materia Medica
Ma Yan 0.93 891.018 Einführung in die Rezeptkunde der TCM
Ma Yan 0.27 891.019 Synopsis der Goldenen Kammer
Ma Yan 0.54 891.102 Forschung in der TCM
Sum 27.56
Total sum SS+WS 43.87
Performance Report 2013 – Division 6
Allergy Research
103
1.5. Division for Allergy Research Head: Barbara Bohle, Professor
1. Publications8 IF pro rata Number Top/Std/Subst
Bohle Barbara 32.386 4 4/0/0
Beatrice Jahn-Schmid 2.409 1
Division-Sum 32.386
Top point score 2 - among top 20 % of journal in field
Standard point score 1 - between 21-60 %, Substandard point score 0,2
2. Supervision of diploma and doctoral students
Bachelor st. Diploma st. Doctoral st.
Bohle Barbara 3 5
Beatrice Jahn-Schmid 2
Claudia Kitzmüller 3
Sum
3. Teaching SS* WS* total W+S oral Exams
Bohle Barbara 14.97 11.23 26.20 2 Beatrice Jahn-Schmid 2.00 6.02 8.02 Claudia Kitzmüller 0.53 2.80 3.33
Sum 17.50 20.05 37.55 2
8 For working groups IFs of all publications including joint publications with other working groups are presented. In contrast, the
given sum of the division represents the net value of IFs without overlaps due to joint publications.
Performance Report 2013 – Division 6
Allergy Research
104
1.5.1. Publications a) Peer-reviewed original articles: n= 4 Nr. Article IF Class pro-rata IF
1. Kollmann, D., M. Geroldinger-Simic, T. Kinaciyan, H. Huber, C. Ebner, J. Lidholm, and B. Bohle. Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy. J Allergy Clin Immunol. 132:1008. doi:10.1016/j.jaci.2013.05.030. 2013
12.047 Top 12.047
2. B. Subbarayal, D. Schiller, C. Möbs, N. W. de Jong, C. Ebner, N. Reider, D. Bartel, J. Lidholm, W. Pfützner,. R. Gerth van Wijk, S. Vieths, B. Bohle. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Allergy Volume 68, Issue 11, pages 1377–86, November 2013.DOI: 10.1111/all.12236
5.883
Top 5.883
3. Geroldinger-Simic, M., T. Kinaciyan, B. Nagl, U. Baumgartner-Durchschlag, H. Huber, C. Ebner, J. Lidholm, D. Bartel, S. Vieths, B. Jahn-Schmid, and B. Bohle. Oral exposure to Mal d 1 affects the immune response in birch pollen-allergic patients. J Allergy Clin Immunol., 131:94. doi: 10.1016/j.jaci.2012.06.039, 2013100. 2013
12.047 Top 12.047
4. Zhang, H., C.E. Nestor, S. Zhao, A. Lentini, B. Bohle, M. Benson, H. Wang. Profiling of human CD4+ T subsets identifies a Th2-specific non-coding RNA GATA3-AS1. J Allergy Clin Immunol. 132:1005. doi: 10.1016/j.jaci.2013.05.033, 2013
12.047 Top 2.409
sum 42.024 32.386 b) Invited Articles & Reviews with IF: n = 0
Nr. Article IF Class pro-rata IF
sum c) Invited Articles & Reviews without IF: n = 0 d) Book contributions: n = 0 e) Abstracts, printed in periodicals: n = 0
Performance Report 2013 – Division 6
Allergy Research
105
f) Abstracts, in congress proceedings or abstract books: n = 13
1. Claudia Kitzmüller, Nora Zulehner, Anargyros Roulias, Peter Briza, Fatima Ferreira und Barbara Bohle. Bet v 1 and homologous food allergens are very similar in their processing by antigen-presenting cells but differ in T cell reactivity. 11th EAACI Winter School, 27. – 30. Jänner, 2013, Pichl bei Schladming, Österreich. Vortrag
2. Claudia Kitzmüller, Nora Zulehner, Anargyros Roulias, Peter Briza, Fatima Ferreira und Barbara Bohle. Bet v 1 and homologous food allergens are similarly processed by antigen-presenting cells but differ in T cell reactivity. 15th International Congress of Immunology, 22. – 27. August, 2013, Mailand, Italien. Poster
3. Claudia Kitzmüller, Nora Zulehner, Anargyros Roulias, Peter Briza, Fatima Ferreira and Barbara Bohle. Bet v 1 and homologous food allergens are similarly processed by antigen-presenting cells but differ in T cell reactivity. 4th Retreat of the Center for Pathophysiology, Infectiology and Immunology, 17. September, 2013, Wien, Österreich. Poster
4. Claudia Kitzmüller, Nora Zulehner, Anargyros Roulias, Peter Briza, Fatima Ferreira and Barbara Bohle. Bet v 1 and homologous food allergens are similarly processed by antigen-presenting cells but differ in T cell reactivity. 2nd Meeting of Middle-European Societies for Immunology and Allergology, 10. -13. Oktober, 2013, Opatija, Kroatien. Poster
5. Claudia Kitzmüller, Nora Zulehner, Anargyros Roulias, Peter Briza, Fatima Ferreira and Barbara Bohle. Bet v 1 and homologous food allergens are similarly processed by antigen-presenting cells but differ in T cell reactivity. International Symposium on Molecular Allergology, ISMA 2013, 5. – 7. Dezember, 2013, Wien, Österreich. Vortrag
6. Stephan Deifl, Christian Zwicker, Eva Vejvar, Claudia Kitzmüller, Gabriele Gadermaier, Birgit Nagl, Susanne Vrtala, Gerhard Zlabinger, Peter Briza, Fatima Ferreira, and Barbara Bohle. Glutathione-S-transferase is a minor allergen in birch pollen because of restricted release from hydrated pollen grains. Center Retreat of the Center of Pathophysiology, Infectiology and Immunology, Vienna, Austria
7. Stephan Deifl, Christian Zwicker, Eva Vejvar, Claudia Kitzmüller, Gabriele Gadermaier, Birgit Nagl, Susanne Vrtala, Gerhard Zlabinger, Peter Briza, Fatima Ferreira, and Barbara Bohle. Glutathione-S-transferase is a minor allergen in birch pollen because of restricted release from hydrated pollen grains. 2nd Meeting of Middle-European Societies for Immunology and Allergology, Opatija, Croatia
8. Stephan Deifl, Christian Zwicker, Eva Vejvar, Claudia Kitzmüller, Gabriele Gadermaier, Birgit Nagl, Susanne Vrtala, Gerhard Zlabinger, Peter Briza, Fatima Ferreira, and Barbara Bohle. Glutathione-S-transferase is a minor allergen in birch pollen because of restricted release from hydrated pollen grains. International Symposium on Molevular Allergology, Vienna, Austria
9. Dries Van Hemelen, Vera Mahler, Ingrid Fae, Gottfried Fischer, Christof Ebner, Barbara Bohle and Beatrice Jahn-Schmid. Application of HLA class II peptide tetramer vs. allergen-induced proliferation for identification of allergen-specific CD4 T cells in the model of mugwort pollen allergy. EAACI Winter School, Pichl Austria, 27.-30.1.2013. Oral Presentation
10. Dries Van Hemelen, Vera Mahler, Ingrid Fae, Gottfried Fischer, Christof Ebner, Barbara Bohle, Beatrice Jahn-Schmid. Application of HLA class II peptide tetramers vs. allergen-induced proliferation for identification of allergen-specific CD4 T cells in the model of mugwort pollen allergy. 15th International Congress of Immunology, Milano 22.8.-27.8.2013. Oral Presentation
Performance Report 2013 – Division 6
Allergy Research
106
11. Immunological analysis of allergic reactions to the carbohydrate alpha-Gal D. Kollmann, C. Ebner, W. Emminger, A. Mangold, H.J. Ankersmit, B. Bohle International Congress of Immunology 2013, Milano, Italy
12. Recombinant Mal d 1 is a reliable diagnostic tool for birch pollen allergen-associated apple allergy. D. Kollmann, M. Geroldinger-Simic, T. Kinaciyan, H. Huber, C. Ebner, J. Lidholm, B. Bohle 2nd Meeting of Middle-European Societies for Immunology and Allergology 2013, Opatija, Croatia
13. Successful use of recombinant allergens for skin testingD. Kollmann, M. Geroldinger- Simic, T. Kinaciyan, H. Huber, B. Bohle
11th EAACI Immunology Winter School 2013, Schladming, Austria
g) Teaching Scripts and Books: n = 0 d) Articles in Medical Journals: n = 0
i) Public activity n = 6 Bohle Barbara: „Ein Frühling voller Pollen“, ORF Radiodoktor auf Ö1,
März 2013 Bohle Barbara: Zukunft der Allergietherapie - was uns die Forschung Neues bringt,
Veranstaltung der IGAV, Pollenwarndienst und MUW, März 2013 Bohle Barbara: „Zukunft der Allergietherapie - was uns die Forschung Neues bringt“,
Tag der Lunge, Veranstaltung der Lungenunion, Rathaus Wien, April 2013
Bohle Barbara: „Allergen-spezifische T Lymphozyten“, Fortbildungsveranstaltung d
Ges. d. Ärzte, News aus der med. Forschung, Billrothhaus, April 2013 Bohle Barbara: „Die Allergie-spezifische Immuntherapie“, Trend Artikel, Oktober 2013 Bohle Barbara: “The Department of Pathophysiology and Allergy Research today: A
platform for translational and disease-oriented research“, Veranstaltung: 140 years department of Pathophysiology, Ges. d. Ärzte, Billrothhaus, Dez. 2013
1.5.2. Research Awards: n = 4 1. Claudia Kitzmüller, Travel grant of the EAACI to attend the 11th EAACI Winter
School, January 27th – 30th, 2013, Pichl bei Schladming, Austria 2. Claudia Kitzmüller, Travel bursary, sponsored by EFIS, for the participation at the 2nd
Meeting of Middle European Societies for Immunology and Allergology in Opatija 2013 3. Dagmar Kollmann, Stipendium of the Medical University of Vienna for the thesis “The
role of alpha-Gal in type I allergy”
Performance Report 2013 – Division 6
Allergy Research
107
4. Dagmar Kollmann, Travel Award from the Austrian Society of Allergology and Immunology for the ICI 2013 in Milano
1.5.3. Invited lectures: n = 4 Bohle Barbara: „Der Apfel fällt nicht weit vom Birkenstamm: Birkenpollenassoziierte
Nahrungsmittelallergien“, BioTech, Fortbildung für PhD Studenten, BOKU, Jänner 2013
Bohle Barbara: "Novel insights into mechanisms of specific immunotherapy",
Symposiumsprecher, EAACI -WAO Congress, Mailand, Juni 2013 Bohle Barbara: "Th1 + Th2 cells", 15. Int. Congress of Immunology, ICI, Milano,
August 2013 Bohle Barbara: „Der Apfel fällt nicht weit vom Birkenstamm: Birkenpollenassoziierte
Nahrungsmittelallergien“, Ärztekongress Wien, Dezember 2013
1.5.4. Congress organization
Division member Name:
National congress Name, date
Function
Intern. Congress, Name, date
Function
Bohle Barbara EAACI Winterschool 27. - 30. 01. 2013
Local organiser
Bohle Barbara ECI 2015 President of the scientific
committee
1.5.5. Hosting speakers division member Speaker´s name Affiliation Date
1.5.6. Mobility
Name Program University, Land Time frame Division In Out
1.5.7. Activities in Advisory Boards
Name Society/Institute/Journal Function
Bohle Barbara Paul Ehrlich Institut, Langen, D Scientific advisor
Performance Report 2013 – Division 6
Allergy Research
108
1.5.8. Editorial Activities
Name Journal Function
Bohle Barbara International Archives of Allergy and Immunology
Editor in chief
Bohle Barbara Clinical and Experimental Allergy
Editorial Board Member
Bohle Barbara Immunotherapy Editorial Board Member
Beatrice Jahn-Schmid Frontiers in Immunology- Immunotherapies and Vaccines
Review Editor
1.5.9. Review Activities
Name Grants/Thesis/Habilitation
Bohle Barbara Grant review for the German Israeli Foundation (GIF)
Bohle Barbara Doctoral thesis committee: Belij-Rammersdorfer Sandra “Conjunctiva-associated lymphoid tissue as a route of immunization”
Bohle Barbara Grant review for the Fonds national de la recherché Luxembourg
1.5.10. Filed and granted patents
Name Patent
Performance Report 2013 – Division 6
Allergy Research
109
1.5.11. Grants Funding agency Title of project Principal investigator
Christian Doppler Gesellschaft und Biomay FA102A0009
Immunmodulation allergischer Erkrankungen.
Barbara Bohle
FWF der Wissenschaftsfonds, Doktoratskolleg Projektnummer: DK APW01212FW
Inflammation and Immunity.
Barbara Bohle
FWF der Wissenschaftsfonds, Projektnummer: APKLI0096FW
Therapy of birch pollen- related food allergy. Barbara Bohle
FWF der Wissenschaftsfonds, SFB Projektnummer: F 04610 FW
The Immunological basis of clinical tolerance to allergens.
Barbara Bohle
FWF der Wissenschaftsfonds, Projektnummer: DK W 1248-B13
Molecular, cellular and clinical Allergology.
Barbara Bohle
Österreichische National Bank Projektnummer: AP13860ONB
Einfluss der Hyposensibilisierung auf allergenspezifische Immunantwort bei Pollenallergikern.
Beatrice Jahn-Schmid
Performance Report 2013 – Division 6
Allergy Research
110
1.5.12. Career Developments a) Habilitations: n = 0 b) Habilitations in progress: n = 0 c) Professorships: n = 0
1.5.13. Teaching a) Bachelor students: n = 3
1. Martin Kastner: Bachelor student, 2012 – Februar 2013, Allergenexpression in Hefe 2. Wilhelm Otto: Bachelor student, Februar 2013 – Juli 2013, Allergenexpression in Hefe,
Aufreiningung rekombinanter Proteine 3. Sophie Walter: Bachelor student, August 2013 – in progress,
Basophilenaktivierungstests in Patienten vor und nach Immuntherapie 4. Thomas Autrata: Laborpraktikum, 01-07-2013 bis 31-07-2013 5. Michele Rauber: Gastforscherin, 22-10-2013 bis 15-09-2014 6. Byrte Voss: Gastforscherin, 13-11-13 bis 30-04-2014 e) Diploma, MDiploma and Master students: n = 0 d) PhD, MDSci, MD students: n = 7
1. Dagmar Kollmann: PhD Thesis: The role of alpha-Gal in allergic reactions to meet. 2. Stephan Deifl: Doctoral Thesis: Development of allergy vaccines using Toll-like
receptor ligands as immunomodulatory component 3. Brinda Subbarayal: Doctoral Thesis, Characterisation of allergen specific IgG4
antibodies 4. Nora Zulehner: PhD Thesis: Characterization of different phenotypes of allergen-
specific Th2 cells 5. Dominika Polak: PhD Thesis: The role of neutrophils in IgE-mediated allergy 6. Dries van Hemelen: part of his PhD thesis (Groningen NL): MHC class II /peptide
tetramers: application in allergy (2011-2013)
7. Nazanin Samadi: PhD Thesis: The role of CD8 T cells in allergy (2013- in progress)
Performance Report 2013 – Division 6
Allergy Research
111
1.5.14. Exams a) Oral examinations: n = 0 b) Diploma and Thesis-Examinations: n = 2
1. Barbara Bohle: Diploma thesis examination of Christian ZWICKER, Biochemical and
immunological characterization of recombinant Glutathione-S-transferase from birch pollen, 05-04-2013
2. Barbara Bohle: Diploma thesis examination of Julia KALSER, Untersuchung der
Immunantwort auf Allergen-Modulator-Fusionsproteine, 26-04-2013 c) Exam supervising: n = 0
Performance Report 2013 – Division 6
Allergy Research
112
1.5.15. Lectures, Seminars, Lab courses SWST pro-rata LV Nr. SS 2013
Bohle Barbara 1.00 1.00 809061 MS: Methoden der Allergologie
Bohle Barbara 4.00 2.00 648000 Anleitung zum wissenschaftlichen Arbeiten
Bohle Barbara 2.00 2.00 648035 Journal Club und Progress Report
Bohle Barbara 2.00 2.00 648036 Dissertantenseminar Ziele und Methoden der Allergologie
Bohle Barbara 2.00 0.20 860007 Special Course: Scientific Presentation
Bohle Barbara 2.00 2.00 860101 Special Course: Cellular allergology
Bohle Barbara 2.00 0.17 860201 IAI-Journal Club
Bohle Barbara 2.00 0.20 860202 Special Course: Basic techniques in molecular and cellular biology
Bohle Barbara 2.00 0.25 860220 Basisvorlesung Immunologie
Bohle Barbara 2.00 0.15 901929 IAI-Basic Seminars
Bohle Barbara 2.00 1.00 901941 Special Course: Allergology
Bohle Barbara 2.00 2.00 902211 Dissertantenseminar: Ziele und Methoden der Allergologie
Bohle Barbara 2.00 2.00 902696 Journal Club and Progress Report
Jahn-Schmid Beatrice 4.00 2.00 648000 Anleitung zum wissenschaftlichen Arbeiten
Kitzmüller Claudia 1.00 0.53 809061 MS: Methoden der Allergologie
Sum 17.50
WS 2013/14
Bohle Barbara 2.00 1.00 648000 Journal Club und Progress Report
Bohle Barbara 2.00 1.00 648006 Dissertantenseminar Ziele und Methoder der Allergologie
Bohle Barbara 4.00 2.00 648100 Anleitung zum wissenschaftlichen Arbeiten
Bohle Barbara 2.00 0.18 860008 Special Course: Scientific Presentation
Bohle Barbara 2.00 0.13 901929 IAI-Basic Seminars
Bohle Barbara 2.00 2.00 901933 Special Course: Cellular allergology
Bohle Barbara 2.00 2.00 902211 Dissertantenseminar: Ziele und Methoden der Allergologie
Bohle Barbara 2.00 0.17 902241 IAI-Journal Club
Bohle Barbara 2.00 2.00 902564 Journal Club und Progress Report
Bohle Barbara 2.00 0.18 902920 Special Course: Basic techniques in molecular and cellular biology
Bohle Barbara 2.00 0.22 861006 MCCA Lecture, Thesis Seminar and Basic Course Series on Allergens
Bohle Barbara 2.00 0.13 861007 MCCA Journal Club
Performance Report 2013 – Division 6
Allergy Research
113
Bohle Barbara 2.00 0.22 861008 Lecture, Seminar and Course Series on Allergic Priming and Effector Phase
Jahn-Schmid Beatrice 2.20 0.67 803003 BL 8 - Krankheit, Krankheitsursachen und Krankheitsbilder
Jahn-Schmid Beatrice 2.00 1.00 648000 Journal Club und Progress Report
Jahn-Schmid Beatrice 2.00 1.00 648006 Dissertantenseminar Ziele und Methoder der Allergologie
Jahn-Schmid Beatrice 4.00 2.00 648100 Anleitung zum wissenschaftlichen Arbeiten
Jahn-Schmid Beatrice 1.00 1.00 902542 Grundlagen der Allergologie
Jahn-Schmid Beatrice 2.00 0.13 861007 MCCA Journal Club
Jahn-Schmid Beatrice 2.00 0.22 861008 Lecture, Seminar and Course Series on Allergic Priming and Effector Phase
Kitzmüller Claudia 2.00 2.00 803009 Problemorientiertes Lernen - 3. Semester
Kitzmüller Claudia 1.13 0.80 801001 BL 1 - Gesunde und kranke Menschen
Sum 20.05
Total sum SS+WS 37.55
Performance Report 2013
Rooms
114
Performance Report 2013
Social Events
115
50-jähriges „Dienstalter“ von Barbara Bohle und Rudolf Valenta
Performance Report 2013
Social Events
116
Performance Report 2013
Social Events
117
Performance Report 2013
Social Events
118
Performance Report 2013
Social Events
119
Performance Report 2013
Social Events
120
Weihnachtsfeier des IPA 2013 im Jugendstilhörsaal und danach im SOHO
Performance Report 2013
Social Events
121
Performance Report 2013
Social Events
122
Performance Report 2013
Social Events
123
Performance Report 2013
Social Events
124